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Abstract 
Critical metabolic steps of the central carbon metabolism pathways have been of 
primary focus for the discovery of novel drug targets against Leishmaniasis, a 
neglected tropical disease caused by Leishmania. It is known that this particular 
protozoan parasite also relies on exogenous amino acids; however, comparative 
studies between exogenous amino acids utilisation and their essentiality for 
parasite growth and metabolism were often less emphasised. 
  
In this thesis, a novel approach was used to apply metabolomics techniques in a 
newly developed amino acids rich chemically defined medium for in vitro culture 
of Leishmania promastigotes. The chemically defined medium allowed for 
controlled customisable environment for deeper understanding of amino acids 
metabolism and parasite growth. A previously reported semi-defined growth 
medium (REIX (Steiger and Black, 1980)) was selected as a starting point. 
Undefined components of REIX were omitted and the composition of the resulting 
defined medium was varied through the addition, individually or in groups of 
amino acids and trace components (including magnesium, calcium, zinc, iron salts, 
biopterin, folate, riboflavin and lipoic acid). Growth assays were performed to 
identify a medium composition, referred to as Nayak medium, that supported 
robust growth over serial passages, at a similar rate to a conventional, serum 
supplemented rich growth medium (HOMEM (Berens et al., 1976)).  
 
Subsequently, the importance of individual amino acids was studied by systematic 
analysis in media containing equimolar quantities of each proteogenic amino acid, 
bar one (termed “amino acid knock out media”). Growth rate, concentration 
dependent growth, cell body length, total cell protein and acetate secretion were 
all recorded. Based on these results, it was found that exogenous supply of L-
Tryptophan, L-Phenylalanine, L-Arginine, L-Lysine, L-Leucine and L-Valine as most 
critical for viability of promastigotes. Hence, it was of interest to further 
investigate the intracellular composition of the other 14 amino acids and their 
anabolic and catabolic pathways within L. mexicana promastigotes. 
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Comparative investigation of intracellular amino acid metabolism was conducted 
using a metabolomic finger-printing technique in log phase L. mexicana 
promastigotes cultured in defined medium. Previous studies on amino acid 
pathways were mostly based on genome annotation or reductionist experimental 
approaches, however, network mapping of metabolomics data as shown in Chapter 
5 allowed to understand new insights about compensatory amino acid metabolic 
pathways, not predicted before. The 45 known components of the defined medium 
allowed for easier distinction from ~400 metabolites of the intracellular samples. 
The free amino acids pool showed increased abundance of L-Alanine, L-Glycine, 
L-Proline, L-Histidine, L-Asparagine, L-Threonine and L-Tyrosine in the 
intracellular metabolome which partly explains the dispensability of these amino 
acids in culture media as observed in single amino acid knock out experiments. 
Approximately 64 metabolites, putatively identified as related to amino acid 
metabolism were analysed by pathway mapping. This showed a unique utilisation 
pattern amongst all amino acids following a two-step transamination and a 
decarboxylation with significant NADH production. The downstream intermediates 
were secreted into the environment, rather than elaborate degradation pathways 
as followed within the mammalian systems. 
Validation of the observed secretion pattern of amino acid degradation was 
conducted using metabolic foot-printing technique at six different time points, 
which provided data on relative quantification of metabolite uptake and secretion 
from the culture media at different growth stages. About ~200 metabolites were 
putatively identified from across the replicates in the dataset collected over a 
growth period of 9 days in both the positive and negative ionisation mode and only 
~70 metabolites could be identified with authentic standards for individual 
mass/charge ratio and retention time comparison. Depletion profiling of the 
culture media showed that L-Tryptophan, L-Aspartate, L-Glutamate, L-Arginine, 
L-Methionine and L-serine were continuously utilised with more than 50% 
consumed over the 9-day growth period. Amino acids such as L-Leucine, L-
Threonine, L-Valine, L-Phenylalanine, L-Tyrosine and L-Lysine were partially 
utilised, while L-Glycine, L-Glutamine, L-Asparagine, L-Proline and L-Alanine were 
continuously secreted during the growth period under conditions tested. Overall, 
~25 % of the total metabolites were found depleted from the medium, ~15% not 
changed significantly, 20% un-identified metabolites and interestingly, about ~40% 
of metabolites were significantly enriched in the medium.  
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Systematic analysis of the 40% secreted small molecules secreted in the culture 
media constituted the exometabolome. The proportion of keto acids exceeded the 
other constituents of the exometabolome, confirming the partial degradation and 
overflow metabolism. Hence, the possibility that keto acids could also contribute 
to virulence was speculated. Early results from various biochemical analysis 
allowed new insights about amino acid derived enol lactones, especially the 
aromatic pyruvates to support the establishment of parasitism, with macrophage 
cells as in vitro experimental model. However, targeted molecular biology studies 
are required to further understand the role of exometabolome in parasitism; 
especially by inhibition of the Leishmania enzymes L-Tryptophan transaminase or 
phenyl pyruvate dehydrogenase as they are non-homologous to mammalian 
systems. 
 
In summary, this study has shown simple, customisable platform for in vitro 
culture of Leishmania promastigotes in defined medium, intracellular and 
exometabolome of Leishmania adaptable for various studies. L-Tryptophan and L-
Phenylalanine were found as the most critical exogenous amino acids for parasite 
viability and their analogues inhibited parasite growth. Hence, warrants further 
studies for their effectiveness as drugs in the field. Also, Leishmania 
exometabolome could serve as diagnostic signature for species identification, 
taxonomical comparisons, virulence patterns, physiological comparisons within 
varied nutrient systems.  
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Chapter 1 Introduction  
             
1.1 Leishmaniasis 
 
Leishmaniasis is an infectious disease affecting some of the poorest parts of the 
world. Leishmaniasis is caused by parasitic protozoa of the genus Leishmania. It 
has been recorded that there are more than 20 species of Leishmania pathogenic 
to human causing a wide range of clinical diseases (Ross et al;1903, Lainson et al; 
1987, Shaw et al; 1994). According to the World Health Report, leishmaniasis is 
classified under the neglected tropical diseases since 1.3 million people develop 
the symptomatic disease each year resulting in 20,000 to 30,000 deaths annually 
affecting poorest people in Asia, Africa and Latin America.  
Leishmaniasis is transmitted to the mammalian host by the bite of insect vectors 
from particular sandfly species. Killickkendrick et al. emphasise that these 
particular species of sand-flies, belonging to the subfamily-Phlebotominae are 
found in places with high temperature and lead to rapid disease transmission 
(Killickkendrick et al; 1990). However, there have been evidences of cases 
reported in non-endemic areas favouring the spread of disease carrying insect 
vectors mainly owing to the factors such as disorganised waste management, 
heavily populated areas of people with signs of malnutrition, weaker immunity 
and migration (Vecsei et al., 2001).  
The endemicity of leishmaniasis as shown in Figure 1.1. Parasitic diseases in 
different hosts exhibit several debilitating clinical symptoms with different forms 
of leishmaniasis (Shaw et al, 1994) in human hosts described as follows: 
• In cutaneous leishmaniasis, skin ulcers usually form on exposed areas, such 
as the face, arms and legs. Most cases heal within a few months although 
certain scars could remain on the skin. 
2 
 
• Diffuse cutaneous leishmaniasis produces disseminated and chronic skin 
lesions resembling those of lepromatous leprosy and poses more difficulty 
for complete treatment. 
• In mucocutaneous forms, the lesions can partially or totally destroy the 
mucous membranes of the nose, mouth and throat cavities and surrounding 
tissues. 
• Visceral leishmaniasis, also known as kala azar, is characterised by high 
fever, substantial weight loss, swelling of the spleen and liver, and 
anaemia. The disease has been reported to have high fatality rate (Croft 
and Coombs, 2003). 
 
Figure 1.1 Endemicity of leishmaniasis  
Data according to WHO report 2015. Those highlighted in red shows areas reported 
with positive cases of leishmaniasis adopted from http: 
//apps.who.int/neglected_diseases/ntddata/leishmaniasis/leishmaniasis.html 
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1.2 Life cycle of Leishmania  
 
Leishmania, a protozoan parasite, require female sand-fly as insect vector during 
the promastigotes stage and mammalian hosts during the amastigotes stage in one 
complete life cycle as shown in Figure 1.2. 
 
Broadly, parasitism has been defined to exhibit three basic properties such as 
infectiousness, establishment and transmission (Zelmer, 1998) between host 
systems. The first step involves the short term process of tolerance during an 
instantaneous exposure to a new environment described as infectiousness.  The 
new environment could be other living organisms of multiple species as known for 
the Leishmania parasite. The second crucial step in parasitism is establishment 
within the host system. Zelmer et al explain that successful establishment of the 
parasite is its ability to tolerate or to evade the host immune system.   The third 
step of transmission mainly involves virulent factors to malfunction host cells or 
host manipulation to facilitate rapid transference to other new host systems as a 
result of other various virulence mechanisms.  
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Figure 1.2 Life cycle of Leishmania parasites between the host systems. 
Adapted from https://www.cdc.gov/parasites/leishmaniasis/biology.html 
available freely under public domain. Numbered stages with description as 
follows: 1. Promastigotes injected within the host during insect bite  
2. Promastigotes engulfed by macrophages or mononuclear cells.  
3. Stage of promastigotes transformed to amastigotes within the macrophages.  
4. Amastigotes multiply within cells and infect other neighbouring cells.  
5. Subsequent sand-fly bites result in ingestion of infected cells with amastigotes.  
6, 7, and 8. Within the sand-fly, the amastigotes transform into promastigotes 
and continue as stage 1 of the life cycle. 
 
       
Promastigotes undergo a dynamic transformation from procyclics reported to 
undertake in 24-48 hours then the nectomonands in 48-72 hours, leptomonads in 
4-7 days and  metacyclics in 5-7 days which infect the host cells and 
haptomonads in 7-9 days forms the lining of the salivary duct (Dostalova and 
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Volf, 2012). The dynamic transformation from procyclics to haptomonad forms 
the lining of the salivary duct of the sand-fly adapted and modified from 
(Dostalova and Volf, 2012) is as shown in  
Figure 1.3 are associated with morphological changes from shorter and stout cell 
body to metacyclics with longer flagella and longer, slender cell body. These 
extracellular flagellated promastigotes at metacylic stages are transmitted into 
the mammalian hosts during infection. 
 
 
 
Figure 1.3 Promastigotes development within the sand-fly 
Picture modified from (Dostalova and Volf, 2012) to describe the transformation 
of promastigotes in the sand-fly digestive tract. Special emphasis has been laid on 
nutrient utilisation required during promastigotes development dependent on the 
blood meal (red) or sugar meal (green) of the sandfly insect feed. 
The development of promastigotes within the sand-fly highly depends upon the 
nutrients from the blood meal and plant sap meals fed by the insect alternatively. 
It has been reported that the sugar gradient in the alimentary tract of the sand-
fly facilitates the differentiation of procyclics leading up to metacyclics that 
a. amastigotes  b. procyclics c. nectomonands,  
d. leptomonads  e. metacyclics  f. haptomonads 
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accumulate at the pharynx of the sand-fly. The sand-fly regurgitates the parasites 
to the mammalian host during its blood meal (Murray et al., 2005). The neutrophils 
are the first immune cells to engulf the parasites and then undergo cell lysis. The 
lysed neutrophils along with the parasites are phagocytosed by the macrophages. 
The macrophages become the major host cells for Leishmania. The parasites 
within self-sustaining membrane-bounded parasitophorous vacuoles at high 
temperature (~37oC) and acidic pH promotes the development of non-dividing, 
metacyclic promastigotes to amastigotes (Biegel et al., 1983, Bates and Tetley, 
1993). Electron micrographs of macrophages have shown a fusion of secondary 
lysosomes with vacuoles containing L. mexicana amasitogotes after internalisation 
within the macrophages to form the phagolysosome (Alexander and Vickerman, 
1975).  
The phagolysosome is a highly acidic, hydrolytic compartment with many 
characteristics of a late endosomal compartment, which is responsible for the 
final stage of the phagocytosis process in an uninfected macrophage. Within the 
phagolysosome, the promastigotes differentiate into amastigotes before 
proliferation. The differentiation process is associated with pre-adaptive 
metabolic changes that enable the Leishmania amastigotes to thrive in an acidic 
condition suitable to the new host environment (Mcconville and Naderer, 2011). 
 
Wenynon et al in 1926 described the intracellular form of amastigotes of L. 
donovani as round-ovoid with a rod like kinetoplast and a nucleus within a 
homogenous mass of cytoplasm unlike the promastigotes with an elongated 
anterior flagellum. Chang et al describe the ultrastructure of Leishmania by thin 
sectioning of the two different life forms for the comparison of promastigotes and 
amastigotes (Chang et al 1955).The structural comparison described for 
amastigotes in the parasitophorous vacuole within macrophages were reported as 
2-4 microns however, the promastigotes in the insect midgut reach up to 14-20 
microns in length and 1.5-3.5 microns in breadth. Thus, the amastigotes undergo 
series of developmental changes for transformation into infective promastigotes 
in the midgut of the sand-fly. 
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These morphological and metabolic transformations of the parasite within the host 
system largely depends upon nutrient utilisation capabilities of Leishmania. The 
factors for nutrient sequestration remains critical on the metabolic ability of the 
parasite to divert host cell resources for their own needs (Glaser and Mukkada, 
1992). Though the Leishmania genome encodes for a diverse enzymatic profile, 
the dynamics of nutrients salvage remains largely unknown. The competition for 
substrate molecules between the host and parasitic transporters, the metabolic 
capability of the parasite to adapt to diverse host environments at different 
temperature, pH and enzymatic repertoire (Darling et al., 1989) of the parasite 
are the key factors that determines the viability of the parasites within the host 
system (Mcconville and Naderer, 2011). Thus, in this study efforts have been made 
in this direction for deeper understanding about the nutrients required for the 
viability, growth and development of Leishmania. 
1.3 Taxonomy 
 
The taxonomy of Leishmania as described in Table 1-1belong to domain 
Eukaryota, kingdom Protista and phylum euglenzoa. Importantly, Leishmania 
belongs to the order Kinetoplastida and to the sub order Trypanosomatina. 
Vickerman et al, 1994 described the evolutionary expansion of Trypanosomatina 
as exclusively parasitic with species containing one flagellum, which notably 
includes Trypanosoma and Leishmania species (Vickerman, 1994). The 
evolutionary hierarchy of Leishmania is as shown in Table 1-1. The other sub 
order of Kinetoplastida is Bodonina which includes ecto-commensal and free 
living species which are biflagellate. Lainson et al, 1987 classified the 53 species 
recognised in this genus based on their location within the insect gut (Lainson et 
al., 1987). However, the classification of the genus to sub genus has been of 
considerable debate, some studies define three subgenera such as Leishmania, 
Sauroleishmania, and Viannia and the position of the two other genera called 
the Euleishmania and Paraleishmania has been placed under the division of 
Leishmania, yet a need for a sub genera to be differentiated by their unique 
metabolic traits (Franco and Grimaldi, 1999, Momen and Cupolillo, 2000, 
Akhoundi et al., 2016). 
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Table 1-1 Taxonomical classification of Leishmania 
 
1.4 Diagnosis  
Current methods for the diagnosis of Leishmaniasis are based on antigen detection 
and serological techniques from patient samples. The advantages and 
disadvantages of few of the techniques have been briefly described here. 
Microscopy serves as a primary technique for identification of Leishmania in many 
clinical laboratories. Giemsa stained smears of lesions, biopsies or scrapings allows 
direct identification of amastigotes and in combination of culture methods 
improves to 85% sensitivity (Ramirez et al, 2000, Blum et al, 2004). However, 
microscopy and culture are time consuming, requires skilled personnel and clinical 
laboratory instruments; not easily applicable in endemic field areas. 
 
Immunochromatograhic techniques based on target interaction between parasite 
antigens and monoclonal antibodies have been designed in various kit formats as 
dipsticks or cassette based. Rapid diagnostic tests (RDTs) detect different antigens 
such as L-Histidine rich protein 2 (HRP2), parasite lactate dehydrogenase (pLDH) 
and aldolase (Piper et al., 1999). Immunofluorescent antibody test (IFA), another 
antigen-based test has been reported with sensitivity between 87-100% and 
specificity in range of 77-100% for positive cases in early infection stages. 
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However, IFA test can only be conducted within clinical laboratory standards and 
not directly applied on field (Iqbal et al, 2002). 
 
Different diagnostic procedures are required depending upon the level of 
infection. For example, asymptomatic Leishmania carriers who carry low levels of 
circulating parasites within their system with not enough accumulation of antigen 
for reliable detection; PCR based methods are adopted (Salotra et al., 2001). In 
the case of leishmaniasis in the dog, anti-leishmania antibodies were reported as 
present in urine with urinary protein/creatinine (U P/C) ratios higher than one. 
ELISA test to detect protein A and IgG2 were found to be positive in the urine of 
Leishmania infected dogs (Solano-Gallego et al., 2001).  
 
KAtex, a latex agglutination test is used to detect Leishmania antigens in urine 
(Attar et al., 2001). The efficacy of KAtex has been monitored in different disease 
prone areas such as Spain (Sarkari et al., 2002), India (Sundar et al., 2005) and 
the middle-east. Latex agglutination tests hold great promise because of good 
specificity (80-100%) and also useful for detection even in immunocompromised 
patients (Vilaplana et al, 2004). However, the moderate sensitivity range of 47% 
to 95% poses questionable results to separate the weak positive cases from 
negative results (Diro et al, 2007; Malaei et al, 2006) and requires longer sample 
preparation procedure such as boiling urine to eliminate false positive results 
(Attar et al, 2001).  
 
Thus, the different species of Leishmania and its geographical distribution brings 
an enormity of variations amongst the level of parasitic infections in host systems 
(Badaró et al, 1983; Boelaert et al, 2004). These different levels of parasite 
infections pose a challenging bottleneck for faster and reliable detection of 
different types of parasite antigens or serological markers. Thus, there is an 
increasing demand for better diagnostic techniques for early intervention.  
 
Discovery of novel antigens is imperative to accelerate diagnosis especially for 
different species of Leishmania. Isolation of antigens depends upon a stable 
platform of in vitro culture of Leishmania; addressed in this thesis by development 
of a defined medium as described in Chapter 3. 
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1.5 Current treatment 
 
Leishmaniasis affected endemic countries have traditionally used pentavalent 
antimonials, pentostam or glucantime, chemically sodium stibogluconate and N-
methylglucamine antimonate respectively. These drugs are known to be required 
for continuous consumption over a long period of time leading to adverse 
consequences administered parenterally for 10-30 days. The exact mode of action 
of these drugs are yet to be elucidated; there have been reports of toxic side 
effects in variable degrees depending upon the immune comprised state of the 
patient (Basselin et al., 2002). 
 
Another widely used drug in the treatment of leishmaniasis in dogs is allopurinol, 
riboside analogue which prevents protein production. Allopurinol serves as a 
substrate of hypoxathine guanine phosphoribosyl transferase enzyme located in 
parasite specific organelle, glycosomes (Pfaller and Marr, 1974). Clinical trails 
with human patients have not shown consistent success. Recent formulations such 
as amphotericin B and miltefosine with a novel mode of delivery using liposomal 
formulation (AmBisome) for oral consumption have been reported to have better 
efficacy for the treatment of visceral and cutaneous leishmaniasis (Rakotomanga 
et al., 2007). 
  
Current treatment also involves vaccination against leishmaniasis, however, the 
combination of antigens and right delivery system for the long lasting central 
memory of the immune system has been a challenging milestone. A short summary 
of different types of vaccines, advantages and disadvantages have been listed in 
Table 1-2 below (Gillespie et al., 2016, Handman, 2001): 
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Table 1-2 Vaccines used in treatment of Leishmaniasis 
Type of vaccines Organisms used Advantages Disadvantages 
First generation 
vaccines 
whole killed/ 
live attenuated 
Prophylaxis 
Asymptomatic 
immune memory 
Relapse of 
virulence and 
infection.  
Second 
generation 
vaccines 
Laboratory 
produced 
recombinant 
protein products 
of Leishmania 
specific antigens 
Safer alternatives 
to the first 
generation 
Ease of 
customisation  
Need for soluble 
stable emulsions 
and extensive 
clinical 
development.  
Third generation 
vaccines 
 
Naked DNA Less immunogenic 
Different mixture 
of conserved 
antigens 
The cost of 
development and 
clinical trials. 
 
Similar to other protozoan parasite with a dynamic life cycle involving multiple 
hosts, Leishmania with female sand-fly as vector affects multiple host systems 
such as humans, cattle and dogs (Kaye and Scott, 2011). Leishmaniasis being a 
vector borne has been difficult to control the spread of the disease(Kaye and 
Scott, 2011). The rise in global warming have caused widespread of sand-flies and 
measures of surveillance and controls are less emphasised than required (Dujardin 
et al., 2008). The increasing problem of vector control, emerging drug resistance 
and hospitalisation expenses amongst other factors demand the need for novel 
therapies for the treatment of diseases caused by the parasitic protozoa. Also, 
increased cost, poor accessibility to disease affected areas and emergence of drug 
resistance have necessitated the need for new and better drugs. 
 
Therefore, greater understanding of the metabolic cues required for the survival 
of the parasite within the host system could accelerate the discovery of novel 
targets for desperately needed anti-parasitic drugs (Tiuman et al., 2011, Monge-
Maillo and Lopez-Velez, 2013, Croft and Coombs, 2003, Ameen, 2010). 
Propagation of the Leishmania within the host depends upon the various 
environmental niche encountered and critically on the nutrient availability within 
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the host system. Mapping the metabolic requirements during the life cycle of the 
parasite would highlight parasitic specific metabolic pathways that could serve as 
potential drug targets. Hence, metabolomics of promastigotes cultured in in-
house developed defined medium at various time points was used in this study to 
deciphering the same. 
1.6 Metabolomics 
 
High throughput “omics” technologies help in analysing complicated biological 
systems by a holistic approach. These methods examine the interacting elements 
of the different biological entities in a global manner. Using omics technologies, 
a particular hypothesis of the experiment could be examined to derive a vast 
amount of data revealing new scientific insights that would have been previously 
inconspicuous. The most challenging aspect of high-throughput techniques is that 
each analytical platform is best chosen depending upon the research question; 
and subsequent integration of data from multiple platforms caters to more holistic 
view than a single technique alone (De Souza et al, 2006, Karimpour et al., 2016).  
 
Metabolomics has been defined as study of diverse nature of small molecules 
constituting the metabolic composition of a cell or biofluid; within a range of 
molecular weight of less than 1500Da (Oliver et al, 1998, Lindon et al; 2003). 
Metabolomics evaluates molecules that arise due to enzymatic processing within 
single cells and forms a subset of metabonomics (Raamsdonk et al; 2001). A broad 
range of information can be captured; for example, about the level of metabolites 
consumed by the system but also provides relative quantitative information about 
the metabolites produced by the organism (Cuperlovic-Culf et al., 2010). Both 
diagnosis and treatment of leishmaniasis can be vastly developed by applying high-
throughput techniques such as metabolomics (Vincent et al, 2012; Saunders et al; 
2011, Creek et al; 2014). 
   
Some of the strategies of metabolomics have been listed below as follows: 
• Targeted metabolomics involves a priori knowledge about particular 
metabolite(s) of interest with tailored extraction and optimisation 
protocols. This technique is mostly followed to obtain quantitative 
information about the metabolites of interest. For example, recent 
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advances in the diagnosis of inborn errors of metabolism have been shown 
to have employed targeted metabolomics to derive specific information 
about acylcarnitines (Scolamiero et al, 2015). Stable isotope labelling is 
based on targeted metabolomics which allows for heavy stable molecule 
incorporation for tracing metabolic pathways of interest and flux 
monitoring.  
• Untargeted metabolomics allows relative changes of metabolites between 
comparative samples to be gain new insights on the system of interest. A 
particular study with samples from patients with crohn’s disease compared 
to healthy individuals revealed differentiating metabolites in the synthesis 
of bile acids, arachidonic acid attributing the contribution of gut microbiota 
to the disease status of the host (Hisamatsu et al, 2012). 
• Metabolite profiling is based on untargeted metabolomics aimed to obtain 
maximum coverage of the metabolome of the system of interest. Often 
multiple analytical platforms with complementing extraction procedures 
are used to achieve the same. Human plasma metabolomics is a typical 
example which has been extensively studied combining different platforms 
due to the complexity of the mixture and importance of the wholesome 
information required for practical purposes (Noguchi et al, 2006, Capacci 
et al, 1984, Saiki et al, 2013, Cui et al, 2017).  
• Metabonomics refers to study of endogenous and exogenous metabolites of 
dynamic or static biological fluids with particular emphasis to extract 
molecular information (Lindon et al; 2003). Analytical platforms such as 
NMR and mass spectrometers have been used for the study of metabolites 
in biological fluids. NMR as an analytical platform provides more 
quantitative data; whilst mass spectrometer provides more broad 
comprehensive coverage of metabolites with minimal sample preparation 
steps. Particularly, LC-MS offers more advantages for broad coverage of 
metabolites without the need for volatilisation, derivatisation, particular 
feature selection which may be required for gas chromatography-mass 
spectrometry sample preparations (Nicolson et al; 1989). Bio-fluids such as 
urine and plasma were analysed by H-1 based NMR metabonomics and 
metabolites such as L-Arginine, succinate, 3-hydroxybutyrate, alpha-
ketobutyrate and L-Valine were indicated as biomarkers after validated 
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using pepsin activity and ROC analysis for chronic atrophic gastritis (Cui et 
al, 2017). 
• Metabolite finger-printing has been used mostly for intracellular samples, 
for example, studies to measure the effect of salinity on tomato fruit 
cultivation allowed classification of salt treated from control fruits. 
Metabolite finger-printing technique allowed to precisely map the 
identification of functional groups such as nitrile containing compounds and 
amino radicals in the spectra as an important response to salinity compared 
to normal conditions (Johnson et al, 2003).  
• Metabolite foot-printing involves the analysis of metabolites in the 
extracellular environment of the system of interest. Thus, metabolite foot-
printing acts as a dynamic reflection of the intracellular activity since 
biological systems function under the principles of homeostasis and any 
change due to external stimuli such as temperature, pH or genetic/drug 
perturbations can be monitored non-invasively (Behrends et al., 2009, Allen 
et al., 2003, Palmer et al., 2007).   
Metabolomics has been applied in the field of parasitic protozoa for drug 
discovery, biomarkers, novel metabolic pathways, etc. Earliest studies of 
metabolomics in T. brucei belonging to kinetoplastida dates back to Mackenzie et 
al, 1983, with the tracing of anaerobic glycolysis using [U-13C] glucose by NMR 
studies (Mackenzie et al., 1983). Similar studies of  [U-13C] glucose incorporation 
in Leishmania promastigotes (Rainey et al., 1991, Saunders et al., 2011) has 
provided many insights on glucose metabolism. Metabolomics has been useful 
technique to unravel drug mode of action, for example, the mechanistic action of 
the anti-parasitic drugs eflornithine through the polyamine pathway against 
trypanosomiasis was elucidated using a metabolomics approach (Vincent et al., 
2012), wherein the level of ornithine accumulated and downstream concentration 
of putrescine decreased in treated cells compared to untreated cells. The changes 
of the metabolites provides holistic phenotypic insights of the system as the 
metabolite levels reflect the dynamic changes of the underlying proteomic and 
genomic expression. 
 
With improvements in high end analytical platforms and advances in mass 
spectrometry; targeted metabolomics with heavy stable isotope incorporation into 
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the culture medium has been used for tracking metabolic pathways of interest and 
also for quantification of metabolites in Leishmania (Chokkathukalam et al., 2013, 
Saunders et al, 2014, Westrop et al, 2015). Using 13C NMR, labelled carbon tracing 
in H13CO3- and succinate, acetate, and L-Alanine as partially oxidised end products 
confirmed the existence of succinate fermentation pathway. Also, the Leishmania 
specific metabolic pathway for the conversion of acetyl-CoA to acetate via the 
mitochondrial acetate: succinyl-CoA transferase unique to Kinetoplastida was 
uncovered using metabonomics (Rainey et al., 1991). 
 
Data analysis plays a crucial role in the interpretation of results from 
metabolomics experiments (Tikunov et al., 2005). Apart from the univariate and 
multivariate analysis for clusters and patterns within the data, information from 
metabolomics experiments are visualised in the form of metabolic pathways. 
Discovery of novel metabolic routes or critical nodes within individual metabolic 
pathways unique to the system of interest is best suited as potential drug targets 
within pharmacological research (Vincent et al., 2012).  
 
The main goal of this study was to capture information about the amino acid 
requirements of Leishmania parasite required for the growth and development 
during the promastigotes stages. This would allow highlight those essential amino 
acid pathways that could be useful as potential drug targets. Amongst the 
different methods of metabolomics; untargeted metabolomics proved to be 
promising strategy for this study. This would allow prediction of metabolic 
pathways directly based on dynamic unbiased metabolomics data unlike inference 
obtained from gene pathway correlations. The important techniques employed in 
this study were metabolomic finger printing and foot printing techniques 
according to protocols described in Chapter 2.  
 
Metabolic finger printing was conducted with log phase cells grown in defined 
medium. This first step was carried out at this one particular time point to 
understand the dynamic intracellular composition in the most active growth phase 
at log stage. Thus, the captured snapshot of molecular information gave 
significant insights about the defined medium composition used for in vitro culture 
and also, allowed to differentiate metabolites derived from the parasite. This has 
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been further analysed using unbiased network mapping to gain new insights about 
the amino acid metabolic pathways as described in Chapter 5.  
 
The metabolic foot printing technique was conducted in time course manner to 
interpret the dynamic state of the medium at various stages of the parasite 
growth. Changes in metabolite levels allows detailed analysis of uptake of 
environmental constituents of defined medium in culture; which has been referred 
to as the depletion profile and also the secretion of metabolites by the cells 
referred to as the exometabolome described in chapter 5 and 6. This allowed the 
amino acids to be evaluated both for the relative rates of uptake/secretion and 
to integrate with the knowledge of amino acid essentiality as derived from the 
growth assays. Finally, this approach was used to classify amino acids based on 
utilisation of Leishmania and highlight those essential pathways that have greater 
potential as new drug targets over other less dispensable pathways as discussed 
in Chapter 5, 6 and 7. 
1.7 Development of in vitro culture medium for 
metabolomics 
Study of small molecules using metabolomics techniques generates a vast amount 
of data that could provide holistic information of the biological system of interest. 
Data analysis and interpretation within the biological context requires careful 
filtration of background noise and signals occurring at the base line of the 
experiment.  Previously, in vitro culture of Leishmania has been based in 
elaborate medium compositions with additional supplementation of undefined 
serum up to various concentrations explained in Chapter 1. Results from the 
metabolomics experiments provide snapshot of metabolism under conditions 
tested. It has been rightly described by Kell et al (Kell et al., 2005) that results 
for metabolomics rely on the composition of the in vitro medium used for culture 
of the organism. In this study, Leishmania metabolism had been reported using 
unbiased mapping of metabolic finger-printing and foot-printing of L. mexicana 
promastigotes in defined media not been reported before. Untargeted metabolic 
finger printing for tracing parasitic specific metabolic pathways was carried out 
to highlight as potential parasite specific pathways as drug targets as shown in 
Chapter 5. 
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Minimizing the metabolites in the defined medium allowed for a significant 
decrease in the background signals in high throughput LC-MS experiment. In turn, 
leads to pronounced changes in relative levels of metabolites during the growth 
of the parasite in the defined medium. This allowed deriving snapshots of 
metabolic capabilities of the parasite and aid in unbiased metabolic mapping as 
described in Chapter 5 and 6. It opens new venues for hierarchal visualisation of 
the metabolic maps and could potentially be used to integrate dynamic 
information about underlying genes and protein expression in a qualitative and 
quantitative manner within genome scale and kinetic models in future research 
(Zech et al., 2013).  
 
Metabolic foot-printing allowed to determine nutrient salvage pathways 
throughout the growth of L. mexicana promastigotes and elucidation of the 
changing exo-metabolome in time resolved manner reflecting the intracellular 
activities as shown in Chapter 6.  Efforts have been made isolate and characterise 
small molecules enriched in the spent media of the defined media by biochemical 
and functional analysis as shown in Chapter 6. 
1.8 Overview of Leishmania metabolism 
 
Nutrients salvage by the parasite depends upon many factors such as competition 
for available nutrients with the host system, regulated expression of transport 
proteins, and enzymatic repertoire of the parasite to metabolise the nutrients to 
high energy intermediates (Mcconville and Naderer, 2011). Nutrients can be 
broadly classified as macronutrients containing the carbohydrates, lipids and 
amino acids/proteins and micro nutrients including metal salts and vitamins. 
Nutrients together contribute to energy, the fundamental driving force of living 
organisms for viability, growth and proliferation. Energy is obtained from the 
efficient use of all of the available nutrients in the immediate environment. As a 
parasitic protozoon, Leishmania during the life cycle encounters the insect and 
vertebrate hosts as their immediate environment with pronounced differences in 
nutrient levels determined by host conditions, pH and temperature. However, the 
ability of the parasite to salvage nutrients from the host system is critical for the 
transmission and infection to a new host, disease manifestation and central 
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component of pathogenesis. In this study, efforts were made to study the nutrient 
salvage by L. mexicana promastigotes to highlight parasite specific metabolic 
routes as drug targets. 
 
Perturbation of permeases responsible for critical nutrients has been reported as 
drug targets (Landfear, 2011, Dean et al., 2014). Few of permeases involved in 
import of certain nutrients such as purines (Ortiz et al., 2010), hexoses (Naula et 
al., 2010, Burchmore et al., 2003), iron (Wilson et al., 2002), polyamines (Colotti 
and Ilari, 2011) and amino acids transporters of L-Arginine (Shaked-Mishan et al., 
2006), L-Lysine (Inbar et al., 2012), L-Proline/L-Alanine (Inbar et al., 2013) and L-
Glutamate (Paes et al., 2008) in Leishmania have been well studied. Genome 
sequencing have accelerated the identification and functional characterisation of 
these permeases. However, genome sequences alone have not been able to 
predict the functional diversification and changing permease activity to a broad 
range of substrates adaptive to the dynamic environment encountered during their 
life cycle in Leishmania parasitic protozoa (Dean et al, 2014).  
 
Here, using untargeted metabolomics in defined medium, unbiased insights about 
nutrient salvage of L. mexicana promastigotes throughout their growth have been 
reported. Both intracellular and extracellular metabolomics reported as changes 
from the naïve medium without cells as base line in Chapter 5 and 6. In this study, 
special emphasis has been placed on amino acids in relation to other nutrients 
metabolism in L. mexicana promastigotes.  
 
1.8.1 Amino Acids  
 
Amino acids make up the fundamental building blocks for proteins required for 
many different biological processes. Leishmania parasites have been reported to 
possess well adapted mechanisms to suit different nutrient environments 
conserved through evolution. The regulated expression of nutrient transporters 
and enzymes of metabolic pathways differs depending upon the growth stages of 
the parasites within the host system (Landfear, 2011). Disruption of the metabolic 
pathways will block the biosynthesis/catabolic process essential for parasite 
viability and transmission and lead to novel treatment therapies against diseases 
caused by parasitic protozoa (Dean et al, 2014). 
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Glucose is the primary source of energy for promastigote thriving within the sugar 
rich conditions of the midgut of the sandfly host; however, amino acids serve as 
their major carbon source in the scarcity of carbohydrates. This has been 
elucidated with previous results reported by our group (Burchmore et al., 2003, 
Akpunarlieva et al; 2017) in  glucose transporter knock out promastigotes show an 
increased amino acids uptake compared to wildtype.  
 
Amino acids are essential for the viability, growth and proliferation of Leishmania 
promastigotes (Hart and Coombs; 1982, Opperdoes and Coombs; 2007, Simon et 
al., 1983). Perturbation of specific amino acid pathway could lead to loss of 
viability and parasite development within the host system. However, 
identification of specific amino acid pathway as a drug target must fulfil certain 
considerations such as essential for viability, unique target metabolic steps not 
homologous to the host system and specificity of target metabolic steps of interest 
(Vincent et al, 2012; Creek et al, 2014). Previous classifications of amino acid 
essentiality was based on the studies in L. tertentolae which is lizard parasite 
(Krassner and Flory, 1971) and L. donovani parasite which causes visceral 
leishmaniasis (Steiger and Steiger, 1977). In this study, systematic investigation of 
amino acids important for the viability of the parasites has been conducted by 
growth analysis in L. mexicana known to cause cutaneous leishmaniasis by defined 
medium development as reported in Chapter 4. Furthermore, individual 
metabolites of amino acid pathways have been mapped (Chapter 5) and data on 
relative changes of metabolites during the different growth stages have been 
elucidated (Chapter 6).   
 
In previous studies, L-Proline has been shown as the prime source of energy in 
glucose deprived condition supplementing the production of L-Methionine, L-
Alanine, L-glutamic acid, L-isoleucine and L-aspartic acid in Leishmania 
promastigotes (Simon et al., 1983, Zilberstein and Gepstein, 1993, Bringaud et al., 
2012, Burchmore et al., 2003). Also, L-Aspartate has been shown to contribute 
significantly to the carbon pool other than glucose by heavy stable isotope 
metabolomics (Saunders et al., 2011). Other amino acids such as L-Arginine has 
been of interest owing to its contribution to the Leishmania specific polyamine 
pathway (Darlyuk et al., 2009, Westrop et al., 2015, Shaked-Mishan et al., 2006, 
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Colotti and Ilari, 2011), whilst L-Arginine in host cells functions to regulate iNOS 
production for clearing the parasitic burden and for the activation of the immune 
system (Wanasen and Soong, 2008, Goldman-Pinkovich et al., 2011). Also, L-
Arginine is noted for phosphoinositide phosphates synthesis which are major 
players of lipid membrane dynamics of the phagolysosome and membrane lipid 
organisation (Wanasen and Soong, 2008). Thus, L-Arginine metabolism has been 
reported as one of the amino acids of interest for drug target (Wanasen and Soong, 
2008, Shaked-Mishan et al., 2006, Kandpal et al., 1996). However, comparative 
investigation of all amino acids systematically in L. mexicana promastigotes under 
identical conditions has not been reported before, which has been the prime focus 
in this study.  
 
Studies on amino acid requirements of other intracellular obligate pathogens, 
e.g.; Mycobacterium leprae have shown that the pathogens alters the degree of 
proteolysis and rates of acidification within the macrophages (Podinovskaia et al., 
2013). A significant reduction in intra-phagosomal lipolysis allowing host lipids to 
be a potential source of nutrients for Mycobacterium within the macrophages was 
demonstrated. Metabolomics studies in Leishmania showed that amastigotes 
within macrophages exhibited more quiescent metabolism, with a shift of nutrient 
utilisation from glucose to lipids (Saunders et al., 2014). Geraldo et al 
characterised the L. amazonensis gene (La-PAT1) encoding a putative amino acid 
transporter by screening a probable list of sequences from the genomic library. 
The functional clone was validated by submitting the translated coding sequence 
to the GenBank protein database. They found that this particular gene is 
conserved within the Kinetoplastida family of parasites. Northern blot results of 
the genomic DNA revealed that La-PAT1 was upregulated in amastigotes. 
Interestingly, this gene belongs to the AAAP (Amino Acid/Auxin Permease; TC 
2.A.18) family which is H+/amino acid symporters required to maintain pH 
homeostasis (Geraldo et al., 2005), vital for parasite survival in the host system. 
Also, the exchange of  amino acids is crucial in maintaining osmolality (Blum et 
al; 1996) both in promastigotes and amastigotes and pH homeostasis within the 
host system. 
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1.8.2 Amino acids metabolism linked to carbohydrate metabolism 
 
Broadly, both amino acids and carbohydrates are metabolised via the TCA cycle 
leading to oxidative phosphorylation for energy generation. Different amino acids 
follow different metabolic pathways in mammalian systems culminating in various 
TCA cycle intermediates as follows: L-Arginine, L-Glutamine, L-Histidine, L-
Proline undergoes transamination to L-Glutamate and alpha-ketoglutarate, while 
isoleucine, L-Methionine, L-Threonine, L-Valine broken down to succinyl CoA. 
Others including L-Alanine, cysteine, glycine, serine, L-Threonine, and L-
Tryptophan to pyruvate. Aromatic amino acids such as L-Phenylalanine, L-Tyrosine 
to fumarate and L-Asparagine, L-Aspartate to oxaloacetate. Oxaloacetate is 
converted to phosphoenol pyruvate leading to glucose production via 
gluconeogenesis. Amino acids are classified as glycogenic and ketogenic, while the 
former can be converted to glucose; the latter amino acids are degraded directly 
to acetyl-CoA. Ketogenic amino acids such as isoleucine, L-Leucine, L-Threonine, 
L-Tryptophan leads to acetyl CoA and L-Leucine, L-Lysine, L-Phenylalanine, L-
Tryptophan, L-Tyrosine leads to aceto-acetyl-CoA converted to citrate in the TCA 
cycle (Lehninger Principles of Biochemistry, Cox and Nelson).  
 
Acetyl CoA to acetate and ATP is unique pathway occurring in Leishmania. The 
presence of unique enzyme acetyl: succinate CoA transferase (ASCT) involved in 
succinyl-CoA and succinate conversion to acetyl CoA to acetate and ATP adds 
further complexity in the link between carbohydrate and amino acid metabolism 
in Leishmania. Interestingly, ketogenesis is a process that is triggered in locations 
where there is a lack of glucose and increase amino acids/fatty acid oxidation for 
energy generation, leading to increase in accumulation of acetyl-CoA. The acetyl-
CoA so formed leads to ketone bodies such as acetoacetate and beta-
hydroxybutyrate, increase in the level of ketone bodies causes a drop in pH as 
they are highly acidic in nature. Unlike mammalian cells which have cholesterol 
in the cell membrane; Leishmania have ergosterol like sterols forming the 
membrane domains. Acetyl CoA plays an important part for steroid biosynthesis. 
The first step involves the enzyme acetoacetyl-CoA thiolase; which links two units 
of acetyl CoA as substrate to form acetoacetyl CoA. Subsequent steps in the 
pathway lead to generation of sterols such as mevalonate and ergosterol 
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highlighting the importance of acetyl CoA in steroids biosynthesis in Leishmania 
(Reithinger et al; 2007, Lepesheva et al; 2011). Acetyl-CoA in post translational 
modifications has been used in histone acetylation which changes gene expression 
and hence promotes proliferation (Wellen and Thompson et al; 2012). Acetylation 
and glycosylation have been suggested to be the key modulators regulating both 
cell signalling and metabolism (Hellemond et al; 1997). 
 
Carbohydrates are mainly metabolised through glycolysis and the pentose 
phosphate pathway for energy generation and/or production of reducing 
equivalents (NAD/NADH), and precursors for nucleotides biosynthesis. There have 
been certain distinct differences reported between promastigotes and 
amastigotes life stages of Leishmania with respect to glucose metabolism (Meade 
et al., 1984). Glucose utilisation has been observed to be greater in promastigotes 
with the rate of glucose catabolism to CO2 per number of cells was up to 10-fold 
higher than that of amastigotes (Hart and Coombs; 1982). Promastigotes exhibited 
optimal rates of glucose uptake at pH 7 while amastigotes were optimal between 
pH 4-5; Pro-1 gene encoding glucose transport in L. enriettii was upregulated in 
the promastigotes, while downregulated in amastigotes (Cairns et al., 1989). It 
has been observed that promastigotes exhibit approximately 10% higher activity 
of the glycolytic enzymes compared to amastigotes. This is in line with the 
physiological adaptation of the promastigotes to survive within the changing 
dynamic environment of the sand-fly gut.  
 
It has been shown D-glucose transporter have similar affinity to glucose molecules  
in both promastigotes and amastigotes (Burchmore and Hart, 1995).  However, the 
parasite transporter has been shown to have higher affinity compared to host cell 
glucose transporter, hence might serve as a valid drug target ( Burchmore et al., 
2003). Glucose transporter knock out parasites maintains viability by relying on 
alternative carbon sources as demonstrated by increased amino acids uptake using 
radiolabelled and heavy stable isotope metabolomics studies (Akpunarlieva et al, 
2017). Mukkada et al (Mukkada et al; 1985) have shown experiments with 
amastigote suspensions incorporated with radiolabelled glucose and L-Proline. A 
significant proportion of labelled CO2 from both glucose and L-Proline was 
observed. Thus, Leishmania exhibits a preference for both glucose and amino 
acids as a carbon source.  
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Interestingly, Rainey et al compared models of the axenic continuous culture of 
L. pifanoi promastigotes with amasitogotes using uniformly 13C-labeled [U-13C] 
glucose under aerobic and anaerobic conditions and reported a significant 
proportion of un-metabolised glucose in both life stage forms of Leishmania. 
Excess glucose is stored as glycogen in mammals, similar storage carbohydrates 
had been reported in Leishmania by Rainey et al, but the identity was not very 
clear from the NMR peaks; although some could be attributed to glycogen and 
trehalose. They found that the NMR peaks did neither resemble PO4-6Gal (β1, 4) 
which is the repeating unit of lipophosphoglycan of L. donovani; nor does it belong 
to the major surface glycoprotein, gp63 (Rainey et al., 1991). Almost a decade 
later, evidence has been found for that the storage carbohydrate was beta 1-2 
mannanoligosaccharides, a homopolymer with 4-40 residues constituting 80-90% 
of the cellular carbohydrate (Ralton et al., 2003). 
  
Low glucose conditions triggered mannan catabolism suggesting a reserve function 
to sustain the parasite growth under extreme conditions. Stress activators like 
mild heat shock or heat shock protein-90 inhibitors have been shown to increase 
mannan levels by 10-25 fold (Ralton et al., 2003, Sernee et al., 2006). However, 
it was uncertain whether mannan was required for parasite differentiation and 
survival within the macrophages. Comparison of L. major null mutant for the gene 
fructose-1, 6, bisphosphatase; an enzyme which catalyses the final committed 
step converting fructose 1, 6 bisphosphate to fructose 6 phosphate in the 
gluconeogenesis pathway to wild type promastigotes cultivated in synthetic 
medium with glucose or glycerol showed higher levels of intracellular beta 1, 2-
mannan; however, the FBP mutant had decreased level of intracellular mannan 
indicating that the FBP mutant was hexose limited. The FBP mutants show a rapid 
depletion of oligosaccharides, which confirms that gluconeogensis is an essential 
pathway, required for supplying the hexose requirements of L. major 
promastigotes. Also, similar rates of infection between wild type and FBP mutant 
parasites of host cells was observed indicating storage carbohydrates like mannan 
does not modulate infection level in the host (Naderer et al., 2006).  
 
Research for the identification of key molecules that modulate infection level in 
the host could bring new insights about potential drug targets; necessary to block 
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transmission of the widespread diseases caused by these parasitic protozoa. It has 
been previously shown that the parasite abrogates host immune responses for its 
own replication (Dogra et al., 2007) and much has been centered around parasitic 
proteins that modulate host infection. However, the effect of small molecules  to 
promote infection of Leishmania with host cells have not been reported much. 
Efforts in this study have been made to elaborate on the impact of amino acids 
and its metabolism on infection with host cells as reported in Chapter 6. Studies 
in other species, for example, anaerobic human microflora and aerobic pathogenic 
bacteria in septic patients have shown phenolic acids of microbial origin regulate 
oxidative stress contributing to the pathophysiology of the disease (Beleborodava 
et al; 2012). Patients suffering from malaria due to infections with Plasmodium 
yoelii, have shown that amino acids and amino acid derived intermediates could 
change the metabolic dynamics of host parasite interaction (Saiki et al., 2013).  
 
1.8.3 Role of amino acids in nucleotides, NADPH and antioxidant 
biosynthesis 
 
The genetic material of any organism is made of fundamental building blocks of 
nucleotides synthesised by the pentose phosphate pathway (PPP) to a large 
extent. Nucleotides, especially purines are imported from the host environment 
in Leishmania (Ortiz et al., 2010, Carter et al., 2001). The pentose phosphate 
pathway also contributes to other cellular processes such as the production of 
reducing equivalents in NADPH, the inter conversion of three and six carbon sugar 
phosphates to ribose-5-phosphate, in-turn used in pyrimidine biosynthesis 
demonstrated in Leishmania, and generation of erythrose-4-phosphate which acts 
as a precursor for aromatic amino acid biosynthesis (Wood, 1986).  
 
Amastigotes have a greater turn-over of nucleotides probably facilitating the 
developmental switch from promastigotes. However, amastigotes have lower 
dividing rate, rather passive state, with lesser DNA compared to RNA. Mukkada et 
al have shown a rate of uridine incorporation to be greater than thymidine 
reflecting increased RNA synthesis (Mukkada, 1985). Amino acids not only 
contribute the nitrogen group for pyrimidines but also involved in regulation of 
cellular oxidative stress conditions to optimise nucleotide biosynthesis. For 
25 
 
example, cysteine plays very important role in reducing oxidative stress within 
the cell. Cysteine is sulphur containing amino acid required for various biological 
processes within the system, but it could be of utmost importance to Leishmania 
because it contributes to thiols (glutathione, trypanothione) production required 
to survive against high oxidative stress within macrophages. The unique aspect 
about trypanosomatids is their dual ability for de-novo synthesis by the 
assimilatory route and also trans-sulphuration pathway for cysteine synthesis 
(Sanderson et al., 2000).  Proteome profiling of axenically differentiated 
amastigote life stage of L. panamensis in comparison to promastigotes by two-
dimensional electrophoresis (2DE) in neutral pH revealed upregulation of cysteine 
proteinase suggesting the importance of this enzyme for the amastigotes (Walker 
J et al., 2006).  
 
There have been other studies emphasising the importance of the pentose 
phosphate pathway (Barrett, 1997, Cronin et al., 1989, Funayama et al., 1977) as 
an important NADPH source and also an instance of increased expression of 
pentose phosphate shunt enzyme, 6-phosphogluconate dehydrogenase in L. 
infantum mutant as an adaption to nitric oxide stress (Moreira et al,2014). 
 
Maugeri et al characterised each enzyme of the pentose phosphate pathway for 
L. mexicana promastigotes. They subjected the cells to oxidative stress by 
methylene blue and found an increased proportion of radiolabelled glucose 
contributing to the PPP. They also showed that free ribose can be taken up more 
efficiently through a carrier mediated process and the presence of ribokinase 
activity was also found in the cells. These results suggest that a high build-up of 
reducing equivalents such as NADPH required for the survival of the parasites 
within the host system and regeneration of cellular antioxidants to combat 
oxidative stress encountered by parasites (Maugeri et al., 2003).  
 
In this study, efforts have been made to understand the role of amino acid 
metabolic pathways and antioxidants that could facilitate parasitism within host 
cells as shown in Chapter 6.   
 
1.8.4 Amino acids profile as diagnostic index 
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The amino index has been used as a diagnostic marker for detection and 
monitoring of disease progression and treatment. For example, studies on amino 
acid profiling between cirrhotic patients and control subjects have postulated 
amino acid index as ratio of concentrations of taurine, citrate, L-Methionine and 
L-Arginine over the pooled concentration of serine and L-Leucine as an additive 
component to ratio of pooled concentration of L-Phenylalanine and ornithine by 
the pool of L-Glutamate and L-Tryptophan in studies related to liver injury 
(Capacci et al., 1984). Liver cirrhosis has been associated with abnormal L-
Methionine metabolism reported in the 1950s, however, it is only recently that 
amino acid concentrations have been used to investigate the underlying gene 
expression. The rate of clearance of L-Methionine pool in cirrhotic patients was 
found to be slow due to low activity of the enzyme L-Methionine 
adenosyltransferase (EC 2.5.1.6) responsible for the conversion of L-Methionine to 
S-adenosyl-L-Methionine (Ramani et al, 2011). Abnormalities of the urea cycle 
utilise citrate and ornithine concentrations as markers for diagnosis (Machado et 
al, 2014). Fischer’s ratio between the branched chain amino acids and aromatic 
amino acids have been used to differentiate fibrosis (Ishikawa et al, 2012). A 
recent study showed the novel combinatorial algorithm to generate an amino acid 
index based on molar ratios to discriminate diabetic rat models from nondiabetic 
rats (Noguchi et al., 2006). This kind of diagnostic profile has been less studied in 
infection related cases. A recent study on amino acid profiling referred to as 
aminogram has been reported as new diagnostic markers for Plasmodium 
falciparum infected blood as a method for disease detection (Saiki et al., 2013). 
The use of amino acid profile in all potential combinations could be used to 
harness data to advance biomedical and nutritional investigations. The first step 
in this direction as being taken in this study by amino acid profiling in serum and 
protein free defined medium of L. mexciana promastigotes in a culture. The 
knowledge from this study also allowed deeper insights about the requirements of 
extracellular nutrients and metabolism in L. mexicana promastigotes in a 
controlled environment for the proposal of novel drug targets. 
 
 
1.9 Aims and objectives of this study 
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Genome sequencing has accelerated the identification and characterisation of 
various nutrient transporters that could serve as drug targets (Dean et al., 2014, 
Landfear, 2011). However, diverse metabolic capabilities of the parasite demand 
novel approaches to understanding the assimilation and metabolism of the broad 
range of nutrients by these parasites. In this study, a novel approach has been 
made for a detailed understanding of unbiased mapping of Leishmania metabolism 
in a chemically defined medium to derive new insights about the physiological 
adaptations occurring during its life cycle. Hence, the aims were set as follows: 
• To develop serum and protein free defined medium for in vitro culture of 
the insect stage of the parasites. 
• To evaluate the importance of amino acids for parasite viability. 
• To identify and highlight Leishmania specific amino acid pathways which 
could serve as a potential drug target. 
The key objective was to elucidate utilisation of important nutrients in human 
infective species, L. mexicana promastigotes as a model organism. This was 
conducted by development and establishment of chemical defined media by 
testing individual components and their concentrations required to support 
viability and growth of L. mexicana promastigotes in culture. Furthermore, single 
amino acid knock out media customised to 20 different amino acid conditions were 
analysed for protein quantification, energy determination and morphometric 
studies. Nutrient utilisation was inspected using metabolic finger-printing and 
metabolic foot-printing at different growth stages of the life cycle to highlight 
unique metabolic routes as drug targets. For the first time, exometabolome of 
Leishmania in defined medium were isolated and characterised using biochemical 
assays. These results demonstrated the unique role of certain amino acid 
intermediates in the establishment of infection with host cells; and potentially 
modulates the parasite and host interaction dynamics during infection.  
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Chapter 2 Materials and Methods 
 
2.1 Cell culture of Leishmania promastigotes 
 
Promastigotes of Leishmania mexicana (MNYC/BZ/62/M379) were derived from 
amastigotes of mouse lesions and stabilates were created and maintained. 
Promastigotes only within few passages (5 passages maximum) from stabilates 
were used for growth analysis and metabolomics experiment. Mid log phase 
parasites were sub-passaged thrice in a week into 5 ml of HOMEM prepared 
according to (Berens et al., 1976) supplemented with 10% (v/v) heat-inactivated 
foetal calf serum (FCS), 1% penicillin-streptavidin and maintained at 27oC, pH 
7.4. Initial parasite concentration was 5 x105 cells / ml. Parasites were grown 
until mid-log phase (5 X 106 cells/ml) about 3-4 days from the day of culture 
initiation and passaged in 1:10 dilution subsequently into fresh medium. 
Promastigotes were cultured in commercial HOMEM (Invitrogen, Paisley, 
Scotland) supplemented with 10% (v/v) heat inactivated-foetal calf serum (FCS, 
example supplier Biosera, Ringmer, UK). HOMEM was also prepared in the 
laboratory following the protocol from Berens et al; 1976. The routine culture 
was carried out using vented culture flasks (25 cm2 Corning).  
 
For all the growth analysis experiments, cultures were initiated in triplicate and 
growth was monitored in appropriate media (REIX/BM/NM/DM as explained in 
2.3). 5 X 106 cells /mL of promastigotes from mid  log phase (day 4) of the culture 
were collected in sterile test tubes and subjected to centrifugation to about 1000 
g and the supernatant discarded. The cell pellet was briefly washed with 
appropriate media with 1000 g slow acceleration and slow deceleration prior to 
re-suspending in the media to an appropriate volume such that starting density of 
promastigotes at 5 X105 cells/mL for growth analysis experiment. Viability and 
integrity of the cells were assessed using the trypan blue dye exclusion test. 
Samples from the culture flask were diluted at 1:1 ratio and assessed by manual 
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examination under a microscope for the number of cells that appeared blue in 
colour (non-viable) amongst the total number of cells counted. Only culture flasks 
with more than 98% viability were considered for further experiments. Growth 
monitored after fixing cells in 2% formaldehyde in PBS by counting cell numbers 
with an improved Neubauer haemocytometer. 
 
2.2 Creating and maintaining stabilates record 
L. mexicana promastigotes from the clonal population were preserved routinely 
by the creation of stabilates of cells in mid-log phase 1:1 (v/v) of a mixture of 80% 
culture media and 20% glycerol to confluent cells at a density of 1 X 106 cells/mL. 
The cryovials were wrapped in cotton wool and stored overnight at -80°C, 
subsequently transferred to liquid nitrogen for long term storage and appropriate 
placement of the vials recorded.  
 
2.3 Preparation of Defined medium  
Stock solutions of individual components (example supplier-Sigma Aldrich) were 
prepared and the REIX composition (Steiger and Black, 1980) was modified 
accordingly as stated in the results section Table 3-2. Briefly, stocks of salts 
including sodium chloride, potassium chloride, sodium phosphate monobasic 
dehydrate and sodium pyruvate were prepared in 4X concentration. To the 
required salt concentration, sodium bicarbonate and HEPES were added directly 
before use. Individual amino acids, L-glucose, adenosine and hemin were added 
from pre-filtered stocks to the aliquots immediately before use. Vitamin mixture 
containing choline chloride, D-calcium, pantothenate, nicotinamide, pyridoxal 
hydrochloride, thiamine hydrochloride, myo-inositol, biotin at concentrations 
specified in Table 3-2 were added from pre-filtered individual stocks for growth 
tests and commercial source (example supplier-Sigma Aldrich- B 6891) for defined 
medium preparation. Individual cofactor stock solutions (1mM) of folic acid, 
riboflavin, biotin, lipoic acid, Biopterin and para-amino benzoic acid dissolved in 
1N sodium hydroxide solution and added at required concentrations from pre-
filtered stocks for growth tests. Individual metal stock solutions (1mM) of 
magnesium septa-hydrate, calcium chloride, iron (III) nitrate nona-hydrate, zinc 
chloride, manganese chloride and cobalt chloride was dissolved in water with drop 
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with concentrated acid or alkali added from the side of the tubes for complete 
dissolution. Cofactors and metals with concentrations specified in the medium 
composition were added as cocktail during medium preparation. The pH of the 
medium was adjusted to 7.4, the medium was filter sterilised using 0.22 mm 
(Millipore filter unit) and stored in aliquots. All components from Sigma Aldrich 
unless otherwise mentioned. Concentrations of individual components of Base 
Medium (BM), Nayak Medium (NM), Single amino acid knock out media (NM-
specified amino acid), Nayak minimal media (NMM) and Defined medium (DM) are 
as listed in Chapter 3, 4, and 5. 
 
Promastigotes were grown in HOMEM for 4 days prior to inoculation. The cells 
were centrifuged at 1000 g for 10 min. The cell pellet washed with BM twice and 
starting cell density adjusted to 5 x 105 cells/mL. A metal mixture of magnesium, 
calcium, zinc, iron, copper, manganese and cobalt were tested at various orders 
of magnitude each at 0.5mM, 0.05mM and 0.005mM. REIX medium was prepared 
according to Steiger et al, 1980 (Steiger and Black, 1980) and the relative 
importance of individual amino acids, co-factors and metals were tested by 
omitting each one from the medium composition. Growth analysis monitored as 
stated above and doubling time of cells calculated with co-factors tested were 
biopterin, folate, PABA, lipoic acid, riboflavin and metal salts of magnesium, 
calcium, zinc, iron, manganese, copper and cobalt both individually and in 
combination. 
 
2.4   Image analysis  
For studying the impact of individual amino acid on the cell morphology, cell body 
length of promastigotes grown in single amino acid knock out media was assessed 
by Giemsa staining as described by Bates et al 1993. Briefly, aliquots from day 6 
of the culture were smeared on glass slides and air dried. The cells were fixed 
using absolute methanol and slides submerged in 10% Giemsa in 10mM phosphate 
buffer at pH 7.2. The slides were examined under a Zeiss Axiovision upright light 
microscope using bright-field. Images captured on an AxioCam MRm camera and a 
scale bar of 10µm bar was used to measure the cell body length of promastigotes 
cultured in single amino acid knock out media. For statistical significance, cell 
body length measurements of the several pairs of populations in different amino 
31 
 
acid starved and replete conditions were measured using Fiji-ImageJ software and 
plotted as their frequency distribution.  
 
2.5 Evaluation of Defined Medium using infectivity test 
The mononuclear cell line, THP1 was used for testing the infectivity of cells grown 
in DM according to the protocol to Jain et al, 2012 with slight modifications. 
Briefly, THP1 cells were cultured in RPMI 1640 (Gibco, Life technologies) plus 10% 
FCS with a starting density of 5x105 cells/ml. These cells were sub-passaged in 1:5 
dilutions every five days. The viability of the cells was tested using trypan blue 
(Sigma) exclusion test (Dutta et al., 2005). Briefly, 0.4% trypan blue solution (3:1 
ratio vol/vol) were added to each well containing macrophages and assessed 
microscopically using haemocytometer. The stained cells were counted as dead 
cells and percent viability of more than 98% were considered for further 
experiments of infection with L. mexicana promastigotes. 
   
THP1 cells were plated on chamber slides for 3 days at 37 oC at 5% CO2 and 
differentiated using 100nM PMA (phorbol myristate acetate) 24 hours prior to 
infection. Promastigotes were prepared at 106 cells in NM/HOMEM after careful 
consideration of cell numbers in HOMEM serially diluted two fold to recover a 
similar percentage of metacyclics on day 6 from the start of culture initiation.  
For infectivity test, the macrophage monolayers were overlaid with 1:10 ratio with 
5 x 106 cells of L. mexicana grown until stationary phase (Day 6 from the start of 
the culture initiation) in either medium containing HOMEM or NM. The cells were 
incubated for 4, 24, 48, 96 and 144 hours at 37oC in 5% CO2. The wells were then 
washed thrice with PBS to remove unbound promastigotes at various time as 
specified in figure legends. The cells in the chamber slides were fixed by brief 
treatment using ice cold methanol and air dried. Alternative chambers were 
treated with DAPI for nuclear staining (Sigma Aldrich) or Giemsa stain for cell body 
length staining (Sigma Aldrich) for 20 minutes and sealed with a coverslip. The 
slides were visualised using a light microscope (Axiovision) and analysed using Fiji-
Image J software. The number of infected macrophages was based on counting an 
average of 100 macrophages and the equation used to calculate is as follows: 
Number of amastigotes/100 THP1 cells= (Number of amastigotes nuclei 
counted/Number of THP1 nuclei counted) * 100  
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Also, the percentage of a total number of infected macrophages were compared 
between NM or HOMEM media conditions.  
 
2.6 Alamar blue assay 
Alamar blue assays developed by Raz et al assess the toxicity of drugs on the 
viability of the cells (Raz et al., 1997). Required drugs for testing were prepared 
in appropriate medium (HOMEM/NM) at twice the maximum concentration tested. 
The first well of the 96 well micro-titre plate (Corning) were added with 200 µL 
of the drug. To the remaining wells, 100 µL appropriate media were added. The 
drug in the first well was serially diluted at 1:2 ratio across 10 wells, leaving the 
last wells drug free. Cells from log phase in serum containing rich medium were 
counted using haemocytometer and diluted to 5x105 cells/ml with fresh medium 
and added to the plate to a final volume of 200µL per well. Cells incubated for 48 
hours at 37 °C, 5% CO2, followed by addition of (20µL of 10% of sample volume) 
0.49mM resazurin (Sigma) in 1 X PBS, pH 7.4 and incubation for another 24 hours. 
Fluorescence was measured on a Pherastar spectrometer (BMG Labtech), with 
excitation wavelength of 544 nm and emission wavelength of 590 nm. 
 
2.7 Growth in single amino acid knock out media 
For studying the amino acid requirements of Leishmania mexicana promastigotes, 
single amino acid “knock out” media, containing 0.5 mM of all 20 proteogenic 
amino acids bar one, were prepared. L. mexicana promastigotes were cultured in 
complete HOMEM medium for 4 days prior to the start of amino acid starvation 
conditions. Cells were collected by centrifugation at 1000 g for 10 minutes. The 
pellet was washed by a quick spin by centrifugation to remove any traces of 
HOMEM medium with defined medium lacking all amino acids referred to as NM-
AA and re-suspended in NM-AA. This was used as an inoculation media for 20 
mL/flask in triplicates of single amino acid knock out medium such that the 
starting cell density set to 106 cells/ml. The integrity of the cells was assessed by 
trypan blue dye exclusion test and cultures were only considered for counting with 
more than 98% viability. Parasite growth was followed daily for 9 days by diluting 
a 0.01mL aliquot 50X with cold 2 % (w/v) formaldehyde-PBS and counting using 
improved Neubauer haemocytometer and growth curves plotted for the calculated 
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of doubling time (hours). HOMEM, NM and NM-AA (no amino acids) were treated 
similar inoculation as single amino acid knock out media to assess the effect of 
the absence of each amino acid on the growth of the promastigotes. Further 
reductions in the number of amino acids were prepared by modification of NM as 
appropriate provisionally referred to as Nayak minimal medium as stated in 
Chapter 4. Data were derived from several independent assays (n=9) each carried 
out in triplicates. All statistical analysis was carried using Graph-pad Prism 
software with significance threshold set at P<0.0001 between comparisons, using 
one way ANOVA with Dunnett’s multiple comparison tests. 
 
2.8 Protein determination in single amino acid knock out media 
L. mexicana promastigotes were cultured in complete HOMEM medium for 4 days 
prior to the start of amino acid starvation conditions. Cells were collected by 
centrifugation at 1000 g for 10 minutes. The pellet was washed by a quick spin by 
centrifugation to remove any traces of HOMEM medium with Nayak medium 
lacking all amino acids referred to as NM-AA and re-suspended in NM-AA. This was 
used as inoculation media for 20 mL/flask in triplicates of single amino acid knock 
out medium such that the starting cell density set to 106 cells/ml. The integrity of 
the cells was assessed by trypan blue dye exclusion test and cultures were only 
considered for counting with more than 98% viability. Subsequently, 107cells were 
collected on day 6 of single amino acid knock out media (NM-and suspended in ice 
cold lysis buffer in PBS containing triton (0.05%), Glycerol (5%), NaCl (150mM) and 
cocktail of protease inhibitors containing (1,10,Phenanthroline (2mM), Leupeptin 
(10µM), Pepstatin (7µM) and E64 (10µM) where are compatible with Bradford 
reagent (from the manufacturer’s manual, example-Biorad) and cell lysed by brief 
pulses of sonication on ice. Bradford protein assay was used to determine the 
amount of protein extracted from an equal number of cells recovered from single 
amino acid knock out media. 96 well flat bottom plates were used to test protein 
concentrations of the sample in different dilutions. Briefly, serial dilution of BSA 
was used as standards (1.0, 0.5, 0.25, 0.125, 0.06, 0 mg ml−1) prepared in the 
same lysis buffer, diluted 1:5 with Bradford reagent simultaneously added to the 
standards and samples. The plates placed on the rotating mixer for 15 min at room 
temperature and absorbance measured at 595 nm.  Simple linear regression was 
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used to determine protein concentration in the samples. Results were derived 
from three independent experiments (n=9) each performed in triplicate. 
 
2.9 Acetate Assay 
Sample preparation for secreted acetate determination was carried out as follows: 
Briefly, L. mexicana promastigotes were cultured in complete HOMEM medium for 
4 days prior to the start of amino acid starvation conditions. Cells were collected 
by centrifugation at 1000 g for 10 minutes. The pellet was washed by a quick spin 
by centrifugation to remove any traces of HOMEM medium with either NM, NM-
glucose or NM-AA and re-suspended in respective media. These were used as 
inoculation media for 20 mL/flask in triplicates for each of NM, NM-glucose and 
NM-specified amino acid in single amino acid knock out media respectively, such 
that the starting cell density set to 106 cells/ml. The integrity of the cells was 
assessed by trypan blue dye exclusion test and cultures were only considered for 
counting with more than 98% viability.  
1 x 107 cells/mL were collected on day 6 from the start of culture initiation and 
centrifuged at 1000 g for 10 minutes and the supernatant transferred to pre-
chilled test tubes on ice without disturbing the pellet.  Acetate secreted in the 
extracellular medium by Leishmania promastigotes were quantified in the culture 
supernatant of NM, NM-glucose and single amino acid knock out media conditions 
according to the protocol from the manufacturer instructions (Sigma MAK086). 
Briefly, 50µL of the samples were taken into micro-titre plate (example supplier, 
Corning) were mixed with reaction mixture from the commercial kit prepared by 
mix of acetate assay Buffer (42 µL), Acetate enzyme mix (2 µL), ATP (2 µL), 
Acetate substrate mix (2 µL) and Probe (2 µL). ATP and NADH in the samples have 
been described to generate background signal; thus, sample blank without the 
addition of acetate enzyme mix was set up for individual conditions. The plate 
was placed on rotating shaker for 40 minutes of incubation time and absorbance 
measured at 450 nm using Pherastar spectrometer (BMG Labtech).  
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2.10 Sample preparation for metabolite finger-printing of 
intracellular extraction 
L. mexicana promastigotes were inoculated at 5 X 105 cells/ml in 50 ml Corning 
flask in triplicates, in HOMEM medium (Berens et al., 1976),  and cultured for 4 
days. On day 4, the cells were collected by centrifugation 1000 g for 10 minutes 
in mid logarithmic growth phase. The cell pellets were washed with DM twice and 
re-suspended in the same medium used as inoculation for three individual flasks 
containing 200mL/flask of DM maintained at 27oC, pH 7.4 with starting cell density 
adjusted to 1 x 106 cells/mL.  
Growth was monitored for 9-day period and integrity of the cells was assessed by 
trypan blue dye exclusion test and cultures were only considered for counting with 
more than 98% viability. Parasite growth was followed daily for 9 days by sample 
dilution at 1:5 ratio with ice cold 2 % (w/v) formaldehyde-PBS and counted using 
improved Neubauer haemocytometer. Defined medium without cells was 
maintained in similar conditions set as positive control. Sample preparation was 
carried out according to (Vincent et al., 2014) with modifications to the protocol 
by omitting the washing step meant for removing traces of serum adhering to 
cells.   
Briefly, On Day 3 from the day of culture initiation, 4x107 cells were pipetted out 
from each flask individually to a 50 mL pre chilled falcon tubes and quenched by 
rapidly cooling cells to 100C using a thermometer, by submerging tube in dry 
ice/ethanol bath for approximately 10 seconds. During the procedure, it was 
ensured that the tubes were constantly shaken in a circular motion to avoid cell 
clumping or freezing or lysis and placed on ice bath whilst handling other samples. 
The tubes were centrifuged at 1000 g, 10 min at 40C.  The supernatant was 
pipetted into another falcon tube without disturbing the cell pellet. The cell pellet 
(metabolite finger-print profiling), supernatant (metabolite foot-print profiling) 
and naïve medium without cells (blank control) were treated with 1:1 ratio with 
CMW extraction solvent (chloroform/methanol/water -CMW extraction solvent, 
1:3:1, v/v/v, example supplier-Thermo Scientific, analytical standard reagent) in 
a pre-chilled Eppendorf tubes and placed on shaker set at maximum speed and 
temperature of 40C for an hour. Subsequently, the Eppendorf tubes were 
centrifuged at 16000 g, 10 min at 40C. Individual samples each at 90µL were 
suspended into an MS glass vial under argon. From each individual samples 5µL 
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were taken and mixed together into one Eppendorf (pre-chilled) used as quality 
control (QC). Samples were placed on dry ice during the transfer to Glasgow 
Polyomics building and the samples were stored in -800C until sample injections 
into the mass spectrometer.  
 
2.11 Sample processing on the mass spectrometer 
 
Metabolomics samples were processed at Glasgow Polyomics, University of 
Glasgow, UK in standardised methods as specified in protocol from (Mwenechanya 
et al, 2017; Akpunarlieva et al, 2017, Van der Hooft JJJ et al; 2017). Briefly, the 
samples were run on zwitterions permanent hydrophilic interaction liquid 
chromatography (Zic-pHILIC column with 150 mm × 4.6 mm, 5 μm column, Merck 
Sequant on a Dionex UltiMate 3000 RSLC system. The mobile phase of the pHILIC 
column consisted of two solvents maintained at 30oC with solvent A with 20mM 
ammonium carbonate in water and solvent B of 100% acetonitrile. The order of 
the solvents used were 80% B to 20% B at 30 min and 5% B at 32 min and held to 
39 min for washing, then 80% B at 40 min. The samples eluted in linear gradient 
over 46 min flow rate at 0.3ml/min.  The injection volume was 10µL and 4oC prior 
to injection. The chromatography system was coupled to high-resolution exactive 
orbitrap mass spectrometer (Thermo Scientific). The settings of mass 
spectrometer for certain other parameters were as follows: Probe temperature 
150oC, Capillary temperature 275oC, resolution 50,000; m/z range 70-1400 and the 
samples were run in both positive and negative ionisation modes.  
 
2.12 Data analysis 
The data-sets from mass spectrometer was analysed according to (Creek et al., 
2012b, Scheltema et al., 2011) with manual verification at each step. Briefly, the 
raw data files from the LC-MS analysis were grouped manually in different folders 
according to their respective biological conditions under each master folder for 
positive and negative ionisation modes. Supporting software such as Proteowizard 
library (version 3) has the msconvert utility to convert raw files to mzXML open 
data format and XCMS (version 3.0.1) has the CentWave feature detection 
algorithm that extracts all the chromatographic peaks (Smith et al; 2006). 
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The core software mzMatch (version 1.0.2)was applied to filter the noise from the 
signal noise by manual setting of parameters for mass and retention time error as 
below 5% so that all peaks arising from artefacts during sample preparation and 
solvent memory (Scheltema et al., 2011) are removed. The PeakML files are 
further processed to discard peaks that are not reproducibly detected in all the 
replicates involved. Peaks from every sample are then aligned on the basis of their 
retention time (RT) and m/z values to be collated as combined PeakML file. 
Information about the RT and m/z from each peak are matched to online 
databases in alignment with metabolomics profiling initiative forum. 
 
To obtain more robust metabolite identification, 250 authentic standards were 
run in parallel during sample processing. These standards files were processed 
using TOXID software (version 2.1) to derive experimental retention time of the 
standard metabolites. These files were used to update the predicted retention 
time as calculated by IDEOM software (version 19c). The peak shape and intensity 
of above 5X103 was selected as appropriate peak for each of the metabolites. The 
relative standard deviation was evaluated to understand about the sample 
variation between replicates and instrument response consistency. Multiple macro 
chosen within IDEOM software filtered the metabolites into the identification and 
rejected list. Manual curation at each stage was carried out to pick false rejections 
and add them to the identification list or vice versa. All steps carried out 
individually for positive and negative mode separately and then used to combine 
all data sets for comparison across samples in the study with schematic as shown 
in appendix figure 4. Multi-variant data analysis was carried out by writing scripts 
using in R and Matlab programming with details as shown in appendix code 1 to 
appendix code 4. 
 
2.13 Sample preparation for metabolite foot-printing of 
extracellular metabolome extraction 
Sample preparation was carried out according to metabolite finger-printing 
elaborated in Section 4.4.  Briefly, On Day 1, 2, 3, 6, and 9 from the day of culture 
initiation, 4x107 cells were pipetted out from each flask individually from the 
three different flasks to a 50 ml pre chilled falcon tubes and quenched by rapidly 
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cooling cells to 100C as measured by thermometer in dry ice/ethanol bath. At the 
same time, 10 mL of naïve medium without cells (sterile media placed in 
incubator) was also aliquoted at similar times and processed as control samples as 
above represented as Day 0 in the data. All sample tubes were centrifuged at 1000 
g, 10 min at 40C. The supernatant was pipetted into another falcon tube without 
disturbing the pellet and used as exo-metabolome samples. These samples were 
diluted in 1:1 ratio with CMW extraction solvent in a pre-chilled Eppendorf tubes 
and placed on a shaker set at a maximum speed and temperature of 40C for an 
hour. Subsequently, the Eppendorf tubes were centrifuged at 16000 g, 10 min at 
40C. The supernatants each at 90µL were put into an MS glass vial under argon gas. 
Then, 5µL was taken from each individual sample and mixed together into one 
Eppendorf (pre-chilled) used as quality control (QC). Samples were placed on dry 
ice during the transfer to Glasgow Polyomics building and the samples were stored 
in -800C until processed by LC-MS and analysed as elaborated in section 2.10, 2.11 
and 2.12. 
 
2.14 Biochemical assays 
The objective for these assays was to determine the impact of small molecules in 
the exo-metabolome on the host cells with THP1 differentiated macrophage cells 
as an infection model. Aromatic pyruvates significantly enriched in the 
exometabolome were further investigated using pure compounds following the 
results from Chapter 4. Since the objective for these assays was to determine the 
role of small molecules during infection with host cells, the samples were 
prepared accordingly to enrich the small molecules without interference with 
bigger molecules such as proteins and ribonucleic acids. 
 
2.15 Sample preparation for biochemical assays of aromatic 
pyruvates 
The samples prepared for metabolomics foot-printing experiments were used for 
biochemical assays with few modifications as follows: Leishmania mexicana 
promastigotes were inoculated at 1 x 106 cells/ml in triplicates. Parasite 
concentration was recorded using the haemocytometer on day 1, 2, 3, 6, and 9 
from the day of culture initiation. Then, 4x107 cells were pipetted out from each 
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flask individually from the three different flasks to a 50 ml pre chilled falcon tubes 
and centrifuged at 1000 g, 10 min at 40C. The supernatant was carefully pipetted 
out into new tubes without disturbing the cell pellet. The supernatant was filter 
sterilised using 3kDa filter to remove traces of large molecules such as 
proteins/peptides which would, in turn, enrich the small molecules within the 
samples without the interference of bigger molecules whilst testing their impact 
on THP1 differentiated macrophage cells as an infection model.  
 
2.16 Effect of parasite exometabolome on host cell viability 
The host cells considered would be THP1 cells (human monocytic cell line) as a 
model system. Here, the assays investigated the role of aromatic pyruvates 
released by the promastigotes during the dynamic growth cycle. Alamar blue assay 
would be carried out to measure the effect of aromatic pyruvates (Indole lactate, 
sodium phenyl pyruvate, para-hydroxy phenyl pyruvate at 1 mM each) on the 
viability of THP1 cells with phenyl arsine oxide as a control.  
The monocytes were maintained in RPMI 1640 medium containing 2 mM Glutamine 
with 10% FBS, 1% penicillin/streptomycin at 37oC, 5% CO2 in liquid suspension. The 
growth of the cells monitored by trypan blue exclusion method to check for cell 
viability and recorded using haemocytometer. 5 x106 cells/mL of THP1 cells were 
plated on chamber slides at 37oC at 5% CO2 and differentiated using 100nM PMA 
(phorbol myristate acetate). After 24 hours, the differentiated macrophages were 
treated with fresh RPMI medium, DM, incubated with exo-metabolome (DM (D6S)), 
or pure compounds of ascorbic acid, indole lactate, phenyl pyruvate, 4-hydroxy 
phenyl pyruvate at 1mM concentration each were taken in triplicates repeats (n=6) 
and phenyl arsine oxide at 10µM for 72 hours. On Day 4 from the start of culture 
initiation, alamar blue reagent, 0.49mM resazurin (Sigma) in 1 X PBS, pH 7.4 and 
incubated for another 48 hours. Fluorescence was measured on a Pherastar 
spectrometer (BMG Labtech), with excitation wavelength= 544 nm and emission 
wavelength= 590 nm. Viability was expressed in percentage with an optical density 
of wells containing THP1 cells in RPMI medium considered as 100% viable. 
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2.17 Reducing power determination for antioxidant activity 
The reducing power of the spent medium would be determined using modified 
protocol from (Lee et al., 2014). Briefly, this assay measures the property of the 
compounds to act as electron donor using potassium ferricyanide reduction. Here 
the Fe3+/ferricyanide complex is reduced to ferrous form.  Colour change from 
yellow to the blue and green range. Ascorbic acid (control) at a range of different 
concentrations from 0.001 mM-100mM was tested, as it is well known for its 
antioxidant activity. Aromatic pyruvates were also tested in the same manner 
from 0.001 mM-100mM. For this, 10 μl of 1% potassium ferricyanide was added. 
The plate was incubated at 50oC for 30 min. The plate was cooled and 10 μl of 1% 
trichloro acetic acid and 10 μl of 0.1% FeCl3 were added and left for 20 min. 
Absorbance was read at 700 nm to determine the amount of ferric ferrocyanide 
(Prussian blue) formed. The higher absorbance of the reaction mixture indicates 
the higher reducing power of the compounds tested. 
 
2.18 Determination of phenolic nature of spent medium  
Parasites secreted low molecular weight metabolites were observed to have 
characteristic enone moiety from structural analysis of metabolomics spent 
medium analysis (Chapter 5). In order to analyse their chemical nature over time, 
phenolic content of spent medium was assessed. Aromatic compounds with 
hydroxyl groups react with the phosphomolybdic acid in Folin-Ciocalteu reagent 
in an alkaline medium to produce a blue coloured complex.  An aliquot of 20 μl of 
spent medium from each day of the culture (D1S, D2S, D3S, D6S and D9S) was 
compared to medium only without cells incubated for similar time lengths. 500 μl 
of Folin Ciocalteu reagent and 1000 μl of distilled water were added. Tubes left 
for 3 minutes at room temperature and 1000 μl of 20 % Sodium carbonate (Na2CO3) 
added. Tubes placed at 37°C in a water bath for 30 minutes. 50 μl transferred to 
the plate in triplicates and samples from eppendorf tubes transferred to a flat 
bottom plate and the absorbance was measured at 600 nm using a model 
PHERAstar FS microplate reader (BMG Labtech). Catechol was used as the 
reference standard with different concentration from 2mg/ml-10 mg/ml (18mM-
90mM), and the results expressed as mg of catechol equivalents/μl. 
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2.19 Effect of exometabolome on nitric oxide radical scavenging 
assay 
 
The experimental set up of the assay was similar to that followed by Hassani et 
al, 2011 (Hassani et al., 2011), with a few modifications. About, 5 x106 cells/mL 
of THP1 cells differentiated using 5ng/mL PMA for 24 hours. Differentiated 
macrophages infected with L. mexicana or incubated with exo-metabolome (Day 
6 supernatant collected as described in experimental procedures after filtration 
using 3kDa-cut off centrifugal column (example supplier-Amicon Ultra) or pure 
compounds of ascorbic acid, indole lactate, phenyl pyruvate, 4-hydroxy phenyl 
pyruvate at 1mM concentration each were taken in triplicates (n=9) for 24 hours.  
After incubation for 24 hours under different conditions, the macrophages were 
washed with defined medium and 200µL of DM was added to all the wells. 
Subsequently, each of the wells was treated and untreated (Control) with 
10ng/mL of LPS for 24 hours. LPS stimulated macrophages released nitric oxide 
which on reaction with Griess’s reagent (50µL) (1% sulphanilamide, 2% phosphoric 
acid and 0.1% naphthylene diamine dihydrochloride) formed stable complex 
proportional to the amount of nitrite in the sample. The amount of nitrite 
measured was compared to standard curve ranging from 0-100µM of nitrite and 
analysed using linear regression analysis at 540 nm.  
 
2.20 Estimation of phenolic nature of parasite secreted low 
molecular weight metabolites. 
The principle of the assay: Phenolic assay was carried out according to the 
procedure (Lee et al., 2014).  Aromatic compounds with hydroxyl groups react 
with the phosphomolybdic acid in Folin-Ciocalteu reagent in an alkaline medium 
to produce a blue coloured complex.  Catechol was used as the reference standard 
with different concentration from 0-10 mg/ml, and the results expressed as mg of 
catechol equivalents/μL. An aliquot of 20 μL of defined medium supernatant from 
Day 0,1,2,3,6 and 9 of culture initiation taken in triplicates (n=6) in Eppendorf 
tubes. Similarly, an aliquot of 20 μL pure compounds of ascorbic acid, indole 
lactate, phenyl pyruvate, 4-hydroxy phenyl pyruvate each at 1mM concentration 
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each was taken in triplicates (n=6) in Eppendorf tubes. Subsequently, 500 μL of 
Folin ciocalteu (Sigma) reagent and 1000 μL of distilled water were added and 
tubes incubated for 3 minutes at room temperature and 1000 μL of 20 % Sodium 
carbonate (Na2CO3) added. Tubes placed at 37°C in a water bath for 30 minutes. 
Then 50 μL transferred to the 96-well microtitre plate (Corning) and the 
absorbance was measured at 600 nm using a model PHERAstar FS microplate 
reader (BMG Labtech). 
 
2.21 Determination of antioxidant activity of aromatic pyruvates by 
reducing power measurement 
The principle of the assay: The reducing power of the spent medium would be 
determined using modified protocol from (Lee et al., 2014). This assay briefly 
measures the property of the compounds to act as electron donor using potassium 
ferricyanide reduction. Here, the Fe3+/ferricyanide complex is reduced to ferrous 
form with colour changing from yellow to the blue and green range. Ascorbic acid, 
well known anti-oxidant was used as control at a range of concentrations from 
0.001 mM-100mM. Aromatic pyruvates such as indole lactate, phenyl pyruvate, 4-
hydroxy phenyl pyruvate at 1mM concentration each were taken in triplicates 
(n=6) for 24 hours. Acetate was also tested in the same manner from 0.001 mM-
100mM. Potassium ferricyanide (1%) of 10 μL was added. The plate was incubated 
at 50oC for 30 min. The plate was cooled and 10 μL of trichloro acetic acid (1%) 
and 10 μL of FeCl3 (0.1%) were added, and further incubated for 20 min at room 
temperature. Absorbance was read at 700 nm and the amount of ferric 
ferrocyanide (Prussian blue) formed was determined. The higher absorbance of 
the reaction mixture indicates the higher reducing power of the supernatant 
sample. 
 
2.23 Estimation of chemical reducing activity of exo-metabolome at different 
growth stages of promastigotes  
Parasites secreted several low molecular weight metabolites bearing an enone 
moiety, as observed from metabolomics spent medium analysis. In order to 
analyse their chemical nature over time, the phenolic content of spent medium 
was assessed. Aromatic compounds with hydroxyl groups react with the 
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phosphomolybdic acid in Folin-Ciocalteu reagent in an alkaline medium to produce 
a blue coloured complex(Lee et al., 2014).  An aliquot of 20 μL of spent medium 
from each day of the culture (D1S, D2S, D3S, D6S and D9S) was compared to 
medium only without cells incubated for similar time lengths. To this, 500 μl of 
Folin-Ciocalteu reagent and 1000 μL of distilled water were added. Tubes left for 
3 minutes at room temperature and 1000 μL of 20 % Sodium carbonate (Na2CO3) 
added. Tubes placed at 37 °C in a water bath for 30 minutes. From this, 50 μL 
transferred to the plate in triplicates and samples from eppendorf tubes 
transferred to a flat bottom plate and the absorbance was measured at 600 nm 
using a model PHERAstar FS microplate reader (BMG Labtech). Catechol was used 
as the reference standard with different concentration from 2mg/mL-10 mg/mL 
(18mM-90mM), and the results expressed as mg of catechol equivalents/μL. 
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Chapter 3 Establishment of defined minimal 
medium for axenic culture 
3.1 Introduction 
Parasitic protozoa belonging to the order Kinetoplastida such as Leishmania are 
pleomorphic with different stages expressed during the course of their life cycle 
(Kaye and Scott, 2011) with complex biochemistry. Understanding the biochemical 
nature of parasites has been a priority for drug target discovery (Vincent and 
Barrett, 2015; Creek and Barrett, 2014; Landfear, 2011). This has been facilitated 
by robust in vitro culture techniques that allow studying these organisms in 
controlled environmental conditions which mimic the biological conditions.  
 
3.1.1 Brief overview of the development of in vitro medium 
culture.  
Formulation of in vitro culture medium for parasitic protists began at the start of 
the 20th century with the development of Novy-McNeal medium for cultivation of 
Trypanosoma  brucei brucei (Novy and Mac Neal, 1904). This was later modified 
by Nicolle as blood agar slants inoculated with infected tissue, referred to as Novy-
McNeal Nicolle (NNN) medium (Nicolle, 1908), and used to culture certain species 
of Leishmania (Limoncu et al., 1997). Subsequently, the formulation of the 
diphasic media, comprising of a solid agar phase containing a mixture of organic 
substances composed of diverse components including peptone, beef infusion, 
glucose, tryptose, liver extract, brain heart infusion, individual amino acids and 
Trypticase soy agars (Cross and Manning, 1973) and the liquid phase comprising 
water condensate or Locke's solution forming on the agar surface (Novy and Mac 
Neal, 1904) or rabbit blood at a concentration ranging from 2.5-50%. Many reports 
suggested that the diphasic media posed two major issues, by limiting the isolation 
of a large number of parasites and contamination from the constituents of the 
solid phase, which posed the need for liquid media (Chang and Hendricks, 1985). 
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Liquid media evolved from many variations of diphasic media composed of 
peptone and yeast extract with 10% foetal calf serum used for cultivation of     L. 
infantum and L. tropica with cell yields (about 106 cells/mL) that was comparable 
to NNN medium (Limoncu et al., 1997). Kar et al 1997 have shown that L. donovani 
isolates from Kala-azar patients could be cultivated with a high concentration of 
folic acid (100 mg/mL) with the base medium of brain heart infusions (Kar, 1997).   
 
3.1.2 Comparison of in vitro media for the culture of Leishmania 
promastigotes. 
There are many other medium formulations reported in the literature, however, 
use of undefined components was prevalent until 1970. Medium HOMEM 
formulated by Berens, Brun and Krassner (Berens et al., 1976) in 1976 developed 
the culture of L. donovani promastigotes that has been routinely used with the 
addition of 10% foetal calf serum. Other media used for in vitro culture of 
Leishmania research involves HOMEM (Berens et al., 1976) and commercially 
available tissue culture media such as RPMI (Moore et al., 1967) or M199 with 10% 
foetal calf serum (FCS) adopted for the culture of certain Leishmania strains  
(Hassani et al., 2011, Moreno et al., 2014b) as listed in Table 3-1. 
 
 
 
 
 
 
 
 
 
 
Table 3-1  Compilation of media formulations used for Leishmania culture. 
Media 
name 
Authors Composition 
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M199  (Morgan et al,1950)  With 5% serum 
RPMI 
1640  
(Moore. G.E. et al,  
1967) 
With 10% serum 
HOMEM  (Berens RL 1976)  With 20% serum 
Grace 
medium 
(Childs, 1978) With 15% serum 
LITR9 (Sadigursky M, 
Brodskyn CI., 1986) 
Elaborate with liver infusion and tryptose. 
REIII (Steiger and Steiger, 
1976) 
Chemically defined media with minimal 
components but only includes 17 amino acids 
Semi 
defined 
(Ali et al., 1998) Casein hydrolysates and urine 
Serum 
free 
(Armstrong and 
Patterson, 1994) 
Urine 
Serum 
free 
(Steiger and Steiger, 
1977) 
Includes BSA 
REIX  (Steiger and Black, 
1980)  
Chemically defined media with minimal 
components but only includes 11 amino acids 
for the growth of L. donovani species 
REX (Steiger and Black, 
1980) 
Chemically defined media with minimal 
components without glucose. 
MD29 (Melo et al., 1985) Chemically defined media with many purines 
and pyrimidines sources 
CDM  (Merlen, 1999)  Chemically defined media with complex fatty 
acids and amino acid intermediates 
   
 
Some of the media compositions with the addition of serum poses significant 
disadvantages as listed below: 
Undefined composition- Although the major constituents of serum include 
proteins, amino acids, glucose, minerals, fatty acids and other growth factors, 
their functions for in vitro culture remain obscure. The concentrations of the 
nutrient components vary with type and age of the serum. The effect of the 
undefined components on the cells has not been fully determined. 
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Batch variability- Serum varies from batch to batch, deteriorating over time. 
Although similarity could be maintained, the identical composition of serum as 
tested in the first batch cannot be met between experimental repeats. Hence, 
eliminating FCS will reduce batch variability and reproducibility between 
laboratories. 
Contamination-FCS obtained from animal slaughter might have the risk of 
contamination with other infectious agents. 
Downstream processing- Procedures such as heat inactivation of sera needs to 
be carried out before use to prevent complement induced cell lysis. With the use 
of serum free media, these procedures could be avoided altogether. 
Cost-Serum free medium would eliminate the high cost of purchase, transport 
and storage of Foetal Calf Serum/ Foetal Bovine Serum (FCS/FBS).  
The availability-increasing problem of global warming and other environmental 
conditions, such as drought in the cattle rearing areas, could restrict the amount 
of serum available. The economic and logistic regulations of individual regions 
are also factors that dictate the availability of serum. Hence, there is a need for 
a paradigm shift to be able to adopt serum-free media for routine laboratory 
research. 
 
3.1.3 Importance of chemically defined media for the culture of 
Leishmania promastigotes. 
Baltz et al showed that serum compatibility for the culture of specific organisms 
differed depending upon the source (Baltz et al., 1985), certain species of 
Kinetoplastida parasites showed preference to rabbit serum over the horse or pig 
sera; since there were additional requirements of external purines, growth factors 
and vitamins. Baltz et al also highlighted that human serum was found toxic for 
the culture of specific strains of Kinetoplastida which required cattle as a host 
system to complete their developmental cycle. Thus, undefined nature of the 
serum poses a significant issue for standardisation across multiple experiments.  
 
Thus, the addition of various undefined components such as serum (FCS), yeast 
extract or albumin fractions adds to the complexity and variability of the culture 
media. These factors might lead to variable growth responses of parasites in 
culture, affecting hypothesis testing. Therefore, medium preparation without a 
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serum component represents an imperative goal for hemoflagellate cultivation. 
Serum derived components such as fatty acid free bovine serum albumin, bovine 
alpha-2 macroglobulin and bovine beta-lipoprotein have been used as serum 
replacing components (Steiger and Steiger, 1977).  
 
A study by Merlen et al (1999) formulated the completely defined medium 
(CDM/LP) composition for Leishmania which showed similar proteinase and 
antigenic profiles compared to parasites cultured in serum containing medium 
(Merlen et al., 1999). The medium components included glucose, amino acids and 
organic salts, ATP, many nucleosides and nucleotides, guanine and hypoxanthine, 
several vitamins, cholesterol, glutathione, Tween 80, five carbon ribose sugars. 
Some of these components in the medium were thought to be dispensable; since 
evidence from gene and protein expression studies have highlighted that 
promastigotes encode for several biosynthetic pathways, for example, exogenous 
sources of glutathione or cholesterol could be dispensable (Beach et al., 1979, 
Romao et al., 1999). Hence, CDM/LP composition has been considered very 
elaborate and the development of minimal media required for in vitro culture of 
Leishmania promastigotes was carried out in this study.  
   
Detailed analysis of another defined medium termed MD-29 compared the cell 
densities of 19 different stocks of Leishmania promastigotes from the New world 
species and showed that incorporation of metal salts such as ferric nitrate allowed 
for cell yields in the order of 107promastigotes/mL over 9-day period at 25oC. The 
base composition of MD-29 was based on modified T. cruzi medium AR-103 with 
the omission of nucleotides and nucleosides such as ATP and AMP but the inclusion 
of many purines and pyrimidines sources (Melo et al., 1985). However, Leishmania 
has the enzymatic potential to inter-convert purine sources and pyrimidine 
biosynthesis de novo; without the need for exogenous pyrimidine sources (Lafon 
et al., 1982).  
 
Simplified medium reported by Steiger and Steiger termed RE I medium 
formulated to support the growth of L. donovani and L. braziliensis which 
contained 17 amino acids in addition to glucose, adenosine, vitamin mix, lipoic 
acid and bovine albumin (Steiger and Steiger, 1977). It was also reported that 
bovine albumin was not essential for in vitro culture conditions and thus modified 
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composition termed as RE III had 14 amino acids and (Steiger and Steiger, 1976); 
subsequent modifications included medium with and without glucose termed, RE 
IX composition contained 11 amino acids with growth experiments optimised for 
the culture of L. donovani promastigotes (Steiger and Black, 1980).  
 
In this chapter, different medium compositions were compared and only those 
components essential for the viability and growth promoting were included in 
development of defined medium for the growth of L. mexicana promastigotes in 
culture. Defined medium for in vitro culture would then allow reproducibility and 
standardisation between experiments and laboratories. Isolation of antigens 
would be more efficient than in serum containing media, cost and diagnosis could 
also be greatly benefitted to describe some of the potential applications further 
elaborated in the discussion section of this chapter. 
 
3.1.4 Research aims  
 
➢ Comparsion of different defined medium compositions for the culture of 
Leishmania. 
➢ Growth analysis of individual components for the growth of L. mexicana 
promastigotes.  
➢ Evaluation of newly developed defined medium by: 
o Morphological examination 
o Infectivity analysis 
o Drug sensitivity 
 
   
                                 
3.2 Results 
3.2.1 Development of serum and protein free defined medium for 
in vitro culture of Leishmania promastigotes 
Two defined media reported for the culture of Leishmania, namely CDM/LP 
(Merlen et al., 1999) were compared to REIX medium (Steiger and Black, 1980) as 
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listed in Table 3-2. CDM/LP contained an elaborate composition with protein 
complex whilst REIX developed for L.donovani promastigotes has a simpler 
composition but with only 11 amino acids. The REIX medium was used as a starting 
reference and systematic modification by the omission of certain undefined 
components provisionally referred to as base medium (BM) was tested for the 
growth of L. mexicana promastigotes for the addition of co-factors and metals as 
shown in results section of this chapter. Detailed comparisons of the three medium 
compositions have been explained in Table 3-2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-2 Comparison of medium compositions. 
 Components CDM/LP 
(mM) 
 
REIX (mM) 
 
    BM 
 (mM) 
Salts     
NaCl 139 136.8 136.8 
KCl 7.00 5.36 5.36 
NaH2PO4 6.22 0.33 0.33 
KH2PO4 0.09   
Sodium Pyruvate  0.99 0.99 
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NaHCO3 24.00 3.57 3.57 
HEPES 20.00 25.01 25.01 
Hemin 7.70 0.0077 0.0077 
Vitamins    
Choline chloride 0.024 0.007 0.007 
D-Calcium pantothenate 0.0009 0.002 0.002 
Nicotinamide 0.0094 0.008 0.008 
Pyridoxal hydrochloride 0.001 0.004 0.004 
Thiamine hydrochloride 0.00034 0.002 0.002 
I-Inositol 0.00025 0.01 0.01 
L-Ascorbic acid 0.00006   
Nicotinic acid 0.00004   
Pyridoxine 
hydrochloride 
0.0054   
Cyanocobalamine 0.004   
Calciferol 0.00005   
Menadione 3H2O 0.00001   
L-α-Tocopherol 0.00001   
Retinol 0.00007   
Co-factors    
PABA 0.009   
Riboflavin 0.00056 0.002  
folic acid 0.003 0.002  
Biopterin    
Lipoic Acid    
D-Biotin 0.0015   
 Components CDM/LP 
(mM) 
 
REIX (mM) 
 
    BM (mM) 
Metals    
MgSO4.7H2O 0.61 0.81  
CaCl2 0.72   
Zinc Chloride    
Fe(No3)3.9H20 0.00036   
Manganese chloride    
Copper     
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Cobalt chloride    
Amino Acids    
L-Tryptophan 0.046 0.245 0.5 
L-Phenylalanine 0.16 0.606 0.5 
L-Lysine hydrochloride 0.32 1.366 0.5 
L-Arginine hydrochloride 1.90  0.5 
L-Leucine 0.60 2.29 0.5 
L-Valine 0.27 0.854 0.5 
L-Aspartic acid 0.26  0.5 
L-Serine 0.42  0.5 
L-Glutamic Acid 0.34  0.5 
L-Glutamine 2.30 2.05 0.5 
L-Histidine hydrochloride-H2O 0.13 0.476 0.5 
L-Isoleucine 0.48 0.763 0.5 
L-Threonine 0.29 3.361 0.5 
L-Methionine 0.14 0.335 0.5 
L-Cysteine 0.60  0.5 
L-Tyrosine 0.17 0.191 0.5 
L-Proline 0.20  0.5 
L-Alanine 0.11*  0.5 
 Components CDM 
concentrations 
(mM) 
 
REIX 
concentrations 
(mM) 
 
    BM 
concentrations 
(mM) 
L-Asparagine 0.36  0.5 
L-Glycine 0.00028  0.5 
Other components    
Adenosine 0.0086 0.074 0.074 
D-Glucose  13.3 11.11 16.6 
Cholesterol 0.0001   
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Glutathione 0.0036   
Hydroxyproline 0.17   
D-Ribose 0.66   
2-Deoxyribose 0.74   
Na acetate 0.12   
ATP(Na2) 0.0036   
Guanine.HCL 0.00032   
Hypoxanthine 0.00052   
Xanthine(Na) 0.0005   
Uracil 0.00062   
Thymine 0.00048   
Tween80                     4mg/L 
 
 
 
 
 
 
 
 
3.2.2 Experimental design 
The overall work flow involved the development of defined medium has been 
depicted in Figure 3.1. Briefly, the REIX (Steiger et al, 1980) was used as starting 
composition referred to as BM with the omission of undefined components and 
addition of all amino acids at equimolar concentrations instead of only 11 amino 
acids as specified in REIX. Addition of cofactors and metal salts were tested and 
together referred to as Nayak medium. Stock solutions of individual components 
were prepared and added to make the different media as specified in Table 3-2. 
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Figure 3.1 Workflow summary  
Pictorial depiction of workflow strategy followed during the development and 
establishment of defined medium referred to as Nayak medium for in vitro culture 
of Leishmania promastigotes. 
 
3.2.1. Growth analysis for the development of defined medium in the presence 
of all amino acids 
As an experimental control for growth analysis, an established and routinely used 
method in our laboratory for the culture of L. mexicana promastigotes (strain 
MNYC/BZ/62/M379) using HOMEM medium (Berens et al., 1976) was used.  HOMEM 
medium was prepared according to Berens et al, 1976 with 10% (v/v) heat-
inactivated fetal calf serum (FCS) (Appendix table). Growth analysis was 
monitored for a period of 9 days in HOMEM, REIX and BM media in triplicate flasks 
and cell count recorded as shown in Figure 3.2. Growth analysis was carried out 
under identical conditions from one set of inoculated cells, temperature and pH 
at 270C and pH 7.4 respectively. 
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Figure 3.2 Cell count of L. mexicana promastigotes in BM (closed squares), REIX (closed 
circles) compared to serum containing HOMEM (open circles) shown over the 9day period 
in (A) passage 1 (p1) and (B) passage 2 (p2).  
Parasites were inoculated at a density of 5 x105 cells/ml and aliquots of triplicate 
culture flasks were counted every 24 hours thereafter as described in 
experimental procedures. Representative data from biological triplicates each in 
independent experiments set up in parallel on multiple days. (Error bars = mean 
± SD, n=9). 
 
A 
B 
56 
 
The viability of cells cultured in REIX medium was below 98% and the cells formed 
clumps as recorded in Figure 3.2 (A) and showed no growth when transferred to 
fresh batch REIX medium for the second passage as shown in Figure 3.2 (B). REIX 
optimised for the growth of L.donovani promastigotes had only 11 amino acids 
namely; L-Tryptophan, L-Phenylalanine, L-Lysine hydrochloride, L-Leucine, L-
Valine, L-Glutamine, L-Histidine, L-Isoleucine, L-Threonine, L-Methionine and L-
Tyrosine. It was observed that BM containing all 20 proteogenic amino acids those 
in REIX along with addition of L-Arginine hydrochloride, L-Aspartic acid, L-Serine, 
L-Glutamic Acid, L-Cysteine, L-Proline, L-Alanine, L-Asparagine and L-Glycine 
instead of only 11 amino acids in REIX significantly improved the viability of the 
L. mexicana promastigotes  as measured by trypan blue exclusion dye reaching a 
cell density of more than 1 x 107 cells/mL over 9 day growth period with active 
motility. Also, the addition of equimolar concentration of all amino acids 
significantly improved the doubling time measured to be approximately 18 hours 
under conditions tested at pH 7.4 at 27oC; whilst it was calculated as 14 hours in 
HOMEM and more than 25 hours for REIX.  
 
3.2.1.2 Growth in the presence of cofactors 
Although the addition of all amino acids caused a significant increase in viability, 
the cells in culture exhibited increased lag period. To overcome these issues, a 
combination of co-factors were tested individually and in conjunction as shown in 
Figure 3.3 to Figure 3.8. 
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Figure 3.3 Cell count of L. mexicana promastigotes in Base medium (BM) in the presence 
and absence of putrescine (10µM). 
(Error bars = mean ± SD, n=9) 
 
From Figure 3.3, it was observed that addition of putrescine had a no significant 
effect on the growth of L. mexicana promastigotes under conditions tested. 
                
Figure 3.4 Cell count of L. mexicana promastigotes in Base medium (BM) in the presence 
and absence of riboflavin (10µM).  
(Error bars = mean ± SD, n=9) 
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From Figure 3.4, it was observed that riboflavin had a positive effect in 
independent experimental repeats with a decrease in lag time during the 9 day, 
growth period tested.  
 
 
 
 
 
 
Figure 3.5 Cell count of L. mexicana promastigotes in Base medium (BM) in the presence 
and absence of Lipoic acid (10µM). 
(Error bars = mean ± SD, *** p<0.001, n=9) 
From Figure 3.5, it was observed that addition of lipoic acid shows distinct positive 
effect (*** p<0.001) to decrease the lag time in growth compared to the absence 
of it.  
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Figure 3.6 Cell count of L. mexicana promastigotes in Base medium (BM) in the presence 
and absence of Folic acid (10µM).  
(Error bars = mean ± SD, *** p<0.001, n=9) 
 
From Figure 3.6, it was observed that addition of folic acid have a positive growth 
effect with an increase in cell density observed over 9 day period. 
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Figure 3.7 Cell count of L. mexicana promastigotes in Base medium (BM) in the presence 
and absence of PABA (10µM). 
(Error bars = mean ± SD, n=9) 
 
From Figure 3.7, it was observed that addition of PABA had no significant effect 
on the growth as observed over 9 day period. 
 
Promastigotes were inoculated at a starting density of 5 X 105 cells/mL with 
various concentrations of biopterin ranging from 0µM to 160µM as shown in Figure 
3.8. Stationary cell density was measured after 96 hours. Representative data 
from several independent experiments with an average of three determinations 
for each biopterin concentration. 
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Figure 3.8  Addition of Biopterin (µM) stimulated the growth of L. mexicana in BM medium.  
(Error bars = mean ± SD, n=9) 
 
From Figure 3.8, it was observed that addition of Biopterin at 10-100µM have a 
constant positive growth effect with an increase in cell density observed over 96 
hours from the start of the culture. *** Asterisks indicate significant growth with 
Biopterin above 10µM with p<0.0005 in comparison to medium without Biopterin 
(0 µM), one way ANOVA with Dunnett’s multiple comparison test. 
 
To test the comparative growth promoting of individual co-factors; with a starting 
cell density of 1 x 106 cells/mL were tested under different conditions of 10µM co-
factor each and final cell density recorded after Day 6 in late log phase of the 
growth cycle as shown in Figure 3.9. 
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Figure 3.9 Growth of L. mexicana promastigotes in BM with and without folic acid (10 µM), 
riboflavin (10 µM), Lipoic acid (10 µM), Biopterin (10 µM). 
(Error bars = mean ± SD, n=9) 
 
 
From Figure 3.9, it was observed that among the co-factors tested biopterin had 
significant growth promoting activity  compared to folic acid, riboflavin and lipoic 
acid. Asterisks indicate significant difference with **** p<0.0001; ** p<0.001 in BM 
plus cofactors comparison to BM, one way ANOVA with Dunnett’s multiple 
comparison test. 
 
The additive comparative effect of growth factors were tested by addition of all 
co-factors bar one. With starting density of 5 x 105 cells/mL, cell density 
estimated on Day 6 at late log phase of the growth cycle from the start of culture 
initiation as shown in Figure 3.10. 
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Figure 3.10 Growth of L. mexicana promastigotes in BM with and without folic acid, 
riboflavin, lipoic acid, biopterin and PABA (10µM) each. 
(Error bars = mean ± SD, n=9) 
 
From Figure 3.10, it was observed that upon single omission of each co-factors, 
biopterin > folic acid> lipoic acid > riboflavin > PABA had an increasing order of 
impact on in vitro growth of promastigotes. Asterisks indicate significant 
difference with **** p<0.0001; ***p<0.0005, *p<0.05  in BM plus individual cofactor 
in comparison to BM plus all cofactors, one way ANOVA with Dunnett’s multiple 
comparison test,  
 
3.2.1.3 Trace metals formulation by maximum growth in the presence/absence 
of metals mixture. 
 
In this attempt to optimise the defined medium composition, mixture of metals 
was tested individually and together with other co-factors stated in section 
3.2.1.2. Metal mixture of magnesium, calcium, zinc, iron, copper, manganese and 
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cobalt were tested at various orders of magnitude each at 0.5mM, 0.05mM and 
0.005mM as shown in Figure 3.11 
 
                
 
Figure 3.11 Comparative growth of L. mexicana promastigotes in HOMEM (open circles), BM 
(open squares) in the presence of equimolar metal mixture at 0.005 (closed triangles), 0.05 
(closed diamonds) and 0.5 mM (open diamonds).  
(Error bars = mean ± SD, n=9) 
Parasites were inoculated at a density of 5 x105 cells/ml and aliquots of culture 
were counted every 24 hours thereafter until Day 9. It was found that equimolar 
metal mixture at a high concentration of 0.5mM and 0.05mM proved to be toxic 
which decreased cell viability by more than 50%; compared to 10-fold lesser 
concentration at 0.005mM. The addition of 0.005mM metals mixture resulted in 
decreased lag phase with growth in BM and improved growth reaching similar 
growth rate of promastigotes cultured in HOMEM as shown in Figure 3.11.
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3.2.1.4 Optimisation of individual metal concentrations 
Metals salts of MgS04.7H20 at 0.81 mM, CaCl2 at 0.72mM, ZnCl2 at 0.03 mM, Fe 
(NO3)3.9H2O at 0.009 mM, CoCl2 at 0.000032 mM, CuSO4 at 0.0005mM and MnCl2 at 
0.000045 mM were tested individually as shown in Figure 3.12.  
 
BM supplemented with cofactors and metals all together hereby, has been 
referred to as NM with complete composition stated in Table 3-3. The total density 
recorded in NM was much higher compared cells in BM as shown in result Figure 
3.14. 
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Table 3-3 Compositions of BM (doubling time = ~25 hours) and                                              
NM medium (doubling time = ~18 hours) for axenic culture of L. mexicana  promastigotes 
 Components     BM 
 
NM 
 
Salts   Concentration (mM)   Concentration (mM) 
NaCl 136.8 136.8 
KCl 5.36 5.36 
NaH2PO4 0.33 0.33 
Sodium Pyruvate 0.99 0.99 
NaHCO3 3.57 3.57 
HEPES 25.01 25.01 
Vitamins   
Choline chloride 0.007 0.007 
D-Calcium pantothenate 0.002 0.002 
Nicotinamide 0.008 0.008 
Pyridoxal hydrochloride 0.004 0.004 
Thiamine hydrochloride 0.002 0.002 
Myo-Inositol 0.01 0.01 
D-Biotin 0.01 0.01 
Co-factors   
Riboflavin  0.05 
folic acid  0.05 
Biopterin  0.1 
Lipoic Acid  0.05 
p-amino benzoic acid  0.01 
Metals   
MgS04.7H20  0.81 
Calcium chloride  0.72 
Zinc Chloride  0.03 
Fe(NO3)3.9H20  0.009 
Manganese chloride  0.000045 
Copper sulphate   0.000030 
Cobalt chloride  0.000032 
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 Components     BM 
concentrations (mM) 
NM 
concentrations (mM) 
Amino Acids   
L-Tryptophan 0.5 0.5 
L-Phenylalanine 0.5 0.5 
L-Lysine hydrochloride 0.5 0.5 
L-Arginine hydrochloride 0.5 0.5 
L-Leucine 0.5 0.5 
L-Valine 0.5 0.5 
L-Aspartic acid 0.5 0.5 
L-Serine 0.5 0.5 
L-Glutamic Acid 0.5 0.5 
L-Glutamine 0.5 0.5 
L-Histidine hydrochloride-H2O 0.5 0.5 
L-Isoleucine 0.5 0.5 
L-Threonine 0.5 0.5 
L-Methionine 0.5 0.5 
L-Cysteine 0.5 0.5 
L-Tyrosine 0.5 0.5 
L-Proline 0.5 0.5 
L-Alanine 0.5 0.5 
L-Asparagine 0.5 0.5 
Glycine 0.5 0.5 
Other components BM 
concentrations (mM) 
NM 
concentrations (mM) 
Adenosine 0.074 0.074 
D-Glucose  16.6 16.6 
Hemin 0.0077 0.0077 
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Figure 3.12 Effect of single omission of metals in defined medium.  
(Error bars = mean ± SD, n=9) 
Growth of L. mexicana promastigotes with starting density of 5 x 105 cells/mL in 
BM with and without the presence of individual metals. Cell density estimated 
after Day 6 from the start of culture initiation in late log phase of the growth 
cycle, independent experimental repeats in triplicates each time. Asterisks 
indicate significant difference with **** p<0.0001; ***p<0.0005, **p<0.001, ns non-
significant with BM plus all metals except one in comparison to BM plus all metals, 
one-way ANOVA with Dunnett’ s multiple comparison test. 
Metals salts containing Iron (Fe), Cobalt (Co), Zinc (Zn), Copper (Cu), Manganese 
(Mn), Magnesium (Mg) and Calcium (Ca) were tested all together except one 
supplemented with BM as shown in Figure 3.12. Absence of manganese (MnCl2, 
0.000045 mM), cobalt (CoCl2, 0.000032 mM), and copper (CuSO4, 0.0005mM), had 
minor effect on the growth rate. Lack of magnesium (MgS04.7H20, 0.81 mM), and 
calcium (CaCl2, 0.72mM) exhibited the significant negative phenotype of growth 
with 75% and 60% decrease in cell viability respectively. Whilst, the absence of 
exogenous zinc (ZnCl2, 0.03 mM), and iron (Fe (NO3)3.9H2O, 0.009 mM) decreased 
total cell density by 35% and 45% respectively.  
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3.2.1.5 Evaluation of growth potential in the presence of both metals and 
cofactors  
 
The growth of L. mexicana promastigotes was monitored in the presence of a 
combination of co-factors and metals and expressed as total cell density recorded 
on Day 6 from the start of culture initiation and doubling time (hours) as shown in 
Figure 3.13 and Figure 3.14. 
 
 
 
 
       
     
Figure 3.13 Cell density of L. mexicana promastigotes grown in BM with and without 
cofactors and metal salts individually and in combination.  
(Error bars= mean ± SD, n=9) 
Parasites were inoculated at a density of 5 x105cells/mL and aliquots of culture 
were counted in independent experimental repeats with triplicates each time on 
Day 6 of culture initiation.  
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Figure 3.14 Effect of cofactors and metals on doubling time of L. mexicana promastigotes 
grown in BM with and without cofactors and metal salts individually and in combination.  
(Error bars= mean ± SD, n=9) 
Parasites were inoculated at a density of 5 x 105cells/ml and aliquots of culture 
were counted in triplicates at every 24 hours thereafter; up to day 6 from the 
start of culture initiation as described in experimental procedures. Doubling time 
calculated from growth curves conducted each time in sets of triplicates, 
repeated independently thrice. Number of Asterisks indicate significant p values 
with **** P<0.0001 and *** p<0.005, one way ANOVA with Dunnett’s multiple 
comparison test. 
From Figure 3.13 and Figure 3.14, the addition of co-factors such as biopterin, 
riboflavin, lipoic acid and folic acid at 10µM together with metals salts such as 
magnesium, calcium, zinc, iron, manganese and cobalt at respective 
concentrations  (MgS04.7H20, 0.81 mM, CaCl2, 0.72mM, ZnCl2, 0.03 mM, Fe 
(NO3)3.9H2O, 0.009 mM, MnCl2, 0.000045 mM, CoCl2, 0.000032 mM and CuSO4, 
0.0005mM) resulted in a total increase in cell density. Also, the addition of these 
supplements increased the growth rate of promastigotes in culture expressed as 
doubling time during the growth period at under conditions tested.             
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3.2.1.6 Evaluation of continuous culture of L. mexicana promastigotes 
Optimised serum and protein free medium with the addition of all amino acids, 
cofactors and metals is henceforth referred to as Nayak medium (NM) with growth 
analysis shown in Figure 3.15. Continuous culture with serial passages within the 
medium was evaluated up until passage 15 as shown in Figure 3.16. 
 
Figure 3.15 Growth of L. mexicana promastigotes in NM (closed squares) compared to 
growth in HOMEM with10%FCS (open circles). 
 (n=9, Error bars = mean ± SD). 
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Figure 3.16 Growth of L. mexicana promastigotes in NM evaluated for the potential to 
support in continuous culture with passage numbered (p) accordingly.  
Parasites were inoculated at a density of 5 x105 cells/mL and aliquots of culture 
were counted (n=9, mean ± SD) on Day 6 with sub passage carried out on Day 3 
from the start of culture initiation as described in experimental procedures. 
 
3.2.2 Evaluation of defined medium 
3.2.2.1 Evaluation of growth potential of components in the presence of 
respective inhibitors 
The growth promoting action of biopterin in the culture media was validated in 
the presence of methotrexate (MTX), a known competitive inhibitor for biopterin 
activity (Kumar et al., 2008) by alamar blue assay as shown in Figure 3.17. 
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Figure 3.17 Alamar blue assay for in vitro drug sensitivity of Methotrexate (MTX) for           L. 
mexicana grown in media NM with and NM without biopterin.  
 
Experimental procedures described in methods for the alamar blue assay showed 
IC50 value = 1.1 µM for NM and IC50 value = 0.7 µM for NM without Biopterin. 
L.mexicana promastigotes were cultured in these two conditions two independent 
experimental repeats in triplicates each, n=6.  
 
The absence of biopterin in the medium increases the susceptibility of 
promastigotes to the drug activity of MTX as shown by low inhibitory concentration 
(IC50 value) in NM-biopterin (grey circles) compared to higher IC50 value in the 
presence of biopterin in the media (black closed squares). Thus, biopterin serves 
an important constituent of the culture media composition of L. mexicana 
promastigotes as shown in Figure 3.17. 
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3.2.1.7 Growth in the presence of metal chelators 
 
It was found that magnesium and calcium had substantial growth prompting action 
compared to other metals such as zinc, manganese, copper and cobalt as shown 
in Figure 3.12. To validate these results, alamar blue assay was carried out with 
competitive inhibitors of metal activity such as metal chelators- 
{ethylenediamine-tetraacetic acid} EDTA and {ethylene glycol-bis (β-aminoethyl 
ether)-N, N, N', N'-tetraacetic acid} EGTA for magnesium and calcium individually 
to adjust the composition of defined medium accordingly as shown in Figure 3.18 
and Figure 3.19. 
 
 
Figure 3.18 Alamar blue assay for in vitro drug sensitivity of EDTA for L. mexicana 
promastigotes grown in NM with and NM without Mg (0.81mM)  
Experimental procedures described in methods for the alamar blue with EDTA was 
tested between 0-100µM to represents the range of concentrations that might 
have an inhibitory growth effect on promastigotes. It was found that the IC50 value 
= 30 µM with magnesium containing medium (NM) compared to modified NM 
without magnesium with IC50 value = 1 µM between the two conditions (n=6, two 
independent experiments). 
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Figure 3.19 Alamar blue assay for in vitro drug sensitivity of EGTA for L. mexicana 
promastigotes grown in NM with and without metal mixture containing Ca (0.72mM). 
Experimental procedures described in methods for the alamar blue with EGTA was 
tested between 0-100µM to represents the range of concentrations that might 
have an inhibitory growth effect on promastigotes. It was found that the IC50 value 
= 10 µM with NM (Nayak medium containing calcium) compared to NM-Ca (modified 
medium without added calcium) with IC50 value = 0.5 µM (n=6, two independent 
experiments). 
 
The sensitivity of chelators determined by the concentration of the chelators 
needed to reduce cell yield by half during growth of L. mexicana promastigotes in 
NM for 5 days has been represented by the IC50 values. The cells grown with EGTA 
and EDTA exhibited decreased sensitivity in the presence of metals mixture. These 
chelators selectively compete with magnesium and calcium respectively. The 
presence of other individual metals did not significantly alter the sensitivity 
pattern compared to magnesium and calcium alone. The IC50 value of EDTA and 
EGTA was increased in the presence of magnesium or calcium in the medium. 
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These results validated the growth promoting action of magnesium and calcium 
on the growth of L. mexicana promastigotes in culture, hence inclusion in the 
medium composition.   
 
3.2.1.7 Growth in the presence of adenosine 
Adenosine was tested at different concentration in NM required to support the 
growth of L. mexicana promastigotes as shown in Figure 3.20. 
 
 
                            
 
Figure 3.20 Growth of L. mexicana promastigotes with starting density of 5 x105 cells/mL in 
serum containing HOMEM (closed circles), NM with adenosine (74 µM, closed squares) or 
less adenosine (7 µM, inverted triangles) or no adenosine (0 µM, closed triangles).  
Cell density estimated every 24 hours in 9-day growth period (Error bars = mean ± 
SD, n=9). 
NM composition was tested under three different conditions with no adenosine, 7 
µM adenosine (equivalent to adenosine concentrations in the serum) and 10-fold 
higher concentration of 74 µM adenosine. It was observed that adenosine serves 
as a major growth limiting nutrient, thus 74 µM adenosine was included in the final 
NM composition (Table 3-3). 
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3.2.1.8 Growth in the presence of glucose 
It was of interest to check the growth of L. mexicana promastigotes with and 
without glucose in defined medium as shown in Figure 3.21.  
 
Figure 3.21 Growth of L. mexicana promastigotes in NM (closed squares) and NM minus 
glucose (closed triangles).  
(Error bars = mean ± SD, n=9 with p<0.0001 in both comparisons, representative 
data from three independent experiments). 
 
 Omission of sugar (glucose 16mM) increased the lag phase with decreased cell 
density at stationary stages. The percentage of metacylics (~80% on Day 6) 
decreased two fold in the absence of glucose (~ 40%) with mixed populations of 
promastigotes of variable length. 
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3.2.2.1 Morphological evaluation of promastigotes growth 
L. mexicana promastigotes were inoculated at a density of 5 x105cells/ml and 
visualised by giemsa staining on day 3 (log phase) and day 6 (metacylics phase) 
from the start of culture initiation in both the mediums (NM and HOMEM) as shown 
in Figure 3.22 and Figure 3.23. 
 
      
Figure 3.22 Cell morphology of L. mexicana promastigotes examined using Giemsa staining 
in HOMEM+10%FCS (top row) and NM (bottom row).  
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Figure 3.23 Nucleus and Kinetoplast position of L. mexicana promastigotes 
examined using DAPI staining in Homem+10%FCS and NM. From Figure 3.22, it was 
observed that promastigotes at log phase were shorter compared to elongated 
forms at stationary phase (Day 6). Also, cells at log phase procyclics promastigotes 
contained higher mean cell volume than at metacyclics stationary phase. This 
morphological pattern during the parasite life cycle could be visualised in NM 
owing to support normal cell growth as observed in HOMEM.  
 
From Figure 3.23, with DAPI staining, the nucleus appeared ellipsoidal with the 
bar shaped deeply stained kinetoplast seen at the base of the flagellum.  
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3.2.2.2 Morphometric evaluation of promastigotes. 
 
Cell body length of L. mexicana promastigotes stained and visualised at day 3 and 
day 6 of the growth cycle was measured as shown in Figure 3.24.  
 
                  
Figure 3.24 Morphometric evaluation of cell body length of L. mexicana promastigotes in 
NM compared to growth in HOMEM with 10%FCS (n=50, Error bars = mean ± SD). 
1 x106 cells/ml from day 3 and day 6 of culture were counted stained using giemsa 
dye. Average of more than 50 images were taken using the camera on Zeiss 
Axiovision upright light microscope and analysed using Image J software for the 
measurement of cell body length of the parasites.  Comparative evaluation of 
growth between the two media showed no statistically significant differences 
indicating promastigotes cultured in NM were the same length as HOMEM as shown 
in Figure 3.24. 
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3.2.2.3 Infectivity test of promastigotes.  
The infective potential of promastigotes compared using differentiated monocytic 
cell line THP1 as a model between cells cultured in NM and HOMEM as shown in 
Figure 3.25, Figure 3.26, Figure 3.27 and Figure 3.28. 
 
 
Figure 3.25 Total number of amastigotes per hundred macrophages measured to determine 
the infectivity of promastigotes cultured in medium containing either HOMEM (open circles) 
or NM (closed squares), heat killed promastigotes in NM (closed triangles). 
(Error bars= mean ± SD, n=9 with independent experimental repeats with 1 x 105 
cells/mL promastigotes grown in either media upon infection in 1:10 ratio with 1 
x 106 cells/ml macrophages counted as number of amastigotes per 100 
macrophages. Heat killed promastigotes in NM served as a negative control). 
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Figure 3.26 Percentage of infected THP1 differentiated macrophages with L. mexicana 
promastigotes grown in medium containing either HOMEM (open bars) or NM (closed bars) 
(n=9, mean ± SD) with heat killed promastigotes as a negative control. 
 
 
Figure 3.27 Giemsa stained images of infected THP1 cells with at 4 hours, 24 hours and 144 
hours post infection as described in experimental procedures. 
 
4 hours 24 hours 144 hours 
NM 
HOMEM 
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Figure 3.28 Nucleus and kinetoplast position of L. mexicana promastigotes (white arrow 
head) and macrophages nucleus (red arrow head) examined using DAPI staining in 
Homem+10%FCS and NM. 
 
From Figure 3.25, the infective potential of the promastigotes was comparable 
between cells cultured in NM and HOMEM with the slight proportion of lysis in 
serum containing HOMEM at 4 hour time point with the lesser attachment of 
promastigotes established within the macrophages at that stage. However, similar 
proportion of metacylics were recorded in both HOMEM and NM and showed similar 
infectivity profiles as shown in Figure 3.26 
The percentage of infected macrophages were similar between 60-80% in both 
medium conditions evaluated at 4 hours, 24 hours and 144 hours post infection as 
shown in Figure 3.26. 
The infected macrophages were visualised using giemsa and Dapi staining as shown 
in Figure 3.27 and Figure 3.28 analysed by image analysis as described in the 
experimental procedures.  
 
 
 
 
 
 
 
84 
 
 
3.2.2.4 Drug sensitivity assay  
 
Drug sensitivity assays were carried out using leishmanicidal drugs (Tiuman et al., 
2011) with amphotericin B, pentamidine and methotrexate to evaluate their 
activity in NM and  HOMEM as shown in Figure 3.29. 
           
 
Figure 3.29  Alamar blue assay for in vitro drug sensitivity of Amphotericin B, Pentamidine 
and Methotrexate for L. mexicana promastigotes grown in media containing either HOMEM 
or NM.  
Error bars = mean±SD, n = 6, two independent experimental repeats in triplicates 
each, asterisks indicate significant differences in drug activity with ***, p<0.0005 
and **p < 0.001 in NM comparison to serum rich HOMEM, one way ANOVA with 
Dunnett’s multiple comparison test). 
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The IC50s obtained in NM in comparison to those obtained in HOMEM showed one 
compound with no significant effect of the media on the IC50 value, whilst the 
differences observed with other two compounds were 2-fold in magnitude. The 
differences in the susceptibility between the drugs could be partly be explained 
because of different mode of action of each of these drugs explained in more 
detail by Basselin et al, 2002. Briefly, the activity of amphotericin B (average IC50 
710 nM and 554 nM) result in similar IC50 values between the two media; possibly 
owing to the fact that amphotericinB affect the intracellular metabolism of the 
cells especially in lipid biosynthesis [Roy Ph.D. thesis, III, UofG, 2016] not directly 
be affected by culture composition alone.  
 
On the other hand, pentamidine (PTM), inhibitor of anionic amino acid channel 
showed increased leishmanicidal activity in NM (IC50 14 nM) compared to HOMEM 
(IC50 390 nM) which might be because of different concentrations of amino acids 
in serum containing HOMEM media compared to NM.  Variable compositions 
between serum batches contributes to variable action of drugs such as PTM.  
Methotrexate (MTX), inhibitor of dihydrofolate reductase has higher 
leishmanicidal activity in NM (IC50 10 nM) than HOMEM (IC50 200 nM). Dihydrofolate 
reductase contributes to pyrimidine biosynthesis but increased concentration of 
folate in serum containing media might alleviate MTX action in HOMEM compared 
to MTX action in NM described in the discussion section of this chapter. Also, 
addition of biopterin to defined medium inhibits the activity of methotrexate; 
which might partly explain the increased leishmanicidal activity of methotrexate 
in NM compared to HOMEM (Beverley et al., 1986). 
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3.2.2.5 Optimisation of the colorimetric assay for growth monitoring in NM  
Growth analysis of Leishmania promastigotes in culture was conducted by 
optimisation of colorimetric assay as shown in Figure 3.30 and Figure 3.31. 
 
 
Figure 3.30 Optimisation of MTS colorimetric assay in NM with O.D (optical density) on Y 
axis and range of wavelength (300nm to 800 nm). 
2 x 105 cells/mL of L. mexicana promastigotes in NM and absorption spectrum 
measured at 24 (blue), 48 (pink), 72 (green), 96 (orange) hours with tetrazolium 
compound MTS ([3-(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) reagent (Promega).  
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Figure 3.31 Optimisation of colorimetric assay to determine appropriate inoculation density 
with O.D (optical density) on Y axis and Day 0 from the start of culture initiation to Day 5 on 
the X axis. 
 
L. mexicana promastigotes with inoculation densities between 1 x 103 cells/mL 
(brown), 1 x 104 cells/mL (pink), 1 x 105 cells/mL (orange), 1 x 106 cells/mL (green) 
cultured in NM with tetrazolium compound MTS ([3-(4,5-dimethythiazol-2-yl)-5-
(3carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) reagent (Promega) 
were aliquoted to measure the optical density at 395 nm on Day 1, 2, 3 and 4 from 
the start of culture initiation. Naïve medium samples (black) without cells and 
heat killed cells (blue) in the medium were also tested at similar times as positive 
and negative controls.  
 
There was an increase in overall value of optical density with the MTS/PMS dye at 
37oC, however, manual morphological examination of parasites showed increased 
percentage of metacyclics with long slender cell body; not expected at day 3 of 
the culture compared to incubation at 27oC. An important inference meant the 
appearance of the coloured product alone cannot be considered as a direct 
measure of growth; since temperature could accelerate the formation of the 
coloured product and not because of metabolically active cells. Hence, the shift 
in OD at a steady temperature owing to the change in reduction of MTS dye alone 
reflects the metabolic activity to accurately reflect the fold difference in cell 
density. 
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 From Figure 3.30, it was also noted that wells with MTS alone without cells had a 
significant increase in OD readings after 24-hour incubation period. Hence, the 
optimal incubation time was up-to 3 hours which correlated linearly with the total 
count of the parasite. Any further increase in OD after this point of incubation was 
observed due to auto-oxidation. Hence, it was not possible for repeated use of 
same culture plates and variable OD values made control subtraction difficult to 
exclude from background values with the maximum peak activity of optical density 
(O.D) at 395 nm respectively.  
 
From Figure 3.31, the increase in optical density throughout the growth cycle of 
promastigotes in NM was measured under different incubation density with 
optimised at 1 x 106 cells/mL. There was an increase in the OD observed with 1 x 
106 cells/200 µL/well, there was no linear correlation between the shift in OD and 
manual growth counts at further time points. Also, the effect of the cofactors 
which could variously modify the mitochondrial dehydrogenase enzyme activity 
could not be ignored. Thus, a shift in OD due to the conversion rate of the MTS/PMS 
dye into coloured formazan product could not be directly accounted for the effect 
of cofactors on growth. Possibly, OD measured at 380 nm might show better visual 
measurement with MTS reagent; if colorimetric optimisations were to be 
repeated. In summary, these results indicated that evaluation of growth kinetics 
in the presence/absence of additional components was best carried out using 
manual counting and morphological examination as elaborated earlier in section 
3.2.1. 
 
3.3 Discussion 
An undefined component such as serum leads to difficulty in purifying parasite 
antigens for vaccine development, variable metabolic response between different 
batches of serum, contamination of the source serum with other organisms. For 
example, advanced filtration techniques have been adopted to avoid mycoplasma 
infection screening, however, these filters have not yet surpassed to remove 
viruses as explained in Section 1.1. Serum from cattle from particular countries 
has been reported to contain a higher percentage of prions associated with the 
risk of bovine spongiform encephalitis amongst the cattle in Europe and North 
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America [Book on culture of animal cells, Freshney]. To achieve purified cultures 
of Leishmania antigens, metabolic profiles, drug testing and reproducible results 
between experimental repeats under identical experimental conditions, we set 
out to develop a serum and protein free medium. The key features for 
consideration for medium composition was based on the rationale that medium 
has minimal buffer base with only HEPES adjusted to pH 7.4 and the medium has 
purified ingredients to substitute for any non-defined components such as bovine 
serum albumin, casein, urine extracts or Tween80 and thirdly, only minimal 
components required to support growth of L. mexicana promastigotes in vitro. 
Initially, the proportions of components in (Steiger and Black, 1980) were 
adapted.  
 
As shown in Table 3-1, the components of Steiger medium were compared to 
components from the Merlen medium and new base medium with minimum 
components was selected based on the impact of the growth of Leishmania 
promastigotes. REIX medium composition has only 11 amino acids but amino acids 
such as L-Arginine, L-Cysteine, L-Aspartate, L-serine, L-Glutamic Acid, L-
Glutamine, L-Proline, L-Alanine, L-Asparagine and L-Glycine were missing in REIX 
composition. The reason these amino acids were not included in the medium could 
partially be because the REIX medium was optimised for L. donovani species. 
Individual nutritional requirements of L. mexicana promastigotes during the 
growth cycle has not been reported before.  
 
Bioinformatics analysis of amino acid essentiality by comparison of genome 
sequences have shown that L-Arginine biosynthesis pathway is missing in L. major 
[52]. L-Arginine has shown to be subverted from the host cells to support and 
maintain parasite viability and proliferation leading to a high infection rate of 
Leishmania within macrophages (Colotti and Ilari, 2011). Thus, efforts in this 
chapter have been focused on designing medium composition with components 
required for the growth of L. mexicana promastigotes in in vitro culture 
conditions. Since individual requirements of amino acids will vary from one species 
to another, the base medium (BM) was supplemented with equimolar 
concentration at 0.5 mM of all amino acids (Figure 3.2) resulted in higher growth 
rate and viability on sub-passage of L. mexicana promastigotes than REIX.  
 
90 
 
HOMEM media supplemented with 10% FCS has been reported elsewhere that 
amino acids between a range of 0.01-1.0 µM (Wishart et al., 2007).  The range of 
amino acid concentrations are approximate and the order of magnitude varies 
with the type/source of serum used in specific experiments. Direct comparison of 
a range of amino acid concentrations affecting the growth of L. mexicana without 
the influence of undefined components such as serum or serum derived 
macromolecules have not been reported earlier. In this study, 0.5 mM of all amino 
acids was used in the base medium as starting point to test the viability of cells 
in multiple passages for continuous culture. The presence of all amino acids in BM 
supports better growth L. mexicana promastigotes compared to REIX with only 11 
amino acids (Figure 3.2).  
 
Further efforts were made to optimise the growth rate in the defined medium by 
addition of co-factors and metals as appropriate. Results from Figure 3.3 to Figure 
3.14, the results showed that the medium composition was improved by the 
addition of co-factor mixture containing biopterin, lipoic acid, riboflavin and folic 
acid supports increasing cell density and required to be added fresh for continued 
passage. To ensure that only minimal components are present in the medium, we 
tested the effect of replacing folic acid with an equimolar mixture of para-
aminobenzoic acid (PABA) and biopterin, which mammals can readily convert to 
folic acid. The presence of PABA in the culture medium did not lead to increase 
in cell density, confirming that absence of either folic acid or biopterin reduced 
mean cell density (P<0.0001 in both comparisons, n=9, representative data from 
more than five independent experiments, one way ANOVA with Dunnett’s multiple 
comparison test). The addition of cofactors combination containing lipoic acid, 
riboflavin, folic acid and biopterin together decreased the doubling time from 30 
hours to 16 hours along with the addition of metals and all amino acids. 
 
Early studies in Leishmania species report higher requirements of vitamins, 
thiamine, nicotinic acid, pantothenate, riboflavin, biotin, heme, high levels of 
folic acid, 6-hydroxymethylpterine and related pteridines for kinetoplastid 
assemblage (Chang and Hendricks, 1985). Hence, individual co-factors were tested 
based on differences in cell densities by manual counting and colorimetric assays 
to optimise the concentrations required to formulate the composition of Defined 
Medium as shown in Figure 3.3 to Figure 3.14. 
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Extensive literature search for medium compositions including Walkinshaw et al, 
Beverly (Lima et al., 2014, Papadopoulou et al., 2002) served as reference for 
optimising the concentrations of putrescine, p-Aminobenzoic acid, Riboflavin, 
Biotin, DL-α-Lipoic acid (oxidised form), Folic acid, 6-Biopterin to be included in 
the Defined medium. For the purposes of a minimal medium, the rationale was to 
include only those exogenous sources which are required for chemical energy 
generation, precursors and co-factors that have growth promoting action for in 
vitro culture of the parasites. 
 
Putrescine has been recently shown to have substantial growth promoting activity 
for T. cruzi, belonging to the same order of Kinetoplastida (Lima et al., 2014). 
Under the conditions of DM in the presence of all amino acids including L-Arginine, 
we observed there was no significant increase in growth with 10 µM of putrescine 
for L. mexicana promastigotes. Putrescine biosynthesis requires ornithine 
decarboxylase/ L-Arginine decarboxylase (ODC/ ADC) enzyme to convert L-
Arginine to putrescine via ornithine.  JM Boitz et al have shown that ODC mutant 
is unable to infect host macrophages and is indispensable for survival within a host 
system(Boitz et al., 2009). Hence, these results re-confirm that Leishmania 
depends upon de-novo biosynthesis of putrescine via L-Arginine metabolism and 
an exogenous source of putrescine does not have additional growth promoting 
effect (Figure 3.3). 
 
Initially, vitamins included in DM were added from commercial stock solution. 
Different manufacturers have various compositions in their mixture, with certain 
commercial solutions not containing riboflavin, biotin or folic acid in their vitamin 
mixture. Riboflavin is an important co-factor required for NADH biosynthesis and 
energy generation (Opperdoes and Coombs, 2007, Castro and Tomas, 2008); 
hence, it was speculated that addition of this precursor molecule could decrease 
the lag period of growth. The addition of riboflavin had a positive effect (P<0.001 
in both comparisons, n=9 several independent experiments, one way ANOVA with 
Dunnett’s multiple comparison test) with a small increase in cell density with 
riboflavin alone (Figure 3.4); but pronounced growth promoting effect in the 
presence of biopterin.  
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Biotin also had a small positive effect (p<0.001) on the growth of Leishmania 
promastigotes, hence was included in the medium composition as shown in Table 
3-3. Biotin acts as an important cofactor for the enzyme carboxylyases required 
for the fatty acid synthesis. Search for Leishmania specific genes in Genebank 
database returned no accession numbers for enzymes involved in the synthesis of 
most vitamins such as biotin, pantothenate, thiamine, folic acid, etc. 
Bioinformatics analysis by CC Klein, et al 2013 using genomic sequences comparing 
trypanosomatid species indicated a lack of enzymes for the biosynthesis of these 
vitamins (Klein et al., 2013).  
 
The addition of Lipoic acid to BM showed distinct positive effect (p<0.001) with a 
decrease in the lag time of L. mexicana promastigotes in culture compared to the 
absence of it (Figure 3.5). However, the growth promoting ability of lipoic acid is 
less than folic acid or biopterin. Lipoic acid serves as co-factor for enzymes such 
as pyruvate dehydrogenase, branched chain dehydrogenase and other enzymes. It 
has been previously shown that Leishmania has both de-novo biosynthesis pathway 
for lipoic acid and also, Leishmania genome encodes specific transporters to 
uptake lipoic acid from the environment (Bissett Ph.D. thesis, III, UofG, 2009). 
 
Folic acid is another important co-factor tested for growth promoting activity 
using L. mexciana promastigotes. In mammals, a complex compound of folic acid 
in the form of tetrahydrofolate (THF) is required for purine synthesis along with 
serine, glycine and formate(Rowe and Lewis, 1973). THF also serves as an 
important catalyst for reactions in L-Methionine recycling and pyrimidine 
biosynthesis. Folate in Leishmania is metabolised by bifunctional DHFR 
(dihydrofolate reductase) TS-thymidylate synthase to further metabolic 
intermediates such as 5, 10-methylene-tetrahydrofolate (required for pyrimidine 
synthesis); 10-formyltetrahydrofolate required for methionyl-tRNA(Met) 
formylation for protein synthesis (Beck and Ullman, 1990). It was observed that 
increasing concentration of folic acid have a positive growth effect with an 
increase in cell density observed over 9-day period (Figure 3.10). This is in 
agreement with previous data about lack of PABA transporters in Leishmania; 
hence more external dependence for folate and biopterin supplementation in 
defined medium culture (Kar, 1997, Beck and Ullman, 1990); also, when tested 
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with L. donovani promastigotes and Vickers et al (Scott et al., 1987, Vickers and 
Beverley, 2011) with L. infantum species.  
 
In higher eukaryotic organisms, folic acid biosynthesis occurs in the presence of 
PABA with the addition of pterin component and glutamic acid by the enzyme 
DHPS (dihydropteorate synthase)(Rowe and Lewis, 1973). Results as shown Figure 
3.3 to Figure 3.9 demonstrated that addition of PABA did not significantly increase 
cell density. Irrespective of the presence of PABA, only folic acid in conjunction 
with biopterin made a significant increase in cell density. Genome search for DHPS 
in TritrypDB.org returned no hits for the enzyme in L. mexicana. Hence, these 
results confirm that Leishmania relies on the uptake of exogenous folic acid, 
rather than de novo folic acid biosynthesis of the same.  
 
This is in agreement with previous radio labelled studies, no uptake of exogenous 
PABA reported in L. major promastigotes (Beck and Ullman, 1990). Antibiotics 
such as sulphonamides, structural analogs of PABA are reported as ineffective 
against Leishmania (Kumar et al., 2008). It has been confirmed in lizard parasite 
L. tarentolae that folic acid biosynthesis does not proceed through DHPS pathway, 
with speculations of an alternative pathway (Papadopoulou et al., 2002). 
 
In mammals there are two pathways for biopterin biosynthesis, one pathway 
involves GTP as a precursor and other from sepiapterin to tetrahydrobiopterin 
catalysed by dihydrofolate reductase (Crabtree et al., 2009). There have been 
many studies highlighting the importance of biopterin for Leishmania and why it 
deserves further investigation as a drug target (Kaur et al., 1988, Ouellette et al., 
2002). Leishmania might obtain their folate from biopterin; whilst mammals 
bypass this pathway as the pterins are recycled by GTPs and in bacteria, GTP 
contributes to folate. The functional roles of biopterin in trypanosomatids are not 
known. In mammals, it acts as co-factor for L-Phenylalanine hydroxylase, L-
Tyrosine hydroxylase, L-Tryptophan hydroxylase for neurotransmitter 
biosynthesis, but in single celled protozoan parasites there is no neurotransmitter 
biosynthesis, and hence the exact role of pterin is still unclear.  
 
Growth promoting activity of folic acid was increased in the presence of biopterin 
(Figure 3.8). Amongst the co-factors tested, it was observed that addition of 
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biopterin had a significant increase in cell density above 107 cells/mL. Serum 
concentration of biopterin ranges from 1-10 µM (Wishart et al., 2007). It was 
speculated that serum free condition might pose a greater need for biopterin. 
Hence, a range starting from 0-200 µM of biopterin was tested in increasing 
concentration. It was observed that the growth promoting activity of biopterin 
was linear up-until 0-10 µM (p<0.0001) and saturated after that concentration. 
However, supplementation of 100 µM biopterin was required for first axenic 
culture. For example, Leishmania promastigotes from stabilates exhibited a 
significant decrease in the lag period of growth with supplementation of 100 µM 
biopterin directly into the flask. 
 
Growth promoting activity has been checked in two approaches; firstly, the 
addition of each component at a time was tested to determine the impact of the 
cofactors on total cell density achieved on Day 6 of the culture. In this case, the 
concentrations adopted were from other medium formulations (Ouellette et al., 
2002, Moore et al., 1967). Among the co-factors, biopterin alone had significant 
growth promoting activity (p<0.0001, multiple comparison, ANOVA). An 
alternative approach used to validate these results was by single omission of a co-
factor in the culture medium at a time. This showed that biopterin > lipoic acid > 
folic acid > riboflavin followed an increasing order of impact on the in vitro growth 
of promastigotes.  
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Figure 3.32 Pictorial summary of cofactors and metals used in NM composition for the 
growth of L. mexicana promastigotes in culture.  
Abbreviations: Mg- magnesium, Ca-calcium, Fe-iron, Zn-zinc, Mn-manganese, Co-
cobalt 
 
Metal ions serve as co-factors for a variety of biochemical reactions and are 
present in critical sites in many proteins. As a result of their incomplete electron 
shells, metals can shift between different oxidation states. Thus, metals help in 
activation and stabilisation of enzymes depending upon the redox states (Andreini 
et al., 2008). Recent studies have shown that concertation of intracellular metals 
such as Magnesium, Zinc, Iron, Nickel, Cobalt, Copper and Manganese in T. brucei 
played an important role in activation of phosphoglycerate mutase, a novel drug 
target in the glycolytic pathway (Fuad et al., 2011).   
  
 
 
Cofactors 
Metals 
96 
 
In this study, it was of interest to test whether the metals concentration from the 
environment would affect the growth of promastigotes, hence be included to 
improvise growth rate in the defined medium. Under the conditions tested, growth 
was diminished in the absence of magnesium, zinc, calcium and iron compared to 
other metals. Various combinations of the test metals were tried in BM at different 
concentrations. The absence of manganese, cobalt and copper had a minor effect 
on the growth rate. Lack of magnesium and calcium exhibited significant negative 
phenotype of growth with 75% and 60% decrease in cell viability respectively 
(Figure 3.12 and Figure 3.13). Similarly, absence of exogenous zinc and iron 
decreased total cell density by 35% and 45% respectively.   
 
Iron is an important co-factor for various enzymes, especially iron superoxide 
dismutases as protection against oxidative damage resulting from activation of 
NADPH oxidase. Iron uptake has been an extensively regulated process in 
prokaryotes and eukaryotes. At neutral pH, iron exits as oxidised ferric (Fe3+) form 
complexed with ferritin, one of the important factors controlling high iron load in 
hematophagous insect (Valenzuela, 2014). Free form of Fe3+ is reduced to Fe+2; 
however, increased accumulation of ferrous iron (Fe2+) in the presence of oxygen 
undergoes Fenton reaction to form highly toxic hydroxy radicals. There are 
evidences for certain metals such as iron is required to support the growth of 
Leishmania. Wilson et al have assessed the knockout of L1T1, an iron transporter, 
to be essential for infecting macrophages (Wilson et al., 2002). It is also known 
that macrophages control the infection progression via restriction of iron to the 
parasites by secreting lipocalin 2, an antimicrobial peptide that captures proteins 
for internalisation (Flo et al, 2004). Lack of iron decreased the total yield of cells 
obtained on Day 6 of the culture, hence, iron (9 µM) was included in the trace 
metals supplement of BM to support optimal growth of     L. mexicana 
promastigotes. 
 
Except for cobalt, copper, manganese; other metals showed increased viability 
with increasing concentration of metals as shown in Figure 3.12 to Figure 3.19. 
However, it has been shown that cobalt and manganese (Fuad et al., 2011) 
responsible for enzyme activation, hence included in the composition. Zinc has 
been shown to exhibit toxic effects at high concentrations against Leishmania, 
however, absence of zinc at 30 µM as tested showed decreased cell density in 
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Figure 3.12, thus included in the composition. A linear relationship was observed 
between the metal concentration and growth for calcium and magnesium; but less 
for zinc and iron. Magnesium and calcium are required at higher concentrations 
and support growth of promastigotes in vitro. Magnesium at 81 µM and calcium at 
72 µM was included in the medium composition. Iron concentration above 50 µM 
was found to toxic range; hence, low concentration as reported from other 
medium [27] at 9 µM was included in the DM composition. The addition of metals 
to the base medium during culture were tested using standard alamar blue assay 
[48] to study its effect on the growth of the first passage of BM inoculum. 
Individual metal salts were tested with growth monitored in the presence and 
absence of metal chelator. The parasites were seeded at 106 cells/mL. The alamar 
blue reagent was added after 72 hours in culture, thus, growth observed based on 
the reduction potential of reazurin from blue to pink accordingly. 
  
To further validate the medium, inhibition studies were carried out in the 
presence and absence of metal chelators as shown in Figure 3.18 and Figure 3.19. 
Metal chelators such as EDTA and EGTA had growth inhibitory action on Leishmania 
promastigotes. Addition of metals competitively inhibited the growth inhibition 
by these chelators decreased due to competitive inhibition by the addition of 
metals in defined medium composition for the growth of L. mexicana 
promastigotes showed improved growth in presence of metals for growth. 
 
Furthermore, growth experiment in the presence and absence of co-factors 
inhibitors serves to validate the inclusion of co-factors in medium that biopterin 
have growth promoting action on L. mexicana promastigotes in culture as shown 
in Figure 3.17. Biopterin in the medium increases the viability of promastigotes 
even under the influence of the MTX drug. 
 
The IC50 value with biopterin in the medium was higher, indicating compensatory 
biosynthesis pathway activation. The synergistic effect of increased substrate 
concentration of folic acid and biopterin on de-novo thymidine biosynthesis 
overcomes the blockage caused by MTX on the activity of DHFR-TS, the bi-
functional single protein exclusively found in Leishmania cells. These results agree 
with literature on the role of biopterin involved in thymidine biosynthesis 
(Beverley et al., 1986). 
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The addition of haemin for in vitro culture of Leishmania has been elaborated in 
most studies. The requirement of free metal salts for the growth of L. mexicana 
has not been noted before; probably because of the presence of trace metals as 
contaminants from organic solvents. The addition of metals to the medium 
composition was tested individually and in conjunction with biopterin. The 
addition of magnesium, zinc, calcium significantly improved doubling time 
(p<0.01) and iron, copper, manganese, cobalt (p<0.001) with significant effect 
observed in the presence of biopterin in the medium as observed from Figure 3.12. 
Thus, in summary, the cofactors and metals included in the improvisation of the 
growth rate of Leishmania promastigotes in Nayak medium were as shown in  Table 
3-4. 
 
 Table 3-4 Summary of co-factors and metals included in NM 
Co-factors Metal salts 
Folic acid Magnesium septa-hydrate 
Riboflavin Calcium chloride 
PABA Zinc Chloride 
Biopterin Iron (III) nitrate nona-hydrate 
Lipoic Acid Manganese chloride 
Biotin Cobalt chloride 
 
Adenosine serves a purine source for increased demand of nucleotides for DNA and 
RNA synthesis required for rapid proliferation in host cells (Ortiz et al., 2010). 
Leishmania genome encodes for enzymes catalysing the interconversion of 
purines; hence, increasing adenosine might cater for the production of other 
purines and pyrimidines. Leishmania genome encode for de novo bio-synthesis of 
pyrimidines, hence, not essential to be salvaged from the environment (Marr et 
al., 1978).  
 
 
Amongst the purines, it has been reported that adenosine is preferential purine 
source interconvertible to other purines such as hypoxanthine, inositol and 
pyrimidines with enzymes encoded in Leishmania genome (Lafon et al., 1982, 
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Carter et al., 2001). Adenosine serves as important co-factor for L-Methionine 
recycling pathway. Adenosine combines with L-Methionine to form S-adenosyl L-
Methionine which acts proton carrier intermediate for various metabolic pathways 
(Crabtree et al., 2009). Adenosine was tested at various orders of magnitude at 0 
µM, 7 µM, and 74 µM on the growth of L. mexicana promastigotes.  
 
Growth in NM with no adenosine and at 7 µM adenosine equivalent to serum 
adenosine concentration was slow with a low yield of cells compared to cell 
density in the presence of adenosine at 74 µM measured from the growth curves 
as shown in Figure 3.20. Increased adenosine concentration played a major role 
in increased cell density, thus serving as a major growth-limiting nutrient. 
Promastigotes thrive within the mid gut of the insect sand-fly rich in various sugars 
such as glucose, fructose, galactose, ribose and mannose (Leslie et al., 2002). It 
has been previously shown that Leishmania have transporter proteins that 
facilitate the uptake hexose and pentose sugars for carbon and energy purposes 
(Naula et al., 2010). In fact, Steiger et al reported that RE X formulation without 
glucose for the culture of L. donovani promastigotes did not affect the growth of 
promastigotes.  
 
Figure 3.21 indicated that the growth of L. mexicana promastigotes in defined 
medium was not significantly decreased. However, there was 33% increase in 
doubling time in conditions without glucose; with a prolonged lag phase. The total 
number of promastigotes in metacyclics phase were significantly decreased than 
in the culture medium with glucose.  
 
The IC50s of AmpB obtained in NM were comparable to those obtained in 
HOMEM.AmpB showed no significant effect of the medium on the IC50 value; 
however, the differences observed with other two compounds were 2 fold 
magnitude. Methotrexate, inhibitor of dihydrofolate reductase shows poor activity 
in HOMEM (average IC50 200 nM) owing to increased concentration of folate; 
however there was higher activity observed in NM (IC50 14 nM). We have previously 
observed that addition of biopterin to defined medium improves growth and 
inhibits the activity of methotrexate as shown in Figure 3.17; which might partly 
explain the increasing activity of methotrexate in NM and not in HOMEM. Defined 
medium was evaluated for drug sensitivity testing using standard alamar blue 
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assay of clinically used drugs against leishmaniasis. Pentamindine and 
Methotrexate showed increased activity in NM than in serum containing HOMEM 
medium; increased bioavailability of these drugs cost effective for multiple drugs. 
The activity of amphotericin B (average IC50 710 nM and 554 nM) result in similar 
IC50 values between the two media; possibly owing to the fact that AmpB drugs 
affect the intracellular metabolism of the cells especially in lipid biosynthesis 
which might not directly be affected by culture composition alone as shown in 
Figure 3.29 
 
The need for serum free medium for the culture of L. mexicana compelled the 
need to take the more laborious approach by the systematic omission of single 
components and then concentrations of those components with growth promoting 
activity was optimised. Defined medium was developed by individually testing 
each component including amino acids, co-factors and metals at a time and in 
conjunction to map the minimum requirements to support parasite growth for in 
vitro culture conditions. Purification of parasite specific antigens, free of 
contaminants could be better accomplished in the absence of undefined serum 
component; hence useful for generation of parasite specific antibodies and 
vaccine development. Drug sensitivity assays carried out using standard 
leishmanicidal drugs, Amphotericin B and Pentamidine showed increased activity 
in DM than in serum containing medium; increased bioavailability of these drugs 
allowed cost advantages since smaller concentrations were sufficient for 
inhibitory effect tested over multiple trails. Hence, given the morphological and 
nutritional response of promastigotes; we note that defined medium would offer 
a more stable platform for drug sensitivity assays. 
 
Also, since all the components of the defined medium are chemically known; the 
variability between experiments are significantly minimised under similar in vitro 
culture conditions. Thus, defined medium offers stable platform compared to 
batch variability in compositions of serum containing media. This is especially 
important for high throughput methods such as metabolomics and proteomics 
involving analytical instruments such as mass spectrometers which generate vast 
amount of data (Kell et al., 2005). The quality of the data relies on the ratio 
between the signals to noise of the individual chemical compounds. There is a 
significant decrease in background signals in the absence of serum and protein 
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molecules free in the defined medium conditions; hence leading to better 
validation of peaks of the spectrum and compound identification. Stage specific 
differences during L. mexicana promastigotes growth were mapped using defined 
medium for the discovery of novel metabolic pathways unique to the insect stages 
of the parasite addressed in Chapter 5.  
 
A large part of the work for the development of defined medium has been based 
on growth analysis of L. mexicana promastigotes. This was done using manual 
examination of the parasite morphology using trypan blue exclusion test (Chapter 
2, Methods) and viable cell counts using the haemocytometer for growth 
evaluation, a standard technique used routinely in most laboratories. Although 
morphological examination of the promastigotes in different medium 
compositions have been evaluated, it was very laborious and time consuming 
method. Therefore, efforts were made to adopt colorimetric assays.  
 
Three different types of colorimetric assays were evaluated as stated. Alamar blue 
assay routinely used for growth evaluation in the presence/absence of drugs (Raz 
et al., 1997). The reazurin dye (blue) is reduced by mitochondrial NADH 
dehyrogenase enzyme into resorufin (pink) coloured product, measured 
spectrophometrically at 570 nm.  
 
MTT assay involves conversion of tetrazolium salt, 3-(4, 5- dimethylthiazol-2-yl)-
2, 5, -diphenyltetrazolium bromide into coloured product. Cells lysis needed to be 
carried out before OD measurement served as major limitation; since the entire 
reaction relied on the principle of conversion of soluble colourless formazan into 
insoluble formazan by mitochondrial dehyrogenase. Measurement of formazan was 
possible only after harsh treatment with chemical reagents such as alcohols and 
dimethylsulfoxide (DMSO) (Henriques et al., 2011). 
 
MTS assay was carried out according to (Berg et al., 1994) but modified for various 
steps of optimisation as stated. 50 µl PMS stock solution was added to 1 mL MTS 
stock solution immediately before use. Mid log phase promastigotes (1 x 105 
cells/ml) per 100 µl/well were seeded in 96 well plates. Heat killed parasites were 
prepared by incubating the parasites at 99oC for 30 min which served as negative 
control. MTS/PMS was diluted to 5:1 with PBS and 20 µl was added to each well 
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and incubated at 37oC for 3 hours. Absorbance was measured at 490 nm using plate 
reader. The optical density of the medium minus the background OD was 
considered as the corrected absorbance value plotted against each parameter 
tested.  
 
The advantages and disadvantages of the different colorimetric methods such as 
Alamar blue, MTT and MTS/PMS dye, were evaluated as shown in Table 3-5. 
Table 3-5 Comparison of colorimetric assays for monitoring growth of Leishmania 
promastigotes 
Name of the compound Advantages Disadvantages 
MTT-3-(4, 5- 
dimethylthiazol-2-yl)-2, 5, 
-diphenyltetrazolium 
bromide 
Enzymatic method Insoluble dye not released 
into the system 
Alamar blue Reliable and optimised for 
L. mexicana drug 
sensitivity assays. 
Lengthy incubation time 
required for the complete 
metabolism of the 
reazurin salt; hence not 
very suitable for 
monitoring subtle changes 
in growth kinetics. 
MTS/PMS dye 3-(4, 5- 
dimethylthiazol-2-yl)-5-
(3-
carboxymethoxyphenyl)-
2( 4 –sulphonyl)-2H-
tetrazolium  
Soluble end product 
rapidly released into the 
system  
 
Lesser incubation time 
Needed to be optimised 
for L. mexicana 
promastigotes growth 
conditions. 
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Extensive optimisation of the assays for the cells of interest, L. mexicana 
promastigotes, was conducted for the parameters involving different inoculation 
densities, different lengths of incubation, temperature and range of wavelength 
for optical density measurement as follows: 
 
a) Evaluation of optimal inoculation cell density-Different densities of cells 
containing 1 x 105, 5 x 105, 1 x 106, and 5 x 106 in 96 well flat bottom plates were 
tested in triplicates as shown in Figure 3.31.  
b) Evaluation of optimal temperature for the assay-The 96 well plates were 
incubated at different temperature of 27oC and 37oC 
c) Evaluation of optimal incubation time-L. mexicana promastigotes with or 
without MTS/PMS dye in 96 well plates were incubated for several time points at 
3, 24, 48, 72, 96, 120 and 144 hours as shown in Figure 3.30. 
d) Evaluation of optimal wavelength- Scanning spectrophotometer was used to 
measure the absorbance spectrum of the formazan product resulting from the 
reduction of MTS at various incubation times as stated above. This was mainly 
carried out to evaluate the background change in optical density due to cell 
debris, fingerprints and other non-specific absorbance as shown in Figure 3.31. 
However, the fold change between the optical densities (O.D) is minimal, 
therefore it could not infer as an accurate measure of the growth of L. mexicana 
promastigotes. 
 
The linear range of the MTS assay was measured for 1 x 105 to 5 x 106 /well/200 
µL. The corrected absorbance was plotted against the starting inoculation density 
(X axis).  For cell density above 5 x 105, the increase in cell density showed a 
positive correlation with the corresponding increase in O.D value; however, the 
opposite was observed for cell densities above 5 x 106 cells/mL with dye 
saturation. Results as shown in Figure 3.31; that there was no shift in the optical 
density in wells with cell density below 105 cells/ml. The values were linear only 
for wells with starting density with 1 x 106; however, the fold difference between 
the OD values was not as significant as observed from manual counting. 
 
Also, there were speculations about any minor toxic role of MTS/PMS reagent on 
the parasites growth. Cell numbers in the presence of MTS/PMS reagent. L. 
mexicana promastigotes cultured in HOMEM and defined medium with and without 
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MTS/PMS reagent in culture wells were also examined for density effect on 
motility. The percent motility of cells was reduced and hence manual analysis was 
chosen as adapted method for analysis of cell viability. 
 
In summary, the development and establishment of defined medium would enable 
design of novel experimental protocol customised to the question of interest. 
Amino acids have been tested for their impact on viability and growth of L. 
mexicana promastigotes as shown in Chapter 4. 
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Chapter 4 Determination of amino acid requirement 
for parasite viability  
 
4.1 Introduction  
 
Amino acids have varied functions ranging from protein synthesis, energy 
production to maintaining homeostasis. In general, amino acids classification has 
been broadly described based on nutrition or chemical nature. The term essential 
and non-essential amino acids as coined by W.C Rose was based on nutrition value 
of individual amino acids (Womack and Rose, 1947, Womack and Rose, 1934, 
Mccoy et al., 1935). However, the essentiality of amino acids has been subject to 
debate depending upon various factors about the metabolic, dietary and 
functional capabilities of a particular organism (Reeds, 2000, Millward and Rivers, 
1988, Boutry et al., 2008).  
 
Much of the knowledge on amino acid essentiality in Leishmania parasites relies 
on early biochemistry work on related species of Kinetoplastida with different 
hosts (Cross et al., 1975, Cross and Manning, 1973). Silber et al in Trypanosoma 
cruzi demonstrated that the insect stage exhibited higher dependence on amino 
acid metabolism (Silber et al., 2005). Especially, L-Proline has been shown as 
carbon source consumed from the host and serves as a major osmolyte during the 
differentiation process from the replicative, non-infective epimastigote to the 
infective, non-replicative trypomastigote stages (Silber et al., 2002). In T. brucei, 
it was observed that the procylic forms depend on amino acids for energy 
metabolism compared to the bloodstream forms, exclusively on glycolysis (Michels 
et al., 2000).  Though genetically similar, Leishmania encounters different 
nutritional host environments as compared to related Trypanosoma species 
(Burchmore and Barrett, 2001).  
 
In human infecting Leishmania promastigotes, it has been shown to utilise amino 
acids as both carbon and energy sources (Burchmore and Barrett, 2001, Saunders 
et al., 2010). Promastigotes are known to undergo a complex developmental cycle 
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in the alimentary tract of the insect, sand-fly (Kamhawi, 2006). It has been 
previously shown that parasites have the metabolic capability to utilise L-Proline 
as their preferred carbon source in the absence of glucose (Burchmore et al., 
2003). Radio labelled studies have shown that L-Proline contributes to the carbon 
skeleton of several other metabolites including other amino acids through the 
transamination process via L-Glutamine (Mukkada, 1985). Amino acids serve as 
precursors for metabolites leading to energy production for growth, regulation of 
oxidative stress (Colotti and Ilari, 2011) and for osomo-regulation (Blum, 1996). 
However, the role of individual amino acids in parasite viability without 
extraneous supplements such as serum and protein is unexplored.  
 
4.1.1 Determination of impact of amino acids on parasite viability 
 
Krassner and Flory (1971) conducted experiments to determine amino acid 
essentiality in Leishmania tarentolae (Krassner and Flory, 1971). Parasite growth 
was monitored for six successive sub-cultures (each 5-7 days long) and reported 
that L-Arginine, L-Histidine, L-Tryptophan, DL-Phenylalanine, DL-serine, L-L-
Tyrosine, L-Threonine, L-Valine, L-Leucine and L-Lysine were found essential. It 
can be argued that amino acids essentiality during six sub cultures might allow for 
adaptive prototrophic growth and also, L. tertentole is a lizard infecting parasite. 
Early work by Steiger et al determined the effect of amino acids on growth of L. 
donovani with variable amino acid concentrations (Steiger and Steiger, 1977). 
Recent studies show that Leishmania species largely differ in amino acid 
metabolism (Westrop et al., 2015), but as in most other studies, was conducted 
in the presence of extraneous supplements such as serum (modified) or proteins 
and other intermediates (Saunders et al., 2011). Because of the paucity of data 
on amino acid essentiality in human infecting L. mexicana species in minimal 
defined media conditions, this study represents the first step towards this 
direction. Here, systematic analysis of amino acid essentiality for the growth of 
L. mexicana promastigotes was carried out by the creation of a novel equimolar 
single amino acid knock out media, modified from serum and protein free Defined 
medium as described in Chapter3.  
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4.1.3 Research aims  
 
➢ The design of novel equimolar amino acid knock out media for the culture 
of L. mexicana promastigotes. 
➢ The impact of individual amino acids on parasite viability was examined in 
novel single amino acid knock out media by: 
o Growth analysis 
o Protein production 
o Acetate overflow quantification 
➢ Growth analysis in presence of selected amino acid analogues as drugs. 
4.2 Results  
 
4.2.1 Preparation of novel single amino acid knock out media 
 
Single amino acid knock out media were prepared by modification of Nayak 
medium composition (Chapter 1) as elaborated in Chapter 2 methods section as 
shown in Figure 4.1. Individual bottles were then adjusted to pH 7.4 and stored at 
4oC. 
                      
Figure 4.1: Workflow for preparation of single amino acid knock out media 
Briefly, Nayak medium minus all amino acids media (NM-AA) were aliquoted into 
21 different autoclaved bottles. To the first medium, each of the 20 proteogenic 
amino acids were added at 0.5 mM, this equimolar amino acid medium is hereby 
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referred to as Nayak medium (NM) and to subsequent bottles, all amino acids bar 
one were added to make the single amino acid knock out media referred to as 
Nayak medium minus each amino acid as specified (NM-specified AA) were used 
for subsequent growth and biochemical analysis. 
4.2.2 Growth analysis in single amino acid knock out media 
 
The growth of L. mexicana promastigotes was monitored in defined media 
containing all but one of the 20 standard proteogenic amino acids, hereafter 
referred to as single amino acid knock out media as described in methods section 
of Chapter 2. Growth curves were compared and doubling time was calculated by 
least square fitting of the growth curve (Steel, 1967) as shown in Figure 4.2. 
Regression analysis was used to find the portion of the curve which is linear during 
exponential phase mostly between 48 and 120 hours in single amino acid knock 
out media. The resulting slope obtained was used to find the growth rate (K), 
substituted in the equation as K = log (2)/ Doubling time which corresponds to 
order the importance of individual amino acids as highlighted in Figure 4.3.  
                           
Figure 4.2: Growth curve of L. mexicana promastigotes in single amino acid knock out 
media.  
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5 x 105 cells/mL of L. mexicana promastigotes in single amino acid knock out 
media containing 0.5mM of all standard proteogenic amino acids bar one, 
specified with 3 letter abbreviations for 9-day growth period at pH 7.4 at 27oC, 
n=9, Error bars = mean ± SD, as described in experimental procedure. HOMEM is a 
standard semi-defined hemoflagellate culture medium with 10% FCS (Berens et 
al., 1976). NM (Table 3-3) is a defined medium containing all 20 proteogenic amino 
acids and negative control, NM-AA media, NM (named amino acid -ve). 
It was observed that in absence of exogenous source of L-Tryptophan or L-
Phenylalanine, the promastigotes were not viable for more than 4 hours in culture. 
Whilst absence of L-Arginine, L-Lysine, L-Leucine there was no viable 
promastigotes in culture beyond Day 3. The absence of L-Valine pronounced lag 
phase and stunted morphology as demonstrated through measurement of cell body 
length explained in Figure 4.3. Thus, the exogenous presence of individual amino 
acids such as L-Tryptophan, L-Phenylalanine, L-Arginine, L-Lysine, L-Leucine and 
L-Valine were noted as important for the viability of promastigotes in culture. 
Growth rate expressed as doubling time was used to calculate the order of amino 
acid importance for the growth of the L. mexicana promastigotes under conditions 
tested were as follows L-Tryptophan > L-Phenylalanine> L-Lysine> L-Arginine> L-
Leucine> L-Valine> L-Aspartate> L-serine> L-Histidine> L-isoleucine> L-Threonine> 
L-Glutamate> L-Methionine> L-Glutamine> L-cysteine> L-L-Tyrosine> L-Proline> L-
Asparagine > L-Alanine> L-glycine in Figure 4.3. 
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Figure 4.3: Doubling time of L. mexicana promastigotes in single amino acid knock out 
media.  
(Single amino acid knock out media contains 0.5mM of all standard proteogenic 
amino acids bar one, as specified in 3 letter abbreviation. HOMEM is a standard 
semi-defined hemoflagellate culture medium with 10% FCS (Berens et al., 1976). 
NM (Table 3-3) is a defined medium containing all 20 proteogenic amino acids and 
NM-AA contains no amino acids. Dashed line to show comparison with doubling 
time in NM. For all samples, doubling time was calculated by least square fitting of 
the growth curve (Steel, 1967). (n=9, Error bars = mean ± SD) The number of 
asterisks indicate significant p values with **** P<0.0001, *** p<0.0005, ** p<0.001 
and * p<0.05 one way ANOVA with Dunnett’s multiple comparison test to NM). 
Statistical significance calculated independently for experimental repeats conducted 
in triplicates each time. 
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4.2.3 Growth analysis in minimal amino acid media 
                         
Figure 4.4: Cell viability expressed as percentage of L. mexicana promastigotes  
 
Cell viability of L. mexicana promastigotes in HOMEM and NM compared to NMM 
(Nayak minimal medium, minimal amino acid media composed of 6 amino acids) 
and in NMM individually lacking component 6 amino acids each condition with n=9, 
Error bars = mean ± SD and statistical significance calculated independently for 
experimental repeats conducted in triplicates each time. 
 
Growth analysis from single amino acid knock out media was further confirmed by 
the preparation of minimal amino acid media referred to as Nayak Minimal Medium 
(NMM). NMM composed of only 6 important amino acids of 0.5 mM of L-Leucine, L-
Arginine, L-Lysine, L-Valine, L-Phenylalanine and L-Tryptophan. It was observed 
that about 80% of L. mexicana promastigotes were viable in NMM compared to 
100% viability in NM and HOMEM plus 10% FCS. However, NMM lacking individual 
component amino acid such as L-Tryptophan, L-Phenylalanine, L-Leucine, L-
Arginine and L-Lysine were non-viable and absence of L-Valine showed more than 
50% decrease in cell viability as shown in Figure 4.4.  
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4.2.4 Growth analysis at different concentrations of amino acids  
   
The six amino acids, L-Tryptophan, L-Phenylalanine, L-Lysine, L-Arginine, L-
Leucine and L-Valine identified as most important exogenous sources required for 
the viability of promastigotes were further investigated in dose dependent manner 
as shown in Figure 4.5. 
 
 
 
Figure 4.5: Growth response of L. mexicana promastigotes in the presence of 0-10mM of 
individual amino acids as specified in appendix table-1. 
  
5 x 105 cells/mL of L. mexicana promastigotes in single amino acid knockout  
media containing 0.5mM of all standard proteogenic amino acids bar one as 
specified for 6 day growth period at pH 7.4 at 27oC, n=6. Experiment was carried 
out using alamar blue assay (Raz et al., 1997) in 96 well plate as described in 
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experimental procedure with each amino acid specified in 24 concentrations by 
serial dilution from 10 mM-0 mM depicted in log(M) values as described in appendix 
table 1. All wells were set at same starting cell density as inoculum and 
absorbance values measured on Day 6 and plotted using Graph pad Prism software. 
The IC50 values for all these six amino acids was found to be in the range between 
0.156 mM and 0.625mM; thus equimolar supplementation of amino acids at 0.5mM 
was considered for Nayak medium composition.  
 
The six critical amino acids, L-Tryptophan, L-Phenylalanine, L-Lysine, L-Arginine, 
L-Leucine and L-Valine identified as most important exogenous sources were 
further investigated and growth of L. mexicana promastigotes tested in the 
presence of increasing concentration of individual amino acid as specified at 
10mM-0mM in serial dilutions with other amino acids constant at 0.5mM each in 
modified NM as shown in Figure 4.5. There were no viable cells in wells between 
0 mM and 0.1 mM (log (M) with constant absorbance values similar to base line in 
wells containing medium only samples. There was an increase in absorbance 
between 0.1 mM and 0.5 mM concentrations of individual amino acids as specified. 
It was observed that presence of increased amino acid concentration of above 
0.5mM showed an improved growth response, especially for L-Tryptophan and L-
Arginine. 
 
 4.2.5 Growth analysis in modified minimal amino acid media 
 
To further investigate the importance of the other 14 amino acids on parasite 
growth, L. mexicana promastigotes were monitored in minimal medium with and 
without the addition of each of the 14 amino acids individually as shown in Figure 
4.6 and doubling time calculated from linear regression analysis from the 
exponential phase according to Steel et al, 1967. 
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Figure 4.6 Growth rate expressed in doubling time for L. mexicana promastigotes in minimal 
amino acid media.  
  
5 x 105 cells/mL of L. mexicana promastigotes cultured in HOMEM, NM, NMM and 
NMM plus specified amino acid indicated with their respective 3 letter 
abbreviation for 9-day growth period at pH 7.4 at 27oC, n=9, error bars = mean ± 
SD, as described in methods chapter 2. HOMEM is a standard semi-defined 
hemoflagellate culture medium with 10% FCS (Berens et al., 1976). NM (Table 3-3) 
is a defined medium containing all 20 proteogenic amino acids at 0.5mM each, 
NMM is a minimal media with 6 amino acid and NMM plus individual amino acid as 
specified at 0.5mM. The number of asterisks indicate significant p values with **** 
P<0.0001, *** p<0.0005, ** p<0.001 and * p<0.05 one way ANOVA with Dunnett’s 
multiple comparison test to NMM. Statistical significance calculated independently 
for experimental repeats conducted in triplicates each time. 
 
Compared to the six amino acids as found in NMM, addition of all amino acids in 
NM significantly reduced the doubling time as shown in Figure 4.6. Especially, the 
exogenous presence of L-Aspartate and L-Glutamate had growth promoting effect 
on L. mexicana promastigotes, followed by L-Glutamine and L-serine compared to 
the other remaining amino acids. 
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4.2.6 Morphological analysis in single amino acid knock out media 
 
To investigate the influence of individual amino acids on the morphology of the 
parasites, average cell body length per 50 L. mexicana promastigotes in single 
amino acid knock out media were assessed by giemsa stain and ImageJ analysis as 
shown in Figure 4.7. 
 
 
 
 
Figure 4.7 Average cell body length in single amino acid knock out media. 
(5 x 105 cells/mL of L. mexicana promastigotes cultured in HOMEM, NM, single 
amino acid media of NM bar one amino acid as specified with their respective 3 
letter abbreviation at pH 7.4 at 27oC, n=9, Error bars = mean ± SD, as described 
in experimental procedure. HOMEM is a standard semi-defined hemoflagellate 
culture medium with 10% FCS (Berens et al., 1976). NM (Table 3-3) is a defined 
medium containing all 20 proteogenic amino acids at 0.5mM each. The number of 
asterisks indicate significant p values with **** P<0.0001, *** p<0.0005, ** p<0.001 
and * p<0.05 one way ANOVA with Dunnett’s multiple comparison test to NMM. 
Statistical significance calculated independently for experimental repeats 
conducted in triplicates each time. Dashed line indicates cell body length in NM. 
For all samples, giemsa stained images were analysed using ImageJ software on 
Day 6 from the start of the culture initiation and represented as their frequency 
distribution.)                                      
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The average cell body length of L. mexicana promastigotes in NM containing all 
amino acids was measured to be ~12µm which was not statistically different to 
~15 µm in serum containing HOMEM medium. Omission of six amino acids including 
L-Tryptophan, L-Phenylalanine, L-Lysine, L-Arginine, L-Leucine and L-Valine 
individually or also L-isoleucine, L-Methionine, L-Histidine and L-Threonine 
individually as shown in Figure 4.7 showed stunted morphology and ~50% decrease 
in cell body length. 
 
However, it was recorded that absence of L-Aspartate, L-serine, L-Glutamate, L-
Methionine, L-Glutamine, L-cysteine, L-L-Tyrosine, L-Proline, L-Asparagine, L-
Alanine and L-glycine did not show significant negative phenotype measured by 
cell body length of metacyclic promastigotes on Day 6 from the start of culture 
initiation as shown in Figure 4.7. 
 
4.2.7 Protein determination in amino acid drop out media and 
bioinformatics approach 
 
Amino acids serve as primary building blocks in proteins synthesis. In order to 
understand relative influence of individual amino acids on protein synthesis, whole 
cell lysates from single amino acid knock out media were analysed for total protein 
concentration as shown in Figure 4.8. 
 
Figure 4.8 Protein quantification in single amino acid knock out media. 
Dashed line indicates protein concentration (mg) in single amino acid knock out 
media compared to NM on Day 6. About 1 x 107 cells were inoculated on Day 0 as 
117 
 
the start of culture initiation in different single amino acid knock out conditions 
with NM (named amino acid-ve) and on Day 6 total protein estimated from all 
samples. 1 x 107 cells/mL of L. mexicana promastigotes were cultured in HOMEM, 
NM as controls at pH 7.4 at 27oC, n=9, Error bars = mean ± SD, as described in 
experimental procedure. HOMEM is a standard semi-defined hemoflagellate 
culture medium with 10% FCS (Berens et al., 1976). NM (Table 3-3) is a defined 
medium containing all 20 proteogenic amino acids at 0.5mM each. The number of 
asterisks indicate significant p values with **** P<0.0001, *** p<0.0005, ** p<0.001 
and * p<0.05 one way ANOVA with Dunnett’s multiple comparison test to NM. 
Statistical significance calculated independently for experimental repeats conducted 
in triplicates each time.  
 
From these results as shown in Figure 4.8, the omission of L-Lysine has the most 
significant impact on protein production followed by L-Leucine, L-Valine, L-
Arginine, L-Tryptophan and L-Phenylalanine compared to other amino acids under 
identical conditions. Interestingly, promastigotes cultured in media without L-
Threonine, L-Histidine, L-isoleucine and L-Methionine were much smaller in size 
and showed significantly less protein production. These results indicate that 
limiting individual amino acids in vitro induces differential nutritional stress 
leading to decrease of global protein synthesis.  
 
To further investigate the relative incorporation of individual amino acids into the 
global proteome, a bioinformatics approach was undertaken. The protein 
sequence files of L. mexicana proteome from TritrypDB database was collected 
and processed using in house script (appendix) to decipher codon usage of 
individual amino acids to calculate the occurrence of individual amino acid 
expressed as relative amino acid frequency per amino acid residues in the global 
proteome as shown in Figure 4.8. 
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Figure 4.9 Amino acid distribution in the global proteome of L. mexicana 
promastigotes. 
 
From Figure 4.9, the number of individual L-Lysine incorporation into proteins was 
found to be high, which is in agreement with the results from Figure 4.8 on the 
importance of exogenous L-Lysine source for protein synthesis. However, the 
number of L-Tryptophan incorporated into proteins was found to be less compared 
other amino acids. These results highlight the differential roles of these amino 
acids and their influence on global protein synthesis in correlation to the growth 
cycle of the organism.     
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4.2.8 Energy determination in amino acid knock out media via 
acetate quantification 
 
 
Acetate is major high energy intermediate at the crossroads between glucose and 
amino acid catabolism. Acetate concentration in the extracellular environment 
has been used as an indicator of the intracellular activities to understand the 
relative contribution of amino acid to energy production as shown in Figure 4.10, 
Figure 4.11 and Figure 4.12.   
                        
 
Figure 4.10 Acetate concentration (mM /107 cells) of L. mexicana promastigotes in NM 
supernatant samples from Day 0 to Day 6 from the start of culture initiation. 
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Figure 4.11 Acetate concentration (mM /107 cells) of L. mexicana promastigotes in NM-
Glucose supernatant samples from Day 0 to Day 6 from the start of culture initiation. 
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Figure 4.12 Acetate concentration (mM/107 cells) in supernatant samples of single amino 
acid knock out media. 
(Dashed line indicates acetate concentration (mM) per 1 x 107 cells in single amino 
acid knock out media compared to NM on Day 6 from the start of culture initiation. 
5 x 105 cells/mL of L. mexicana promastigotes cultured in HOMEM, NM, single 
amino acid media of NM bar one amino acid as specified with their respective 3 
letter abbreviation at pH 7.4 at 27oC, n=9, Error bars = mean ± SD, as described in 
experimental procedure. HOMEM is a standard semi-defined hemoflagellate 
culture medium with 10% FCS(Berens et al., 1976). NM (Table 3-3) is a defined 
medium containing all 20 proteogenic amino acids at 0.5mM each. The number of 
asterisks indicate significant p values with **** P<0.0001, *** p<0.0005, ** p<0.001 
and * p<0.05 one way ANOVA with Dunnett’s multiple comparison test to NM. 
Statistical significance calculated independently for experimental repeats conducted 
in triplicates each time).  
 
Here, in Figure 4.10, it was found that acetate overflow increased in the 9 day 
growth period tested. From Figure 4.11, it was found that without glucose, the 
amino acids contributed less to overall acetate overflow. And from Figure 4.12 it 
was understood that with the exception of L-glycine, L-Asparagine and L-Alanine, 
the supernatant of single amino acid knock out media of other amino acids were 
found to contain less acetate concentration. These results are in agreement with 
growth analysis that absence of specific amino acids resulted in decreased growth 
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leading to decreased metabolism, hence decreased acetate overflow in the 
supernatant samples.  
 
4.2.9 Amino acid analogues as drugs 
 
The aromatic amino acid analogues for L-Phenylalanine (p-fluro-L-Phenylalanine), 
L-Methionine (Norleucine), L-Tyrosine (3-Fluro-L-Tyrosine) and L-Tryptophan (5-
fluro-L-Tryptophan) were tested. 12 different concentrations were serially diluted 
starting from 100 µM to 49 nM depicted as log of molar concentration described in 
appendix table 2. The drug activity on the parasites was measured 120 hours using 
alamar blue assay described in methods section of chapter 2.  
 
 
Figure 4.13 Differential inhibition by amino acid analogues on the growth of L. mexicana 
promastigotes in NM with Norleucine (inverted triangle), 5-fluro-L-Tryptophan (asterisk), p-
fluro-L-Phenylalanine (inverted cross) and 3-Fluro-L-Tyrosine (cross). 
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Table 4-1 Table of IC50 of amino acid analogues 
Amino acid Analogues IC50 (µM) 
L-Methionine Norleucine  2.39 
L-Phenylalanine P-fluro-L-Phenylalanine 2.62 
L-Tyrosine 3-fluro-L-Tyrosine 1.47  
L-Tryptophan 5-fluro-L-Tryptophan 1.09 
 
From the alamar blue assay, it was observed that the growth of promastigotes is 
considerably affected by increasing concentration of the amino acid analogues. 
The presence of even small concentration (IC50 1.09 µM) of 5-fluro-L-Tryptophan, 
L-Tryptophan analogue proved detrimental for the viability of the Leishmania 
promastigotes. The IC50 values for amino acid analogues for L-Tyrosine (IC50 1.47 
µM) followed a similar pattern as L-Tryptophan. The results for both p-fluro-L-
Phenylalanine and nor-L-Leucine showed a similar pattern of inhibition of growth, 
but at a higher concentration than the former two; as specified in Table 4-1 
described in more details in discussion section. 
 
4.3 Discussion 
 
4.3.1 Growth analysis in single amino acid knock out media 
Amino acids play a fundamental role in many biological processes such as protein 
synthesis, alternative energy production and homeostasis. Studies about amino 
acids required to maintain osmoregulation within the host system (Blum, 1996), 
and unique metabolism of amino acids leading to antioxidant-polyamine 
biosynthesis (Colotti and Ilari, 2011) within Leishmania has been reported.  
However, amino acid requirements of Leishmania had been mostly based on early 
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biochemistry research on related species of kinetoplastida with different hosts 
(Krassner and Flory, 1971, Coombs et al., 1982, Steiger and Steiger, 1977, Steiger 
and Steiger, 1976, Steiger and Black, 1980). Lack of missing enzymes within 
metabolic pathways might highlight alternative routes of metabolism that could 
be targeted for potential drugs. A thorough understanding of amino acid utilisation 
and metabolic pathways in Leishmania would aid in the discovery of novel drug 
targets (Zilberstein, 1993, Goldman-Pinkovich et al., 2011).  
 
Here, our aim was to identify amino acids in their order of importance required 
to support growth for L. mexicana promastigotes. Single amino acid knock out 
media were prepared by methods elaborated in Chapter 2 and growth and 
biochemical analysis were monitored by culturing of L.mexicana promastigotes 
lacking each individual amino acid at a time. Our experiment allowed us to study 
the comparative effect of each amino acid on growth and determine their 
physiological importance.  
 
Growth analysis from single amino acid knock out media demonstrated the order 
of importance of amino acids as L-Tryptophan > L-Phenylalanine> L-Lysine> L-
Arginine> L-Leucine> L-Valine> L-Aspartate> L-serine> L-Histidine> L-isoleucine>  
L-Threonine> L-Glutamate> L-Methionine> L-Glutamine> L-cysteine> L-L-
Tyrosine> L-Proline> L-Asparagine > L-Alanine> L-glycine under identical 
conditions of starting inoculum, temperature and pH.  
  
The viability of L. mexicana promastigotes in the absence of L-Tryptophan or L-
Phenylalanine decreased significantly in as less as four hours in culture Figure 
4.2. Lack of L-Tyrosine showed sustained growth, yet small increase (** p<0.001) 
in doubling time compared to growth observed in defined medium with an 
equimolar mixture of all amino acids. These results are in agreement with Beverly 
et al that PAH knock out Leishmania major promastigotes showed viability in L-
Tyrosine deficient media but unable to survive in L-Phenylalanine or L-
Tryptophan deficient media (Lye et al., 2011). But the fact that our study 
compared all amino acids at the same time and highlights L-Tryptophan and L-
Phenylalanine as most important for viability indicates an additional role in 
supporting parasite viability. It has been shown that L-Phenylalanine acts as an 
important regulator of starvation signalling in mammalian systems via mtor 
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pathway (Vendelbo et al., 2014). Phenylalanine might act similarly in Leishmania 
with signalling role in gene expression and regulation required to support growth 
in these parasites. Leishmania genome encodes for L-Phenylalanine hydroxylase 
(PAH) responsible for L-Tyrosine biosynthesis from L-Phenylalanine, but knock out 
of this particular gene proved that the gene was not essential for viability, further 
emphasising the fact that exogenous L-Phenylalanine may be involved in multiple 
roles required to sustain the viability of L. mexicana promastigotes.  
 
The absence of L-Arginine, L-Lysine, L-Leucine showed no proliferation, hence no 
doubling time of promastigotes as shown in Figure 4.3. However, the absence of 
L-Valine showed sustained viability, albeit, less efficiently with significantly 
increased doubling time (P<0.0001) and distorted morphology. The importance of 
L-Arginine for viability could be attributed to many roles of L-Arginine in the 
production of antioxidants such as spermidine and putrescine in the polyamine 
biosynthesis, trypanosomatid-specific antioxidant molecule, trypanothione has 
been reported extensively (Colotti and Ilari, 2011, Wanasen and Soong, 2008). L-
Arginine is also reported to be converted to phosphoarginine, high energy 
phosphagen,  in peroxisome like organelles, known as glycosomes (Voncken et 
al., 2013). The presence of exogenous L-Lysine was observed important for the 
viability of L. mexicana promastigotes which was observed primarily due to its 
contribution to protein production. Amongst the branch chain amino acids, L-
Leucine proved to have a significant effect compared to L-Valine and L-
isoleucine. It has been previously shown that L-Leucine in Leishmania is 
catabolised into 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) which is 
incorporated into sterols (Ginger et al., 2001, Ginger et al., 1999) with unique 
enzyme HMG-CoA synthase not found in mammals. The absence of L-Valine had 
pronounced lag phase with distorted morphology as observed through giemsa 
staining. Hence, an exogenous source of six amino acids namely L-Tryptophan, L-
Phenylalanine, L-Lysine, L-Arginine, L-Leucine and L-Valine were found to be 
most important for the viability of L. mexicana promastigotes.  
 
To further confirm the impact of other amino acids, provisional medium referred 
to as NMM (Nayak minimal medium) with and without each of the other amino 
acids were tested.  From these experiments, the growth rate of promastigotes 
significantly improved in the presence of L-Aspartate, L-Glutamate, L-serine and 
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L-Glutamine. L-Aspartate has shown to contribute its carbon skeleton for the 
formation of various TCA cycle intermediates, including oxaloacetate, succinate 
and fumarate confirmed by heavy stable isotope in targeted metabolomics 
(Saunders et al., 2011), and also been shown in production of glucose and 
contribution to storage molecule mannonogen (Rodriguez-Contreras and 
Landfear, 2006). Thus, L-Aspartate serves as fuel for oxidative phosphorylation 
and gluconeogenesis might contribute to the growth promoting action of L-
Aspartate.  
 
In the presence of both L-Glutamate and L-Glutamine in the medium, parasites 
showed a significant decrease in doubling time. This indicates that L. mexicana 
promastigotes prefer an exogenous source of L-Glutamate and L-Glutamine, 
despite the metabolic capability for L-Glutamate and L-Glutamine biosynthetic 
pathways. It has been shown that labelled carbon from glucose converted to 
pyruvate undergoes transamination reaction with alpha-ketobutyrate leading to 
L-Glutamate production catalysed by L-Glutamate dehydrogenase (GDH) 
(Opperdoes, 2008). L-Glutamate fuels the TCA cycle either by conversion primary 
intermediate alpha-ketobutyrate or by conversion to succinate via 4-
aminobutanoate pathway. L-Glutamate also serves as a major source for L-
Glutamine synthesis via the L-Glutamine synthetase. L-Glutamine reported being 
the key player for regulation of nitrogen metabolism (Manhas et al., 2014) and 
nitro group donor for pyrimidine biosynthesis (Carter et al., 2008) and amino 
sugar production (Naderer et al., 2008).   
 
From the growth analysis of, the addition of L-serine to minimal medium 
significantly improved doubling time p<0.01. The presence of exogenous serine 
improves the growth rate of L. mexicana promastigotes, which is in agreement 
with results from bioinformatics approach in Leishmania major genomes predict 
not all enzymes for serine biosynthesis are present in the genome (Payne and 
Loomis, 2006). Serine serves as an important precursor for sphingolipid, 
glycerolipid and phospholipid biosynthesis(Hanada, 2004) apart from cysteine 
synthesis. Lack of lipids in the NM composition (Chapter1) might further add to 
the need of exogenous serine source. Serine is metabolised by three different 
routes via serine dehydratase, serine amino transferase and serine hydroxyl-
methyl transferase to pyruvate, hydroxy-pyruvate and glycine production 
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respectively. Thus, supplementation of equal amounts of all 20 proteinogeneic 
amino acids referred to as NM including L-Aspartate, L-Glutamate, L-Glutamine 
and L-serine recorded as higher cell density from day 4 to day 6 in 9 day growth 
period as shown in Figure 4.6 with similar doubling time to serum containing 
HOMEM medium compared to NMM. These results indicate that growth and 
development of L. mexicana promastigotes vastly depend upon the exogenous 
supply of amino acids from the extracellular environment or the host system, 
rather than de novo biosynthesis with dynamic regulation. Thus proteins involved 
in uptake and metabolism of these important amino acids and their 
analogues/inhibitors serve as for drug targets. 
 
Amino acids play vital roles in protein synthesis and as carbon or energy source. 
Amino acids influence protein synthesis two fold, either absence of amino acid 
for the required synthesis of protein macromolecule or downstream regulation on 
gene expression controlling protein synthesis. Hence the availability of amino 
acids influences a variety of regulatory processes including mRNA activation, 
transcription, translation, protein maturation, turnover, and autophagy. Thus, 
amino acids impose a cumulative effect on cellular metabolism as a whole. It has 
been shown in other species that activation of amino acid response pathway 
might occur in time dependent manner through expression of Atf3, Chop and Asns 
genes during amino acid deprivation (Anderson et al, 2014). Hence, amino acid 
deprivation has been suggested to induce restriction in protein production from 
DNA.  
 
It has been observed from single amino acid knock out media, absence of amino 
acids in the following order had decreasing order of impact on protein production 
as follows: L-Lysine > L-Leucine >  L-Valine > L-Arginine > L-Tryptophan > L-
Phenylalanine >  L-Threonine >  L-Histidine >  L-isoleucine > L-Methionine > L-
Aspartate > L-Glutamate > L-serine > L-Glutamine > L-Proline > L-Tyrosine > L-
cysteine > L-Asparagine > L-Alanine > L-glycine as shown in Figure 4.8. These 
results clearly demonstrated that presence or absence of exogenous amino acids 
determines the nutritional stress encountered by the parasites affecting the 
global protein production. Especially, the absence of L-Methionine, L-Threonine, 
L-Isoleucine, and L-Histidine from the exogenous supply caused no negative 
effect on growth rate observed during of in vitro culture period but significant 
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decrease in protein production as shown in Figure 4.8. In 2007, Opperdoes and 
Coombs suggested that all genes for the de novo biosynthesis of L-Methionine and 
L-Threonine are present, but experimental evidence for these four metabolic 
pathways involving L-Methionine, L-Threonine, isoleucine and L-Histidine have 
not been tracked before.  
 
To understand this, further investigation was carried out using untargeted 
metabolomics from the intracellular data to map individual amino acid pathways 
as shown in section 4.2.9. Thus, amino acids were classified into 4 categories as 
shown in Table 4-2 based on the impact of each amino acid on parasite viability, 
growth and protein production. Viability of promastigotes in this context 
indicates that parasites were alive. However, slightly motile when examined 
under the microscope and exhibited more like a dormant state, with lack of 
growth and doubling; whilst supplementation of additional amino acids allowed 
to clearly decrease the lag phase with decrease in doubling time and protein 
synthesis. 
 
 
 
 
 
 
 
 
 
Table 4-2 Classification of amino acids based on exogenous requirements for the growth of 
L. mexicana promastigotes 
Exogenous 
supply critical for 
viability 
Exogenous 
supply critical 
for increased 
growth rate  
Exogenous 
supply critical 
for protein 
synthesis 
Exogenous 
supply not 
important  
L-Tryptophan L-Aspartate L-Threonine L-Alanine 
L-Phenylalanine L-Glutamate L-Histidine L-Glycine 
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L-Arginine L-Serine L-Isoleucine L-Cysteine 
L-Lysine  L-Glutamine L-Methionine L-
Aspargine 
L-Leucine  
  
L-Proline 
L-Valine  
  
L-Tyrosine 
 
 
 
4.3.2 Energy quantification in amino acid knock out media using acetate as indirect 
measure of amino acid catabolism. 
 
Amino acids are involved in acetate and ATP production via the ASCT pathway. 
Trypanosomatids encode for Acetate-Succinate CoA transferase (ASCT) enzyme 
involved in acetate and ATP production, not found in mammals (Hellemond et al., 
2005). This particular pathway occurs with direction conversion of certain amino 
acids such as L-Methionine, L-Valine and L-Leucine to succinyl-CoA, metabolised 
by the enzyme ASCT for acetate and ATP production. Also, metabolism of amino 
acids to intermediates of TCA cycle leading to succinyl CoA production also leads 
to acetate production via reversible reaction from acetyl CoA to acetate and ATP 
formation as illustrated in Figure 4.14. 
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Figure 4.14 Schematic illustration of amino acids utilisation for acetate production in 
Leishmania.  
(Unique amino acid metabolism in Leishmania promastigotes with direct route of 
amino acids to energy generation in the form of ATP by the enzyme acetate 
succinate CoA transferase (ASCT) leads to acetate production and overflow which 
has been quantified under different experimental conditions). 
 
Acetate overflow has been well demonstrated pathway reported in 
trypanosomatids due to aerobic fermentation. Acetate concentration in the 
supernatant serves as an indicator of internal metabolic activity. To understand 
the relative contribution of individual amino acids to energy production, acetate 
was used as an indirect measure of amino acid catabolism. Acetate in the 
supernatant of defined medium under different experimental conditions was 
quantified by using bioassay kit as described in experimental methods. Acetate 
concentration in the medium supernatant increased from Day 0 to Day 6 of the 
culture from the start of culture initiation secreted by L. mexicana promastigotes 
development from procyclics to pre-infective metacyclic stages as shown in Figure 
4.10. It was also found that the acetate concentration in the supernatant of 
culture media containing glucose was 80 fold higher than medium without glucose, 
indicating that glucose metabolism contributes to higher acetate production than 
amino acids alone as shown in Figure 4.11.  
 
Further, acetate determination in the supernatant of single amino acid knock 
out analysis showed that absence of L-Tryptophan, L-Phenylalanine, L-Lysine, L-
Arginine, L-Leucine and L-Valine significantly decreased acetate in the spent 
media compared to absence of L-Aspartate, L-serine, L-Histidine, L-isoleucine, 
L-Threonine, L-Glutamate, L-Methionine, L-Glutamine, L-cysteine, L-L-Tyrosine, 
L-Proline, L-Asparagine, L-Alanine and L-glycine as shown in Figure 4.12. These 
results validate the observations from growth analysis that exogenous supply of 
amino acids, especially L-Tryptophan and L-Phenylalanine as most important for 
viability and normal metabolic functioning of L. mexicana promastigotes 
summarised in  
Figure 4.15.   
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Figure 4.15 Proposed model of amino acids requirements and interconversion in                   
L. mexicana promastigotes 
(Amino acids classified based on their requirement for the growth of L. mexicana 
promastigotes. Exogenous supply of amino acids critical for viability are shown in 
blue circles, (Abbreviations: Trp - L-Tryptophan, Phe – L-Phenylalanine, Lys - L-
Lysine, Arg – L-Arginine, Leu - L-Leucine and Val – L-Valine) Orange circles denotes 
those required for increased growth rate (Asp - L-Aspartate, Glu – L-Glutamate, 
Gln - L-Glutamine, Ser – L-Serine) Green circles denotes those required for 
increased protein production (Thr - L-Threonine, Met – L-Methionine, His - L-
Exogenous supply critical for viability 
Exogenous supply critical for protein production 
Exogenous supply critical for increased growth rate 
Exogenous supply not critical for viability 
Environment 
Leishmania 
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Histidine, Ile – L-Isoleucine) Pink circles denotes not critically important as 
exogenous sources (Ala - L-Alanine, Pro – L-Proline, Gly - L-Glycine, Asn – L-
Asparagine, Tyr- L-Tyrosine, Cys-L-L-Cysteine). Amino acids interconversion 
specified using arrow heads.  
4.3.3 Amino acid analogues as drug targets 
It has been shown in other organisms that amino acid analogues could compete 
with natural amino acids occurring in proteins and serve as biological inhibitors 
(Richmond, 1962). The extent of inhibition depends upon various effects on the 
active sites of enzymes and degree of substitution caused and also the relative 
level of the intracellular pool of free amino acids available to compete differs at 
different growth stages(Simon et al., 1983). Amino acid analogues might effect 
growth and general metabolism via decreased enzyme activities or unknown 
mechanisms.  
 
Traditionally, drug target strategies have involved structural analogues, inhibitors 
of uptake of nutrients, antagonists/agonists of receptors, fluorine substitutions, 
etc. Woods et al in 1940 have shown that structural analogues such as 
sulphonamides competitively inhibit p-amino benzoic acid reaction to form 
dihydro-folic acid required for purine synthesis(Woods, 1962). Imatinib used to 
treat leukemia is chemically known to be 2-phenyl amino pyrimidine which 
occupies the active site of L-Tyrosine kinases specific to oncogenes, inhibits 
subsequent phosphorylation and downstream signalling cascades to block 
proliferation of cancerous cells (Druker et al., 2001). 
 
Analysis from single amino acid knock out media indicated that the exogenous 
source of aromatic amino acids, especially L-Phenylalanine and L-Tryptophan are 
most important to support parasite viability followed by other amino acids as 
shown in Figure 4.2. From other the previous results, it was observed that absence 
of aromatic amino acids L-Tryptophan and L-Phenylalanine from the exogenous 
supply also has the most significant negative effect on protein and energy 
production as shown in Figure 4.8 and Figure 4.12. Hence, in this experiment, 
amino acid analogues of L-Tryptophan, L-Phenylalanine, L-Tyrosine and L-
133 
 
Methionine i.e. 5-fluoro L-Tryptophan, p-flourophenylalnine, 3-Fluorotyrosine and 
norleucine respectively were tested.  
 
From the alamar blue assay, it was observed that the growth of promastigotes was 
considerably affected with increasing concentration of the amino acid analogues 
as shown in Figure 4.13. Especially, the presence of an even small concentration 
of 5-fluro-L-Tryptophan competes with naturally occurring extracellular L-
Tryptophan and proved detrimental to the viability of the Leishmania 
promastigotes with the IC50 found to be 1.09 µM under conditions tested. Followed 
by L-Tyrosine analogue, 3-Fluro L-Tyrosine was found to have an IC50 of 1.47 µM 
with the growth inhibition pattern for L-Tryptophan and L-Tyrosine analogues 
were similar; potentially indicating competitive substrate binding to a single 
protein transporter for the two amino acids or affecting fresh protein synthesis in 
a similar way. Also, it was found that L-Phenylalanine and L-Methionine analogues 
i.e. p-fluro-L-Phenylalanine and norleucine were found to have an IC50 of 2.62 µM 
and 2.39 µM respectively and exhibited similar inhibition pattern potentially 
competitive substrate for same transporter protein. This is in agreement with 
Hasne et al (Hasne and Barrett, 2000), demonstrated that in    T. brucei procyclics 
encode for the same transporter protein involved in the transportation of both L-
Phenylalanine and L-Methionine.  
 
Thus, amino acid analogues especially of L-Tryptophan could be most effective as 
drug target against the growth of L. mexicana promastigotes within the insect 
vector. Effects of L-Tryptophan analogues such as 5-fluro-trytophan, 7-azaL-
Tryptophan have been shown to result in defective protein formation, growth 
inhibition and blockage of heterocycst differentiation (Mitchison and Wilcox 
1973). Blocking L-Tryptophan uptake and metabolism might serve as preferential 
drug candidate compared to other amino acids because of dual inhibition on 
viability and protein synthesis required for developmental cycle of parasites 
within the insect vector. The knowledge from these results could facilitate the 
design of effective insecticides and better vector control methods, which are 
often less elaborated. However, understanding the amino acid metabolic 
pathways in an unbiased manner would allow identification of unique parasite 
routes to be designated as a potential drug target as elucidated using intracellular 
metabolomics in Chapter 5. 
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Chapter 5 Determination of intracellular amino 
acids metabolic pathways by unbiased network 
mapping. 
 
5.1 Introduction  
 
In this chapter, unbiased mapping of amino acid metabolic pathways has been 
elucidated using intracellular metabolomics. Early studies on tracing amino acid 
metabolic pathways involved incorporation of radiolabelled precursors into the 
system of interest (Sporn et al., 1959). For example, uptake kinetics of 
radiolabelled amino acids such as L-Proline, L-Arginine, L-Lysine and L-Glutamate 
in Leishmania have been reported (Burchmore et al., 2003, Shaked-Mishan et al., 
2006, Inbar et al., 2012, Paes et al., 2008, Colotti and Ilari, 2011).  Previously, 
metabolic pathways have been characterised using enzyme activity assays in 
promastigotes and amastigotes stages of Leishmania (Hart and Coombs, 1982, 
Coombs et al., 1982). Also, descriptions of metabolic pathways in Leishmania has 
been based on whole genome annotation (Opperdoes and Coombs, 2007) and 
bioinformatics approaches (Payne and Loomis, 2006). These methods allow only 
partial understanding of metabolic pathways of the parasite; without taking into 
effect the niche environmental impact on metabolism. 
 
5.1.1 Intracellular amino acid utilisation using untargeted 
metabolomics 
 
Metabolomics holds great promise to the field of tracing metabolic pathways in 
any level within the system of interest (Creek et al., 2012a). The activities of the 
underlying enzymes at multiple steps in individual metabolic pathways determine 
the varied effects of amino acids on the viability of the parasites. Thus, complete 
elucidation of global unbiased mapping of metabolites by untargeted 
metabolomics especially in complete defined media would allow for novel 
biomarker discovery unreported before. Deeper insights about the parasite 
metabolism could aid in accelerating drug development and to unravel the unique 
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metabolic routes that play crucial roles required for the survival of parasites 
within the host system. 
 
Kindt et al reported Leishmania metabolome cultured in serum rich medium with 
sample preparation methods for LC-MS study (Scheltema et al., 2010, T'kindt et 
al., 2011). Silva et al (Silva et al., 2011) demonstrated that promastigotes cultured 
in serum rich medium underwent significant changes of glycerophospholipids 
which correlated to the parasite development and rapid lipid turn-over using 
untargeted metabolomics in Leishmania donovani promastigotes. Saunders et al 
(Saunders et al., 2011) showed the potential of targeted metabolomics using heavy 
stable isotopes with emphasis on tri-carboxylic acid cycle and carbohydrate 
metabolism. Recently, Westrop et al reported untargeted metabolomics to 
highlight differences between species of Leishmania using semi defined medium 
which contained dialysed serum (Westrop et al., 2015).  
 
5.1.2 Research aims  
 
Untargeted metabolic finger-printing of the intracellular metabolome were 
carried out as follows: 
 
• Defined medium was used to culture L. mexicana promastigotes with 
optimisation of sample preparation method for maximum coverage of 
metabolites. 
 
• Multivariate data analysis and data exploration. 
 
• Novel unbiased mapping of amino acid metabolites to highlight metabolic 
differences from mammalian host as drug targets. 
 
 
 
 
 
5.2 Results  
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5.2.1 Study objectives  
The results from previous section of single amino acid knock out media (Chapter 
4) highlighted that exogenous supply of only six amino acids are critical for the 
viability of promastigotes.  Thus, in the following sections of the chapter, 
untargeted metabolomics of L. mexicana promastigotes cultured in defined media 
allowed new insights into the metabolic routes of amino acids by network 
mapping. Relative levels of amino acids maintained in the intracellular 
metabolome of the parasites have also provided information about the activation 
of certain alternative pathways; not found in mammalian host. In this chapter, 
aspects about the optimisation of sample preparation steps has been described; 
including analysis of the intracellular metabolome data of promastigotes cultured 
in defined medium, mapping of individual metabolites leading to amino acid 
pathways construction, relative abundance of metabolites within the intracellular 
metabolome has allowed to highlight alternate metabolic pathways as suitable 
drug targets.  
 
5.2.2 Experimental design 
 
Here, defined medium composed of commercial solution of non-essential (2X) and 
essential (1X) amino acids have been used (Table 5-1) to understand the nature of 
amino acids uptake and intracellular metabolism. Equimolar composition of amino 
acids in NM proved useful to understand the order of importance of amino acids 
under identical conditions of inoculation, temperature and pH (Chapter 4) 
required to support the viability of promastigotes. However, it was thought that 
amino acids at variable concentrations might better mimic the environment of 
promastigotes development in vivo within sand-fly mid gut. Nayak medium (NM) 
with equimolar amino acids have been modified and provisionally termed as 
modified Nayak medium (mNM) for metabolomics experiments. It was not within 
the time limit of this project for testing metabolomics profiles at different amino 
acid concentrations. The amino acids pathways constructed using intracellular 
metabolome for tracing parasite specific metabolic pathways have been 
highlighted as drug targets. 
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Table 5-1 Composition of NM and mNM for axenic culture of Leishmania promastigotes 
 Components NM 
concentrations (mM) 
   mNM 
concentrations (mM) 
Salts     
NaCl 136.8 136.8 
KCl 5.36 5.36 
NaH2PO4 0.33 0.33 
Sodium Pyruvate 0.99 0.99 
NaHCO3 3.57 3.57 
HEPES 25.01 25.01 
Hemin 0.0077 0.0077 
Vitamins   
Choline chloride 0.007 0.007 
D-Calcium pantothenate 0.002 0.002 
Nicotinamide 0.008 0.008 
Pyridoxal hydrochloride 0.004 0.004 
Thiamine hydrochloride 0.002 0.002 
I-Inositol 0.01 0.01 
Co-factors   
Riboflavin 0.05 0.05 
folic acid 0.05 0.05 
Biopterin 0.1 0.1 
Lipoic Acid 0.05 0.05 
D-Biotin 0.1 0.1 
Metals   
MgSO4.7H2O 0.81 0.81 
CaCl2 0.72 0.72 
Zinc Chloride 0.03 0.03 
Fe(No3)3.9H20 0.009 0.009 
Manganese chloride 0.000045 0.000045 
Copper sulphate  0.000030 0.000030 
Cobalt chloride 0.000032 0.000032 
(continued) 
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 Components NM 
concentrations (mM) 
   mNM 
concentrations (mM) 
Amino Acids   
L-Tryptophan 0.5 0.05 
L-Phenylalanine 0.5 0.2 
L-Lysine hydrochloride 0.5 0.39 
L-Arginine hydrochloride 0.5 0.59 
L-Leucine 0.5 0.4 
L-Valine 0.5 0.4 
L-Aspartic acid 0.5 0.2 
L-Serine 0.5 0.2 
L-Glutamic Acid 0.5 0.2 
L-Glutamine 0.5 2.048 
L-Histidine hydrochloride-
H2O 
0.5 0.2 
L-Isoleucine 0.5 0.4 
L-Threonine 0.5 0.4 
L-Methionine 0.5 0.1 
L-L-Cysteine 0.5 0.1 
L-Tyrosine 0.5 0.19 
L-Proline 0.5 0.2 
L-Alanine 0.5 0.2 
L-Asparagine 0.5 0.2 
Glycine 0.5 0.2 
Other components   
Adenosine 0.074 0.074 
D-Glucose  16.6 16.6 
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5.2.3 Protocol optimisation steps of sample preparation for 
untargeted metabolomics 
 
Early methods reported in literature for Leishmania parasites involved rapid 
quenching of Leishmania cultures and washing cells with ice cold PBS to remove 
the serum rich extracellular medium. Here, sample preparation was optimised for 
cells cultured in defined medium by omission of washing step and centrifugation 
speed at 1000 g with slow acceleration and slow deceleration to avoid cell lysis. 
Results from LC-MS experiment were visualised using principal component analysis 
to compare intracellular samples of L. mexicana promastigotes cultured in Defined 
medium with naïve medium (without parasites) and culture supernatant on Day 3 
by untargeted metabolomics as shown in Figure 5.1. 
 
 
Figure 5.1 Principal component analysis of intracellular data 
(21 samples from L. mexicana promastigotes (4 x 107 cells/mL) in log phase Day 3 
from the start of culture initiation in defined medium processed and analysed LC-
MS metabolite finger-printing data. Individual groups shown by different colours:  
Red- Intracellular samples (plus_G3 cells 1, 2, 3 in triplicates), Green -Spent 
samples (plus_G3 spent 1, 2, 3 in triplicates) and Blue-Naïve medium samples 
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(plus_G0 1, 2, 3 in triplicates) are clearly separated from each other and from 
Pink-Quality controls (Pool samples 1-12)). 
 
Here, the pooled samples forming the quality control QC forms a cluster separated 
from the intracellular, spent and medium samples probably indicating increased 
salts in pooled samples compared to others. However, principal component 
analysis accounts for 80% of variance that could be explained in two components 
as shown amongst the data points projected in Figure 5.1. The clusters showed 
distinct separation between the intracellular samples, spent medium samples and 
naïve medium from each other. Furthermore, the robustness between the 
replicates has been visualised using hierarchical cluster analysis (HCA) as shown 
in Figure 5.2. 
 
 
Figure 5.2 Hierarchical cluster analysis of intracellular data 
Individual groups shown by different colours:  Red- Intracellular samples (plus_G3 
cells 1, 2, 3 in triplicates), Green -Spent samples (plus_G3 spent 1, 2, and 3 in 
triplicates) and Blue-Naïve medium samples (plus_G0 1, 2, 3 in triplicates) and 
Pink- Quality controls (Pool samples 1-12) are clearly separated from each other.  
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HCA analysis showed that triplicates within each group clustered together 
indicating reproducibility amongst the samples and validation of the sample 
preparation step. 
Spectral analysis of intracellular metabolome was simplified by subtraction of 
background signals of the in vitro defined medium used for culture, known 
composition allowed for easier data interpretation of the spectral peaks not 
crowded by undefined serum molecules. Mass accuracy (ppm error) as observed 
from LC-MS (Thermo Orbitrap) and peak shapes verified for inclusion of 
metabolites below confidence score 7-10 using the Thermo software Quant 
browser and PeakML software from the total ion chromatogram as shown in Figure 
5.3. 
 
Figure 5.3 Total ion chromatogram of intracellular metabolite pool in             L. mexicana 
promastigotes.  
 
 
Extensive data processing steps allowed identification of 402 putatively identified 
metabolites peaks with mass and retention time (RT) as shown in Figure 5.4 with 
approximately 23 out of 45 components of the defined medium. 
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Figure 5.4 Bubble plot of all metabolites detected in the intracellular dataset 
(Mean peak intensity of metabolites expressed as relative radius of the circles).  
 
Amongst the 402 metabolites recovered from the intracellular dataset; ~252 
metabolites are depicted as circles relative to their abundance in the intracellular 
metabolome as shown in Figure 5.4. These 252 metabolites could be assigned to 
metabolic pathways as specified by IDEOM software (Creek et al; 2012b). Hence, 
only ~60% of metabolites found either in the intracellular extract, spent sample 
or fresh medium could be assigned to metabolic pathways. The putatively 
identified metabolites could then be divided between the different pathways 
expressed as bar graph shown in Figure 5.5. The remaining 150 metabolites were 
assigned as class 2 identifications not matched with authentic standard; and 
subjected as putatively identified by the instrument. 
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Since, the sample preparation method was focused on extraction of polar 
metabolites such as amino acids; authentic standards included during the sample 
preparation were mostly polar compounds too. Amongst the 252 metabolites, 64 
metabolites were associated with amino acid metabolic pathways within the 
intracellular metabolome as shown in Figure 5.5.   
 
 
Figure 5.5 Pathways identified within the intracellular metabolome of L. mexicana 
promastigotes 
 
The number of metabolites in individual pathways from the intracellular 
metabolome of log phase L. mexicana promastigotes on day 3 from the start of 
culture initiation have been depicted in Figure 5.5. Pathway names depicted as 
annotations represented in KEGG database (Kanehisa and Goto, 2000). 
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Amongst the  64 metabolites related to amino acid metabolism, only 44 could be 
identified with authentic standards, whilst the remaining have been validated 
using mass, retention time and chemical identity using databases such as 
chemspider, Metacyc, KEGG, etc.  
 
The rate of depletion of the amino acids have been expressed as relative ratio of  
amino acids level in spent medium compared to  naïve medium incubated to 
similar time as shown in Figure 5.6. 
 
        
 
Figure 5.6 Relative quantification of amino acids in spent medium (culture supernatant) on 
day 3 from the start of culture initiation. 
 
The height of the bar (n=3, Error bars = mean ± SD) is proportional to the log 2 fold 
change of amino acid levels in the spent medium (culture supernatant day 3 from 
the start of culture initiation) compared to naïve medium shown in Figure 5.6. The 
amino acids levels are further annotated according to the classification shown in 
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Table 4-2  to highlight correlation between amino acid essentiality based on growth 
data of Chapter 4 and intracellular metabolome. 
 
The amino acids depleted from the spent medium on Day 3 culture supernatant of 
the log phase L. mexicana promastigotes were found to be L-Threonine, L-
Arginine, L-Glutamate, L-serine, L-Leucine, L-Valine, L-Tryptophan and L-
Aspartate as shown in Figure 5.6. 
 
 The metabolites and the instrument response recorded in the form of their peak 
intensity are as shown in Table 5-2. 
Table 5-2 Index of bubble number and corresponding metabolite names as per KEGG 
annotation 
Bubble number Putative metabolite Instrument response 
recorded as peak 
intensity  
1 L-Citrulline 6437385 
2 Indole-3-acetaldehyde 6345 
3 L-Pipecolate 2454765 
4 4-Imidazolone-5-propanoate 1126898 
5 Urocanate 4320 
6 Creatine 5664 
7 L-Ornithine 13664 
8 5-Guanidino-2-oxopentanoate 53601 
9 N6,N6,N6-Trimethyl-L-Lysine 968 
10 Indolelactate 1071576 
11 N2-(D-1-Carboxyethyl)-L-Arginine 8197 
12 Trypanothione disulfide 302976 
13 N6-Acetyl-L-Lysine 980627 
14 Choline 45479 
15 4-Guanidinobutanoate 158854 
16 L-Alanine 118701 
17 [FA oxo,amino(6:0)] 3-oxo-5S-amino-hexanoic acid 5193 
18 N-Acetylputrescine 3560 
19 D-Lysine 8504 
147 
 
20 L-Leucine 902516 
21 4-Imidazolone-5-acetate 752 
22 4-Guanidinobutanamide 18005 
23 L-Proline 235 
24 indole-3-glycol 2590 
25 L-Methionine 345 
26 8-[(aminomethyl)sulfanyl]-6-sulfanyloctanoic acid 622636 
27 L-Kynurenine 11967 
28 L-Threonine 30644 
29 Pantothenate 503 
30 N-Acetyl-D-glucosamine 325 
31 L-Histidine 1200 
32 L-Glutamate 5-semialdehyde 6197 
33 L-Arginine 8771 
34 L-Formylkynurenine 2607825 
35 L-Lysine 1,6-lactam 14532 
36 N,N-Dimethylglycine 12980 
37 O-Acetyl-L-homoserine 1046 
38 L-Valine 2052950 
39 LL-2,6-Diaminoheptanedioate 1586564 
40 L-Tyrosine 917 
41 L-Phenylalanine 9384 
42 Imidazole-4-acetate 16989 
43 L-Methionine S-oxide 4854 
44 L-Asparagine 7727 
45 N-gamma-Acetyldiaminobutyrate 28492 
46 L-Cystine 56851 
47 L-Glutamine 53456 
48 Glycine 1144 
49 L-Tryptophan 2430 
50 L-Serine 57402 
51 Indole-3-acetamide 1416 
52 L-Glutamate 2180 
53 L-Aspartate 100046 
54 indole-3-glyoxal 628288 
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55 Indole-3-acetate 61894 
56 (S)-1-Pyrroline-5-carboxylate 548 
57 N4-Acetylaminobutanal 2367 
58 Homoarginine 6786333 
59 Spermidine 5429 
60 Glutathione 16002 
61 gamma-Glutamyl-gamma-aminobutyraldehyde 173108 
62 gamma-L-Glutamyl-L-cysteine 179084 
63 N(pi)-Methyl-L-Histidine 190815 
64 Methyl-L-Histidine 1256 
 
Visual analysis of the 64 metabolites as shown in Table 5.5 which were associated 
with amino acid metabolism within the intracellular metabolome were considered 
for further analysis using bubble plots as shown in Figure 5.7 and 5.8.  
 
The relative abundance of all the amino acid intermediates are shown in Figure 
5.7 (A) and amino acids shown as sub set in Figure 5.7(B) for more clear data 
exploration.  
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Figure 5.7 Intracellular metabolome of L. mexicana promastigotes  
Bubble plot of (A) all amino acid intermediates and (B) amino acids. Peak intensity 
of metabolites proportional to the relative radii of circles. The metabolites were 
identified as belonging to amino acid pathway as annotated from Kegg database 
(Kanehisa and Goto, 2000). 
 
The order of increasing peak intensities of amino acids in the intracellular samples 
of  L. mexicana promastigotes in log phase, Day 3 from the start of culture 
initiation as observed from Figure 5.7 (B) were found as follows L-Alanine > L-
Glutamate > L-Glutamine > L-Glycine > L-Proline > L-Histidine > L-Valine > L-
Asparagine > L-Phenylalanine > L-Threonine > L-Tyrosine > L-Aspartate > L-Leucine 
> L-Arginine > L-Methionine > L-Tryptophan > L-Lysine > L-Serine and L-Cysteine.  
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Figure 5.8 Bubble plot of amino acid intermediates  
 
Further data exploration of amino acid intermediates was done plotting individual 
subsets of data as represented in Figure 5.8 (A) and (B). This showed that certain 
amino acid intermediates highlighted in Figure 5.8 (A) such as L-Citrulline (Bubble 
plot number 1), L-Indole-3-acetaldehyde (Bubble plot number 4) and L-Pipecolate 
(Bubble plot number 3) were significantly accumulated in the intracellular 
metabolome. A sub-set was plotted to understand which other metabolites 
accumulated in the intracellular metabolome by masking the above mentioned 
first three abundant metabolites showed that trypanothione (Bubble plot number 
12), imidazole acetate (Bubble plot number 42) and N6-N6-N6 tri-methyl L-Lysine 
(Bubble plot number 9) were found to be  accumulated within the intracellular 
metabolome shown in Figure 5.8(B). 
 
Most of the metabolites detected in the intracellular samples were not present in 
the naïve medium. Furthermore, the efficiency of cell disruption during sample 
preparation were checked by comparing the peak intensities in naïve medium and 
supernatant samples versus the intracellular metabolome. Metabolic 
intermediates such as gamma-Glutamyl-gamma-amino-butyraldehyde, gamma-L-
Glutamyl-L-cysteine and trypanothione biosynthesised exclusively in Leishmania 
were considered as key markers as shown in Table 5-3. There was no metabolite 
leakage due to cell disruption during sample preparation as observed from Table 
5-3. 
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Table 5-3 shows relative mean peak intensity values compared between the intracellular, 
spent medium and naïve medium. 
Bubble number Putative metabolite Mass 
 
RT Peak intensity 
 
Day 3 cell extract 
12 Trypanothione disulfide 360.644 15.635 302976 
40 gamma-Glutamyl-gamma-amino-butyraldehyde 216.110 10.571 173108 
41 gamma-L-Glutamyl-L-cysteine 250.062 12.138 179084 
42 Glutathione 307.083 12.226 16002 
 
Intracellular metabolites exclusive to Leishmania metabolism such as gamma-
glutamyl-cysteine and, trypanothione were not detected in the spent medium. 
This result validated the protocol optimisation steps of ensuring minimum shear 
physical stress with slow centrifugation method during sample preparation and 
avoiding the washing step allowed to capture the metabolic snapshot without 
delays. Absence of leakage of intracellular metabolites also highlighted the 
separation efficiency of intracellular metabolites between cells extracts, 
supernatants and naïve medium treated under similar conditions. 
  
Table 5-4 Number of metabolites per pathway detected in the intracellular 
dataset.  
Name of the pathway No. of metabolites 
detected in the 
intracellular 
dataset 
No. of total 
metabolites annotated 
in Kegg pathway 
databases 
Alanine, L-Aspartate and L-
Glutamate metabolism 
7 25 
L-Arginine biosynthesis 5 19 
Tyrosine metabolism 4 75 
Cysteine and L-Methionine 
metabolism 
3 54 
Glycine, serine and L-
Threonine metabolism 
6 45 
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Sulfur metabolism 4 22 
L-Tryptophan metabolism 3 80 
L-Arginine and L-Proline 
metabolism 
8 67 
Lysine degradation 3 42 
Phenylalanine metabolism 4 64 
Phenylalanine, L-Tyrosine and 
L-Tryptophan biosynthesis 
6 31 
Valine, L-Leucine and 
isoleucine biosynthesis 
4 23  
Valine, L-Leucine and 
isoleucine degradation 
2 32 
 
Comparison of metabolites detected to number of total metabolites annotated in 
KEGG pathway database KEGG (Kanehisa, Goto et al. 2006) charted using Pathos 
(A metabolomics tool from Glasgow Polyomics accessible at 
http://motif.gla.ac.uk/Pathos/) (Leader, Burgess et al. 2011), and MetaCyc, 
accessible at http://metacyc.org/)) 
 
The metabolites from the amino acid pathway were variously populated as shown 
in Table 5-4 to calculate the number of metabolites detected per pathway. Pathos 
software was used to compare the different metabolites detected in this study of 
L. mexicana intracellular data set compared to total number of metabolites 
annotated in KEGG pathway database (Leader et al., 2011) in a non-organism 
specific manner. Thus Table 5-4 highlights the specific differences of particular 
pathway metabolism in Leishmania compared to standard annotated pathway in 
public database such as KEGG (Kanehisa, Goto et al. 2006). These metabolites 
were of interest since network mapping in an unbiased manner would allow new 
insights to be gained from the data as shown in section 5.2.4. 
 
5.2.4 Metabolite levels of individual amino acid pathways in L. 
mexicana promastigotes 
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Intracellular metabolites of L. mexicana promastigotes at Day 3 in defined medium 
from the start of culture initiation are measured using the values of peak 
intensities specific to instrument response at conditions as specified in the 
methods section of chapter 2. The metabolites of individual amino acids in 
metabolic pathways are shown below in the order of importance of proteogenic 
amino acids as reported in section 4.1. 
 
 
 
             
 
Figure 5.9 L-Tryptophan metabolism  
 
Metabolites shown in Figure 5.9 were intracellular samples of 4e+107 cells of L. 
mexicana promastigotes from Day 3 from the start of culture initiation in DM in 
triplicates as described in experimental procedures. Instrument response of peak 
intensity of metabolites recorded for the intracellular samples with n=3, Error bars 
= mean ± SD. Those metabolites detected in the naïve medium (incubated for 
similar time) are represented as (d).  
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L-Tryptophan is metabolised with major flux directed to indole acetaldehyde and 
indole lactate as shown in Figure 5.9. Other intracellular intermediates include 
indole-3-glycol, indole 3 acetate, indole 3 glyoxal, indole acetamide, L-
kynurenine, L-formylkynurenine are found in lesser abundance. 
 
 
 
 
Figure 5.10 L-Phenylalanine metabolism  
 
Metabolites shown in Figure 5.10 were intracellular samples of 4e+107 cells of L. 
mexicana promastigotes from Day 3 from the start of culture initiation in DM in 
triplicates as described in experimental procedures. Instrument response of peak 
intensity of metabolites recorded for the intracellular samples with n=3, Error bars 
= mean ± SD. Those metabolites detected in the naïve medium (incubated for 
similar time) are represented as (d).  
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Intracellular metabolites of L-Phenylalanine metabolism detected and putatively 
identified in this study through the LC-MS data were L-Phenylalanine, L-Tyrosine 
metabolised to relatively abundant concentration of  3-Hydroxyphenyl-pyruvic 
acid (also called as phenylpyruvate),  and 3-(4-Hydroxyphenyl) lactate (also called 
as phenyllactate) compared to  4-Hydroxyphenylacetaldehyde (also called 
phenylacetaldehyde) and 2-phenylacetamidine (also called phenylacetate) as 
shown in Figure 5.10 
 
 
 
                               
        
Figure 5.11 L-Histidine metabolism  
 
Metabolites shown in Figure 5.11 were intracellular samples of 4e+107 cells of L. 
mexicana promastigotes from Day 3 from the start of culture initiation in DM in 
triplicates as described in experimental procedures. Instrument response of peak 
intensity of metabolites recorded for the intracellular samples with n=3, Error bars 
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= mean ± SD. Those metabolites detected in the naïve medium (incubated for 
similar time) are represented as (d).  
 
It has been observed that Imidazol-5-yl-pyruvate followed by Imidazole lactate 
were found in relatively more abundance compared to 4-Imidazolone-5-acetate 
and Imidazole-4-acetate. Also, methylated L-Histidine in the form of N-(pi)-
Methyl-L-Histidine was observed in the intracellular metabolome linked to L-
Histidine metabolism as represented in Figure 5.11.  
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Figure 5.12 L-Arginine metabolism  
 
Metabolites shown in Figure 5.12 were intracellular samples of 4e+107 cells of L. 
mexicana promastigotes from Day 3 from the start of culture initiation in DM in 
triplicates as described in experimental procedures. Instrument response of peak 
intensity of metabolites recorded for the intracellular samples with n=3, Error bars 
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= mean ± SD. Those metabolites detected in the naïve medium (incubated for 
similar time) are represented as (d).  
 
Putative identifications of metabolites from the L-Arginine metabolism are as 
follows: L-Arginine, L-Glutamate 5-semialdehyde, (S)-1-Pyrroline-5-carboxylate, 
Spermidine, gamma-Glutamyl-gamma-aminobutyraldehyde, N4-
Acetylaminobutanal, L-Citrulline, L-Ornithine, 4-Guanidinobutanamide and 
Creatine as shown in Figure 5.12.  
 
 
Figure 5.13 L-Lysine metabolism  
 
Metabolites shown in Figure 5.13 were intracellular samples of 4e+107 cells of L. 
mexicana promastigotes from Day 3 from the start of culture initiation in DM in 
triplicates as described in experimental procedures. Instrument response of peak 
intensity of metabolites recorded for the intracellular samples with n=3, Error bars 
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= mean ± SD. Those metabolites detected in the naïve medium (incubated for 
similar time) are represented as (d).  
Putative identifications of metabolites from the L-Lysine metabolism are shown in 
Figure 5.13 increased relative abundance of intermediates such as N6,N6,N6-
Trimethyl-L-Lysine, N6-Acetyl-L-Lysine, (R)-piperidine-2-carboxylate and 2-
Amino-5-oxohexanoate and L-Lysine. 
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Figure 5.14 L-Aspartate metabolism 
  
Metabolites shown in Figure 5.14 were intracellular samples of 4e+107 cells of L. 
mexicana promastigotes from Day 3 from the start of culture initiation in DM in 
triplicates as described in experimental procedures. Instrument response of peak 
intensity of metabolites recorded for the intracellular samples with n=3, Error 
bars = mean ± SD. Those metabolites detected in the naïve medium (incubated 
for similar time) are represented as (d).  
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Metabolites associated with L-Aspartate metabolism as shown in Figure 5.14 were 
found as follows N-gamma-acetyl-di-amino-butyrate, O-acetyl-L-homo-serine, 8-
[(amino-methyl)-sulphonyl]-6-sulphanyloctanoic acid, 2-oxo-pentanoate, 2-
Hydroxy-2-methyl-3-oxobutanoate, AMP and NAD+, were found to be more 
abundant than L-Serine, L-Methionine, L-Methionine S-oxide, L-L-Cysteine, L-
Asparagine, L-Threonine, L-isoleucine, Imidazole-4-acetate, L-Histidine, 
Carbamoyl phosphate, Uracil and Thymine.  
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Figure 5.15 L-Glutamate metabolism  
 
Metabolites shown in Figure 5.15 were intracellular samples of 4e+107 cells of L. 
mexicana promastigotes from Day 3 from the start of culture initiation in DM in 
triplicates as described in experimental procedures. Instrument response of peak 
intensity of metabolites recorded for the intracellular samples with n=3, Error bars 
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= mean ± SD. Those metabolites detected in the naïve medium (incubated for 
similar time) are represented as (d).  
Metabolites linked to L-Glutamate in the intracellular metabolome in the 
decreasing order of relative abundance at log phase of growth were L-Glutathione, 
gamma-L-Glutamyl-L-cysteine, L-Alanine, (S)-1-pyrroline-5-carboxylate, L-
Proline, L-Glutamate 5-semialdehyde, N-Acetyl-D-glucosamine, L-Glutamine and 
L-Glutamate as shown in Figure 5.15. 
 
The relative levels of metabolites associated with individual amino acid pathways 
within the intracellular metabolome shown above has been visualised by novel 
network mapping of the metabolites in an unbiased manner without limitations 
from genome annotations, but purely on the metabolic snapshot data; as 
elaborated in the next section 5.2.5. 
 
5.2.5 Novel unbiased mapping of amino acid metabolites  
Here, unbiased mapping of amino acid metabolic pathways were constructed to 
using intracellular metabolome data. Metabolites for each individual amino acid 
pathway have been separately analysed and non-homologous differences between 
Leishmania and mammals were highlighted to indicate the presence of alternative 
routes and novel metabolic enzymes/pathways as potential drug targets. 
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Figure 5.16 Schematic representation of L-TL-Tryptophan metabolism  
L-Tryptophan utilisation in L. mexicana promastigotes using intracellular 
metabolomics data shown with the step for NADH regeneration compared to 
metabolic routes in mammals (Homo sapiens) is highlighted. 
 
As observed from Figure 5.9, L-Tryptophan is metabolised with major flux directed 
to indole acetaldehyde and indole lactate. Other intracellular intermediates 
includes indole-3-glycol, indole 3 acetate, indole 3 glyoxal, indole acetamide, L-
kynurenine, L-formylkynurenine are found to lesser abundance, indicating low 
activities of these enzymes described in discussion section 
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Figure 5.17 Schematic representation of L-Phenylalanine metabolism  
 
L-Phenylalanine utilisation by L. mexicana promastigotes using intracellular 
metabolomics data shown with the step for NADH regeneration compared to in 
mammals (Homo sapiens) is highlighted. 
 
Intracellular metabolites of L-Phenylalanine metabolism detected and putatively 
identified in this study through the LC-MS data as shown in Figure 5.10 has been 
used for network mapping to show L-Phenylalanine is metabolised to L-Tyrosine 
by the enzyme L-Phenylalanine hydroxlase (PAH) present in Leishmania and 
mammals. However, an additional step forming phenyllactate is responsible for  
NADH generation and detection of metabolites such as phenylacetaldehyde and 
phenylacetate gave insights that new enzyme involved in L-Phenylalanine 
metabolism called L-Phenylalanine carboxylase (PCL) converts phenyl-
acetaldehyde to phenylacetate for NADH regeneration as an alternative route not 
reported before.     
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Figure 5.18 Schematic representation of L-Histidine metabolism  
 
Histidine utilisation by L. mexicana promastigotes using intracellular 
metabolomics data shown with the step for NADH regeneration compared to in 
mammals (Homo sapiens) is highlighted. 
 
Metabolomics data was examined for metabolites of the L-Histidine pathway as 
shown in Figure 5.11, such as imidazol-5-yl-pyruvate, imidazole lactate, 4-
imidazolone-5-acetate, imidazole-4-acetate has been putatively detected and 
verified using Chemspider for chemical synonyms. These metabolites indicate that 
L-Histidine could potentially be degraded by alternative pathway not found in 
mammals. Instead, from network mapping of these metabolites as shown in Figure 
5.18, L-Histidine catabolised to yield Imidazol-5-yl-pyruvate /1H-Imidazole-5-
propanoic acid by the broad spectrum L-Histidine-pyruvate aminotransferase. 
However, it is the detection of the downstream metabolites of imidazole lactate, 
4-imidazolone-5-acetate and imidazole-4-acetate are metabolites which 
participate in NADH regeneration. These enzymes are not present in the 
mammalian systems, hence serve as potential drug targets. 
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Figure 5.19 Schematic representation of L-Arginine metabolism  
 
L-Arginine utilisation in L. mexicana promastigotes using intracellular 
metabolomics data shown with the step for NADH regeneration compared to in 
mammals (Homo sapiens) is highlighted. 
 
L-Arginine metabolism reported as unique for Leishmania not present in mammals 
due to polyamines production. Polyamines are required for defence and oxidative 
stress regulation within the intracellular metabolism (Colotti and Ilari, 2011). 
Putative identifications of metabolites from the L-Arginine metabolism are as 
follows: L-Arginine, L-Glutamate 5-semialdehyde, (S)-1-Pyrroline-5-carboxylate, 
Spermidine, gamma-glutamyl-gamma-aminobutyraldehyde, N4-
Acetylaminobutanal , L-Citrulline, L-Ornithine, 4-Guanidinobutanamide and 
creatine as shown in Figure 5.12. 
 
 
 
 
168 
 
 
Figure 5.20 Schematic representation of L-Lysine metabolism  
 
L-Lysine utilisation in L. mexicana promastigotes using intracellular metabolomics 
data shown with the step for NADH regeneration compared to in mammals (Homo 
sapiens) is highlighted. 
 
The intermediates shown in Figure 5.13 were schematically represented as N6-
Acetyl-L-Lysine, 2-Amino-5-oxohexanoate found to oxidised forms of L-Lysine and 
subsequently (R)-piperidine-2-carboxylate is oxidised to form 2-amino-adipate 
which facilitates NADH regeneration as observed in degradation pathways of other 
amino acids in L. mexicana promastigotes as shown in Figure 5.20. 
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Figure 5.21 Schematic representation of L-Aspartate metabolism 
 
Aspartate utilisation in L. mexicana promastigotes using intracellular 
metabolomics data shown with the step for NADPH regeneration described in 
discussion section. 
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Figure 5.22 Schematic representation of L-Threonine metabolism  
Threonine utilisation in L. mexicana promastigotes with enzymatic steps for 
isoleucine biosynthesis shown with the step for NADH regeneration.  
 
Isoleucine biosynthesis described in discussion section verified using blast analysis 
against the genome from NCBI blast tool at 
https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins provided in Appendix 
Figure .   
 
 
Figure 5.23 Schematic representation of L-Glutamate metabolism  
 
L-Glutamate utilisation in L. mexicana promastigotes using intracellular 
metabolomics data shown with the step for NADH regeneration compared to in 
mammals (Homo sapiens) is highlighted with details in discussion section. 
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Figure 5.24 Schematic representation of L-Proline metabolism  
 
Proline utilisation in L. mexicana promastigotes using intracellular metabolomics 
data shown with the step for NADH regeneration with details in discussion section. 
 
 
5.3 Discussion 
 
Use of Defined medium for untargeted metabolomics of L. mexicana 
promastigotes allowed for reproducible trends for compounds with similar 
behaviour as analysed by their mass and retention time; despite variations of 
instrument response of peak intensity values introduced by machine drifts 
compromising sensitivity and resolution. Huge biological variability due to 
background signals from serum molecules and variation between different serums 
batches are overruled by the use of the chemically defined medium for in vitro 
culture. The significant advantage of metabolomics is to be able to capture 
information at particular time point reflecting the appropriate phenotype (Fiehn, 
2002). Previously, most metabolomics sample preparation has been optimised for 
Leishmania culture in rich medium containing 20% v/v foetal calf serum (De Souza 
et al., 2006, Kamleh et al., 2008, T'kindt et al., 2011). In the next section, results 
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of optimisation for metabolome extraction of L. mexicana promastigotes in 
Defined medium carried out by modification of certain steps in the protocol has 
been discussed.  
 
5.3.1 Protocol optimisation for quenching and washing Leishmania promastigotes 
 
Intracellular metabolome of L. mexicana promastigotes cultured in Defined 
medium were compared between naïve medium (without parasites) and culture 
supernatant on Day 3 from the start of culture initiation by untargeted 
metabolomics. Sample preparation for untargeted metabolomics involves steps for 
immediate arrest of metabolism by quenching the cells (Dunn et al., 2012) and 
separating the intracellular metabolome. Early methods for Leishmania parasites 
involved rapid quenching of Leishmania cultures to 0oC using a dry ice/ethanol 
bath and washing cells with ice cold PBS to remove the extracellular medium. 
These steps was mainly carried out to remove any contaminants surrounding the 
cells, since routine Leishmania culture involved rich medium containing (up to 20% 
v\v) foetal calf serum. This extensive washing procedure carried out to remove 
the growth medium using PBS as washing buffer causes additional stress and delays 
metabolic arrest (Dunn et al., 2012). Hence, protocol was optimised as described 
in experimental procedures and mass spectrum data analysed using IDEOM (Creek 
et al., 2012b) and mzMatch software (Scheltema et al., 2011). Data visualised 
using principal component analysis as shown in Figure 5.1.  
 
Multivariate methods deals with separation of signal from the noise, reduces the 
dimensionality by removing the redundancy and provides more stability for further 
analysis. Principal component analysis allows for projection of data taking into 
consideration all variable features for explanation of the underlying correlation 
structure (Swartzla.Ee, 1974) with total of 80% variance explained in two 
components and distinct separation between the intracellular samples, spent 
medium samples and naïve medium was observed. The robustness between the 
triplicates were visualised using hierarchical cluster analysis as shown in Figure 
5.2 which showed good reproducibility between samples. 
 
Amongst the 252 metabolites, those from the medium include the 45 different 
chemical components, with changes in amino acids, glucose and adenosine 
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matched with standards within the data set. Other remaining components such as 
vitamins, including biotin, thiamine, inositol, salts, cofactors and metals were 
only putatively identified as the signal intensities were low and features could not 
be distinguished by the software mzMatch (Scheltema et al., 2011) and IDEOM 
(Creek et al., 2012b). Most of these metabolites detected in the intracellular 
samples were not detected in the naïve medium only samples. Since, only 64 
metabolites were matched with the authentic standards, most of these 
metabolites are represented as putative identifications with more emphasis on 
the pattern of change in metabolites with underlying biological context 
 
5.3.2 Relative quantification of amino acids in L. mexicana promastigotes 
 
To understand about the amino acids salvaged from the environment, the peak 
intensity calculated as ratio between intracellular metabolites and naïve medium. 
The extracellular metabolite concentration secreted by the cell is calculated as 
fold change of the metabolite in defined medium and the spent medium (Culture 
supernatant). Amino acids depleted on Day 3 from the start of culture initiation 
from the extracellular medium were found to be L-Threonine, L-Arginine, L-
Glutamate, L-serine, L-Leucine, L-Valine, L-Tryptophan and L-Aspartate as shown 
in Figure 5.6. 
 
The relative abundance of the amino acids has been represented as bubble plot 
as shown in Figure 5.8. Depending upon the experimental conditions tested in this 
study. The peak intensities as detected by the instrument response of free amino 
acids in the intracellular metabolome under experimental conditions used in this 
study showed the following order with L-Alanine > L-Glutamate > L-Glutamine > 
L-Glycine > L-Proline > L-Histidine > L-Valine > L-Asparagine > L-Phenylalanine > 
L-Threonine > L-Tyrosine > L-Aspartate > L-Leucine > L-Arginine > L-Methionine > 
L-Tryptophan > L-Lysine > L-Serine and L-L-Cysteine.  
 
L-Alanine is abundantly detected in the intracellular metabolome which has been 
shown in previous studies (Inbar et al., 2013, Hart and Coombs, 1982, Coombs et 
al., 1982) as it is important for osomo-regulation, has active biosynthesis pathway 
in Leishmania and participates in transamination reactions, etc. L-Glutamate and 
L-Glutamine detected in the intracellular samples serve as amino group 
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acceptor/donor in transamination reactions which is one of the reasons for high 
turn-over of these amino acids in the intracellular metabolome compared to 
others. Here, the defined medium used for in vitro culture have been composed 
of amino acids at concentrations as specified in Table 5-1. The concentrations of 
the amino acids might influence the level of salvage from the extracellular 
medium. It was not within the time limit of this project for testing under different 
amino acid concentrations; the results discussed were for observations under 
experimental conditions tested. However, unlike carbohydrates and lipids, amino 
acids cannot be converted to storage forms and hence, subjected to high 
metabolism. In the next section, untargeted metabolomics of the intracellular 
metabolome has been carried out to trace individual amino acid pathways. 
Emphasis in this study has been to trace trends and patterns of changes of 
metabolite levels in the biological context of parasite specific unique metabolic 
pathways. These alternative routes described have not been found in mammals 
and hence, are proposed as more promising potential drug targets.  
 
Novel unbiased mapping of amino acid metabolites to highlight metabolic 
differences from mammalian host as drug targets. 
 
Previously, certain studies have used radioactive compounds to trace metabolic 
pathways and gene knock out studies for validation of particular steps using 
reductionist approaches. Predictions from whole genome annotations and 
bioinformatics approaches have shown to accelerate biochemical pathway 
mapping (Payne and Loomis, 2006, Opperdoes and Coombs, 2007); however, these 
methods have limitations due to static data analysis. In this chapter, dynamic 
intracellular metabolome data are presented from Figure 5.9 to Figure 5.15. 
Unbiased mapping of metabolites of the amino acid intermediates were 
constructed from these data and also, the differences between Leishmania and 
mammals have been highlighted from Figure 5.16 to Figure 5.24 to propose the 
presence of alternative routes that could potentially serve as drug targets.  
 
In-silico analysis for Leishmania have shown that a possibility of 1101 metabolites 
annotated from the genome (Chavali et al., 2008). In this study, 402 metabolites 
were putatively identified within the intracellular metabolism with defined 
medium as control and only 252 compounds were matched to mass/charge ratio 
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(m/z) and retention time to KEGG chemical identifiers. Network mapping at 
structural, functional and empirical levels have also revealed new insights about 
alternative amino acid pathways based on metabolite detection that were not 
previously predicted using genome annotation or experimental evidence.  
 
Here, amino acid pathways are studied using two approaches; firstly to collect the 
information of intracellular metabolites from untargeted metabolomics 
experiment and then, compare it to total number of metabolites as observed in 
KEGG database to construct amino acid pathways. A comparative overview of 
enzymes between Leishmania and mammals have been highlighted to propose 
specific parasite specific enzymes that could serve as drug targets. With 
metabolomics experiments, there can be varied number of metabolites which are 
fragments or adducts not identified as a particular metabolite. Thus,, unique 
metabolites with authentic standards and confident identifications  detected  
reproducibly in the parasitic intracellular  samples were being considered for 
further scrutiny. 
 
5.3.2.1 Aromatic amino acid metabolism 
 
As observed from Figure 5.9, L-Tryptophan is metabolised with major flux directed 
to indole acetaldehyde and indole lactate. Other intracellular intermediates 
includes indole-3-glycol, indole 3 acetate, indole 3 glyoxal, indole acetamide, L-
kynurenine, L-formylkynurenine at lesser abundance. From the intracellular 
metabolomics data set, these metabolites were between the confidence score of 
8-10, hence would be referred to as putative identifications compared to first 2 
metabolites identified with authentic standards. Relative quantification of 
metabolites have been calculated and expressed as peak intensity as shown in 
Figure 5.9. Compared to static network of L-Tryptophan pathway from the KEGG 
pathway database; here, a more dynamic representative biological network of L-
Tryptophan metabolism is shown in Figure 5.16 corresponding to log phase 
responsible for NADH generation. 
 
Network mapping of metabolites found in the intracellular data set indicate that 
extracellular L-Tryptophan has been uniquely utilised by L. mexicana 
promastigotes for NADH regeneration. Berger et al argued that the amount of 
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NADH regenerated would be quantitatively lesser and stressed that these aromatic 
amino acids mainly act as preferential nitrogen source for L-Methionine recycling 
(Berger et al, 1996). However, particular enzymes involved in L-Tryptophan 
metabolism such as L-Tryptophan transaminase and indole pyruvate 
dehydrogenase with no homologs found in mammalian species deserves further 
attention as novel drug targets. From the growth analysis as shown in Chapter 4 
and intracellular metabolome data in this chapter confirms that L-Tryptophan is 
salvaged from the environment and not biosynthesised by L. mexicana. The 
transport of L-Tryptophan is critical for the viability of the parasites. In 
mammalian systems, L-Tryptophan is utilised for production of neurotransmitters 
such as serotonin or metabolised via the glutaryl CoA pathway for acetyl CoA 
production. 
 
Montemartini et al proposed that aromatic amino acids, L-Tryptophan, L-
Phenylalanine and L-Tyrosine serve as important NADH regeneration in 
Trypanosoma cruzi (Montemartini et al., 1994). Database mining for Leishmania 
encoded enzymes was carried out, which indicated that L-Tryptophan/L-
Phenylalanine carboxylyase (PCL) has putative Gene Id-LmjF.28.1580 unique to 
L.mexicana, not found in other trypanosomatids. Furthermore, this particular 
enzyme has no mammalian homologue, hence might prove novel drug target 
unreported before. This gene was found to be homologous to fungal species 
responsible for anaerobic utilisation of L-Phenylalanine to phenylacetate 
production (Prasuna et al., 2012) using the Ehrlich pathway. Ehrlich pathway 
involves a set of reactions for the conversion of certain amino acids especially L-
Leucine, L-Valine, L-Methionine, L-Phenylalanine by transamination followed by a 
decarboxylation reaction. In glucose abundant batch cultures of Saccharomyces 
cerevisiae samples, Ehrlich pathway involved amino acids catabolism to aldehyde 
and then reduced to fusel alcohols. However, in glucose limited conditions, the 
aldehydes are majorly oxidised to fusel acids (Hazelwood et al., 2008). It has been 
suggested that Ehrlich pathway may have implications on the overall cellular redox 
metabolism. Excess NADH oxidised by glycerol-3-phosphate dehydrogenase during 
formation of glycerol from glucose requires ATP and thus is energetically 
unfavourable. Also, amino acids catabolised through the Ehrlich pathway provides 
an energy efficient alternative pathway for NADH regeneration. From the 
177 
 
intracellular metabolomics network mapping as shown in Figure 5.17, L. mexicana 
promastigotes show evidence of an Ehrlich pathway for NADH regeneration. 
 
Intracellular metabolites of L-Phenylalanine metabolism detected and putatively 
identified in this study through the LC-MS data as shown in Figure 5.10 were L-
Phenylalanine, L-Tyrosine, 3-Hydroxyphenyl-pyruvicacid (also called 
phenylpyruvate), 3-(4-Hydroxyphenyl) lactate (also called phenyllactate), 4-
Hydroxyphenylacetaldehyde, 2-phenylacetamidine. In mammalian systems, L-
Phenylalanine is metabolised to L-Tyrosine by the enzyme L-Phenylalanine 
hydroxlase (PAH), which is present in Leishmania; and an additional step forming 
phenyllactate.  However, Leishmania genome encodes for an additional enzyme 
involved in L-Phenylalanine metabolism called as L-Phenylalanine carboxylase 
(PCL) to form phenyl-acetaldehyde to phenylacetate for NADH regeneration.                                                                                         
 
In certain species of bacteria and fungi, this pathway has been determined in 
which phenylpyruvate is metabolised to phenylacetate through 
phenylacetaldehyde. The enzyme phenylpyruvate decarboxylase catalyses the 
non-oxidative decarboxylation of various substrates such as phenyl-pyruvate, 
indole pyruvate and other substrates with characteristic feature with more than 
6 carbon atoms in a straight chain with  Phenylacetaldehyde dehydrogenase 
requires NAD as cofactor and hence, allows for NADH regeneration. 
 
Interestingly, belonging to the same class of aromatic amino acids, L-Histidine has 
received less attention in the past research in Leishmania. Metabolomics data was 
examined for metabolites of the L-Histidine pathway as shown in Figure 5.11, such 
as imidazol-5-yl-pyruvate, imidazole lactate, 4-imidazolone-5-acetate, imidazole-
4-acetate has been putatively detected and verified using Chemspider for 
chemical synonyms. These metabolites indicate that L-Histidine could potentially 
be degraded by alternative pathway not found in mammals. Instead, from network 
mapping of these metabolites as shown in Figure 5.18, L-Histidine catabolised to 
yield Imidazol-5-yl-pyruvate /1H-Imidazole-5-propanoic acid by the broad 
spectrum L-Histidine-pyruvate aminotransferase. However, it is the detection of 
the downstream metabolites of imidazole lactate, 4-imidazolone-5-acetate and 
imidazole-4-acetate are metabolites which participate in NADH regeneration. 
These enzymes are not present in the mammalian systems, hence serve as 
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potential drug targets. Berriman et al, 2005 from the Leishmania genome 
predicted that Leishmania have no enzymes for L-Histidine degradation (Berriman 
et al., 2005). This is the first report with experimental evidence for L-Histidine 
pathway for NADH regeneration not reported in Leishmania before.  
 
5.3.2.2 L-Arginine metabolism 
 
 
L-Arginine utilisation is primarily responsible for protein synthesis and contributes 
to high energy intermediates via the TCA cycle as observed in most organisms 
(Paselk, 1983). There had been considerable debate in Leishmania about L-
Arginine biosynthesis, since genome annotation suggests that the parasites have 
incomplete urea cycle encoding for the formation of arginosuccinate from L-
Aspartate; however, no further conversion to L-Arginine (Opperdoes and Coombs, 
2007). From growth analysis as shown in Chapter 4, there was no growth recorded 
in the absence of exogenous L-Arginine. Thus L-Arginine serves as critical 
exogenous source required for the viability of promastigotes.  
 
In mammals, L-Arginine has been used for energy generation in the cell by creatine 
production in muscles. Rapid interconversion of creatine and creatinine leads to 
ATP replenishment (Darlyuk et al., 2009). Using in vivo mouse models for 
nutritional studies, L-Arginine has been shown to be the major contributor of 
citrulline followed by L-Glutamine. It has been verified using tracer experiments 
that L-Arginine contributes to approximately 40% to citrulline synthesis followed 
by L-Proline (3.4%) and L-Glutamine (0.5%) negligible. L-Glutamine incorporates 
ureido group upon conversion to carbomyl phosphate, leading to citrulline 
synthesis (Marini et al., 2010). The main purpose of this pathway being ATP 
generation.  
 
L-Arginine metabolism reported as unique for Leishmania not present in mammals 
due to polyamines production. Polyamines are required for defence and oxidative 
stress regulation within the intracellular metabolism (Colotti and Ilari, 2011). 
Putative identifications of metabolites from the L-Arginine metabolism are as 
follows: L-Arginine, L-Glutamate 5-semialdehyde, (S)-1-Pyrroline-5-carboxylate, 
Spermidine, gamma-glutamyl-gamma-aminobutyraldehyde, N4-
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Acetylaminobutanal , L-Citrulline, L-Ornithine, 4-Guanidinobutanamide and 
creatine as shown in Figure 5.12. It has been reported by fragmentation analysis 
that L-citrulline annotated as arginic acid (Westrop et al., 2015). Apart from 
polyamines, it has been shown using genome analysis that there is no specific 
enzyme with creatine kinase activity; whilst, the phylogenetic analysis indicate 
similarity between sequences of creatine kinase activities with Leishmania 
genome. Thus, it has been speculated that parasitic protozoa must have different 
type of enzyme with function similar to creatine kinase, leading to ATP production 
(Voncken et al., 2013). Hence, the schematic overview representation of L-
Arginine utilisation in L. mexicana promastigotes is shown in Figure 5.19.  
 
5.3.2.2 L-Lysine metabolism 
Lysine metabolism intermediates in the intracellular metabolome as represented 
in Figure 5.13. Significant (p<0.05) levels of N6, N6, N6 tri-methyl L-Lysine found 
in the intracellular metabolome. The methyl groups could be obtained through 
the S-adenosyl L-Methionine cycle or intracellular proteolysis leads to release of 
methyl-lysines.  In mammals, other than L-Lysine contribution towards protein 
production; L-Lysine to tri-methyl L-Lysine is also involved in carnitine 
biosynthesis. Carnitine is responsible to transport fatty acids to mitochondria for 
oxidation and energy production. Although, N6, N6, N6 tri-methyl L-Lysine, the 
precursor for synthesis of carnitine (Hulse et al., 1978) has been found in the 
intracellular metabolome, it is not clear whether Leishmania genome encode for 
carnitine biosynthesis.  The different steps of carnitine biosynthesis including 
oxidation, release of glycine residue, dehydrogenation and re-oxidation of tri-
methyl-L-Lysine to carnitine formation was individually analysed by bioinformatics 
approach using blast analysis but no gene annotations were found for the same 
(Appendix table for Lysine).  
The intermediates shown in Figure 5.13 were schematically represented as N6-
Acetyl-L-Lysine, 2-Amino-5-oxohexanoate found to oxidised forms of L-Lysine and 
subsequently (R)-piperidine-2-carboxylate is oxidised to form 2-amino-adipate 
which facilitates NADH regeneration as observed in degradation pathways of other 
amino acids in L. mexicana promastigotes as shown in Figure 5.20. 
5.3.2.4 L-Leucine, L-Valine and L-Isoleucine metabolism 
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Leishmania genome encode for many enzymes involved in elaborate degradation 
pathway of branch chain amino acids of L-Leucine, L-Valine and L-Isoleucine 
according to KEGG pathway database. However, the extraction methods adopted 
in this study (Chapter 2, methods) was more suitable for polar metabolites and 
organic acids, whilst branch chain amino acids have shown to be incorporated into 
lipids and CoA molecules which are much less emphasised in this study. 
Radiolabelled studies in L. mexicana using labelled L-Leucine have indicated the 
carbon skeleton of L-Leucine are directly incorporated into sterol biosynthesis 
(Ginger et al., 2001). Isoleucine and L-Valine are degraded into pathways that 
lead to succinyl coenzyme A but analysis of CoA (coenzyme A) derivatives requires 
targeted extraction procedure as explained elsewhere (Basu and Blair, 2012).  
 
5.3.2.5 L-Aspartate and related amino acids metabolism 
 
The first step in L-Aspartate degradation is mediated by L-Aspartate 
aminotransferase (AAT) which has been shown to have broad spectrum substrate 
specificity unique to Leishmania (Leblancq and Lanham, 1984). AAT has been 
described to have multiple isoforms with localisation with both glycosome and 
mitochondrial specific. Aspartate converted to oxaloacetate which enters the TCA 
cycle by mitochondrial L-Aspartate aminotransferase, alternative route involves 
L-Aspartate conversion to fumarate by the purine-nucleotide cycle (Marciano et 
al., 2009).  In the past L-Aspartate utilisation in Leishmania has been described 
with respect to TCA cycle and energy generation (Saunders et al, 2014). However, 
in other biological organisms, for example, in bacteria and fungi, it has been 
shown that L-Aspartate leads to production of various other amino acids including 
L-Threonine, L-Methionine, isoleucine, phosphoribosyl pyrophosphate, L-Histidine 
(Rees et al., 2009) and pyrimidines (Paselk, 1983).  
 
Within the intracellular metabolome recovered from L. mexicana promastigotes 
in defined medium, the metabolites belonging to L-Aspartate metabolism have 
been shown in Figure 5.14. In this study, efforts have been made to schematically 
represent metabolites associated with L-Aspartate as important precursor 
supporting the biosynthesis of most of the amino acids following the metabolic 
pathway as shown in Figure 5.21. Absence of L-Aspartate significantly increased 
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the doubling time (Chapter 4) indicating the importance of exogenous supply of 
L-Aspartate required during the growth cycle of promastigotes. Aspartate 
degradation via the asparatokinase enzyme is alternative route of action 
compared to L-Aspartate amino transferase leading to oxaloacetate contribution 
to oxidative phosphorylation via the TCA cycle. Aspartate broken down to aspartyl 
phosphate is energy consuming reaction with ATP to ADP conversion leading to 
aspartyl phosphate via asparatokinase. Further, L-Aspartate dehydrogenase leads 
to production of L-Aspartate semialdehyde formation with the conversion of 
NADPH to NADP. Aspartate semialdehyde leads to homoserine biosynthesis via the 
enzyme homoserine dehydrogenase (Flavin and Slaughte.C, 1967). O-acetyl L-
Homoserine putatively identified in the intracellular dataset as shown in Figure 
5.14.L-Homoserine biosynthesis is the first committed step before L-Methionine 
and L-Threonine biosynthesis. It has been shown in bacterial systems that 
homoserine biosynthesis could be negatively regulated by increased concentration 
of L-Threonine or L-Methionine within the cells (Vitreschak et al., 2004).  
 
Threonine serves as an indispensable amino acid to mammals as no biosynthesis 
pathway encoded. Enzymes involved in both biosynthesis/degradation cycle of L-
Threonine metabolism are proposed as important candidates to be considered for 
further investigation as drug target because these enzymes were found not 
encoded in the genome of Homo sapiens (Reeds, 2000).  
 
L-Aspartate metabolism includes sub branch leading to L-Methionine biosynthesis 
as shown in Figure 5.14 is another Leishmania specific pathway needs further 
investigation. The enzymes encoded within Leishmania for specific L-Methionine 
metabolism pathway was found to have no mammalian homologs. From the results 
from single amino acid knock out experiments (Chapter 4) , growth in the absence 
of L-Methionine was comprised with increase in doubling time and cell body 
appear smaller in size with lesser protein production. From the untargeted 
metabolomics data, there were other metabolites putatively identified such as 
homoserine, cystathionine and homocysteine not highlighted before. In the 
intracellular metabolome, the relative abundance of homoserine at 0.44 < lesser 
than downstream metabolites from the pathway such as cystathionine and L-
Methionine each at 0.46 and 0.52 as shown in Figure 5.14. This allows to map the 
pathway using metabolomics data as shown in Figure 5.21. In-order to survive 
182 
 
within the insect vector, the parasites may modify their metabolic repertoire to 
meet the changes in nutrient availability and maximise the chance of survival by 
efficient use of resources. These results indicated that Leishmania encode residual 
L-Methionine biosynthetic pathway to maximise viability under nutrient deprived 
conditions as tested. 
 
L-Methionine biosynthesis pathway has been well studied in E .coli, although not 
universal in all organisms, it has been considered as standard pathway for 
comparison (Flavin and Slaughte.C, 1967). The first step in L-Methionine synthesis 
starts from activated homoserine as shown in Figure 5.21. Met A gene encoding 
for the enzyme homoserine O-succinyltransferase transfers the succinyl group 
from succinyl-CoA to gamma-hydroxyl group resulting in O-succinylhomoserine. 
Met B encodes for cystathionine gamma synthase which catalyses the trans-
sulfurlyation reaction by transfer of the thiol group from cysteine to homoserine 
forming cystathionine. This has been subjected to cleavage by cystathionine beta 
lyase encoded by Met C resulting in homocysteine, pyruvate and ammonia. Met H 
encodes cobalamin dependent L-Methionine synthase with cobalamin cofactor 
serving as acceptor or donor of methyl group from 5-methyl tetrahydrofolate to 
homocysteine (Koutmos et al., 2009). However, an alternative pathway in the 
absence of exogenous cobalamin with the aid of Met E encoded enzyme cobalamin-
independent L-Methionine synthase which transfers the methyl group directly 
from the tri-L-Glutamate derivative of 5-methyl-tetrahydrofolate to homocysteine 
(Whitfiel.Cd et al., 1970).  
 
It has been shown in L. donovani and L. infantum species (Berger et al., 1998) 
that there is evidence for L-Methionine recycling using inorganic keto-thio-
butyrate and aromatic amino acids as nitrogen donor as alternative metabolic 
pathway for maintaining intracellular L-Methionine concentration. Thus, 
dependence on exogenous L-Methionine might depend upon the intracellular 
concentration of the promastigotes at particular stage in the life cycle. L. 
tartentole has been shown to assimilate inorganic sulphur for L-Methionine 
biosynthesis, and hence does not depend upon exogenous L-Methionine 
(Steeleda.F and Krassner, 1971). Methionine is an important amino acid with 
many functions: it is the first amino acid added during protein translation, 
essential for cysteine biosynthesis and acts as preferential methyl donor during 
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most biochemical reactions. Methionine degraded to succinyl-CoA and succinate 
and feds into the TCA cycle. Methionine also converted to acetyl CoA by acetate 
succinyl CoA transferase to form acetate and ATP. Methionine has shown to have 
regulatory role in protein activation and inactivation owing to its chemical 
properties to undergo reversible oxidation (Drazic and Winter, 2014).  
 
L-Aspartate metabolism contributes to the phosphoribosyl pyro phosphate (PRPP) 
via carbamoyl phosphate pathway. PRPP serves as precursor molecule for synthesis 
of pyrimidines and L-Histidine schematically represented in Figure 5.21. The 
pyrimidines and intermediates of L-Histidine biosynthesis pathway were as shown 
in Figure 5.14 within the intracellular metabolome. These results indicate that 
increased accumulation of L-Histidine or downstream intermediates supports 
parasite viability even in the absence of exogenous supply of L-Histidine during 
the first passage in culture.  
 
Increased presence of pyrimidines such as uracil and thymine as shown in Figure 
5.14 indicate high level of pyrimidines maintained within the intracellular 
metabolome. It has been previously reported that pyrimidines biosynthesis occurs 
within Leishmania by interconversion and purine source (Serafim et al., 2012). 
However, exogenous supply of purine such as adenosine is essential for the 
viability and growth of Leishmania as shown in growth analysis (Chapter 3). 
 
In summary, results from unbiased mapping of intracellular metabolomics data 
have shown presence of compensatory biosynthetic metabolic pathways; highly 
conserved with dependence on the extracellular or the host environment required 
to support viability of promastigotes under conditions of absence of exogenous 
supply of L-Threonine, L-Methionine, L-isoleucine and L-Histidine as recorded 
during growth analysis shown in Figure 4.15 (Chapter 4). These evidences also 
suggest that amino acid utilisation pathways for NADH regeneration other than 
protein synthesis, cell structure maintenance amongst other functions within L. 
mexicana promastigotes.  
 
 
5.3.2.6 Glutamate and related amino acids metabolism 
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According to genome annotation, L-Glutamate has been shown as primary source 
for L-Proline and L-Glutamine production in Leishmania (Berriman et al., 2005). 
All the intermediates of L-Glutamate metabolism as shown in Figure 5.15 with the 
relative intensity value as observed under experimental conditions of defined 
medium. Glutamate metabolism occurs in two different localisations, with the 
putative cytosolic NADPH dependent L-Glutamate dehydrogenase and 
mitochondrial NAD dependent isoenzyme. Glutamate on deamination forms alpha 
keto butyrate that feds into the TCA cycle as represented in Figure 5.23. The 
transamination reaction involving L-Glutamate to 2-oxoglutarate is coupled with 
L-Alanine degradation to form pyruvate. The intra-cellular pool of L-Alanine is 
maintained very high in Leishmania Figure 5.15 and has shown to play an 
important role to maintain osmoregulation (Inbar et al., 2013) with dynamic 
extracellular environment of the host system. Unlike in mammals where L-
Glutamate utilised for production of neurotransmitters such as gamma amino n-
butyric acid; in Leishmania promastigotes, L-Glutamate on reaction with cysteine 
forms gamma glutamyl cysteine, which  contributes to the production of 
Kinetoplastida specific polyamines, trypanothione; important for redox 
homeostasis (Paes et al., 2008) as represented in Figure 5.23. Furthermore, 
Glutamate contributes to L-Glutamine by amidation (Figure 5.23) and L-Proline 
via L-Glutamate semi aldehyde (Saunders et al, 2014) . It was observed from the 
metabolomics data that L-Glutamine, L-Proline and L-Alanine are the most 
abundant amino acids in the intracellular pool of promastigotes as shown in Figure 
5.8. The carbon skeletons of L-Alanine, L-Glutamine and L-Proline are shown to 
be incorporated to gluconeogenic intermediates (Saunders et al., 2011) leading to 
the production of glucose via the TCA cycle in Leishmania promastigotes as 
represented in Figure 5.23.   
 
From growth analysis of promastigotes cultured in the single amino acid knock out 
media as shown in Chapter 4, it was observed that the parasites were viable even 
in the absence of exogenous supply of L-Threonine, L-Histidine, L-isoleucine and 
L-Methionine. This indicates that biosynthesis could be active in Leishmania 
promastigotes but negatively regulated because of high amino acid availability 
within the insect midgut. Thus, possible routes of biosynthesis have been discussed 
to highlight the enzymes involved in the biosynthesis of these amino acids as 
potential drug target not found in mammals. 
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Threonine biosynthesis pathway involves 2 enzymes, Homoserine kinase (HSK) is 
the enzyme involved in the first step of L-Threonine biosynthesis. It has been 
shown in related kinetoplastida, Trypanosoma brucei, that this particular step 
from the conversion of homoserine to L-Threonine biosynthesis occurs only in L-
Threonine limited conditions (Ong et al., 2015). One of the peculiar feature of 
HSK exist as bifunctional enzyme with AK activity.  They also explain the 
localisation of the enzyme in insect vector tsetse endosymbionts encode for the 
production of these unusual metabolites such as 3-oxohexanoylhomoserine 
lactone. Genetic and biochemical studies reported from the paper indicated that 
HSK null mutant were unable to compensate for the non-availability of L-
Threonine compared to wild type T. brucei. They demonstrated that wild type 
parasites were able to grow with the homoserine. Wilson et al 1991. Similar studies 
in plants by Weisemann and Matthews, 1993 have reported HSK as bifunctional 
protein. Bioinformatics approach was used to comparative phylogeny mapping of 
the enzyme Homoserine kinase in Leishmania shows early branch point in 
evolution from eukaryotes and similar to T. brucei forms (Ong et al., 2015). 
Threonine synthase catalyses the second step with the conversion of O-phospho L-
homoserine to L-Threonine with the addition of water moiety and release of the 
phosphate group as schematically represented in Figure 5.21. Thus, L-Aspartate 
could serve as major precursor molecule for many other amino acids as shown 
from schematic mapping in Figure 5.21 
 
Threonine degradation involves 3 pathways. Threonine degradation I involves the 
enzyme THF-dependent serine hydroxymethyltransferase (SHMT) to form glycine, 
undergoes reversible reaction in serine production. Serine is converted to 
pyruvate. Threonine degradation II involves L-Threonine catabolism via the 
Ser/Thr dehydratase to alpha keto butyrate that feds to the TCA cycle to form 
succinyl CoA. From the intracellular data as shown in Figure 5.14, the relative 
abundance of 2-oxobutonate is high which indicates that the major flux of L-
Threonine degradation to generate high energy TCA cycle intermediates. Thus, L-
Threonine deaminase plays major role to form 2-oxobutonate from L-Threonine. 
Subsequent reaction of 2-oxobutonate into propionyl CoA has not be identified, 
which may be because of the analytical method used in this study is focused on 
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polar metabolites and not CoA which might be cleaved off and small size of the 
ion was beyond detection of parameters chosen.  
 
Earlier literature indicated the contribution of L-Threonine to TCA cycle via the 
propionyl pathway unique to species of Leishmania and T. cruzi, not found in T. 
brucei (Opperdoes, 2008). L-Threonine contributes to L-serine and subsequently 
to L-glycine (Opperdoes and Coombs, 2007) . Glycine is metabolised by the glycine 
cleavage system to form formic acid and CO2. Glycine is also converted to serine 
and pyruvate by the THF-coupled serine hydroxyl-methyltransferase, and Thr/Ser 
dehydratase which is reversible reaction. Glycine can also be formed from the 
glyoxylate via the enzyme serine pyruvate aminotransferase which has not been 
completely characterised in Leishmania before. The third pathway of L-Threonine 
metabolism to L-Isoleucine biosynthesis has not been less explored. Threonine 
degradation through alternative pathway leading to isoleucine biosynthesis 
(Levinthal et al., 1973) as detailed in schematic representation in  
Figure 5.22. The 4 enzymes involved in the isoleucine biosynthetic reactions 
involve: 
 
Step 1: Formation of acetolactate: This intermediate has been putatively 
detected in the intracellular dataset as 2-Hydroxy-2-methyl-3-oxobutanoate 
validated by chemspider for synonym as acetolactate with molecular formula 
C5H7O4 and average mass 131.107 Da. The mass/charge was verified in the 
intracellular dataset and 4 compounds were identified with similar mass range of 
131 Da. Further filtering of the data by molecular formulae indicate mass detected 
at 131.06 and retention time at 13 as 2-Hydroxy-2-methyl-3-oxobutanoate. 
Caution was exercised since it is only putative identification at this stage.  Blast 
analysis using gene sequence from UNIPROT ID I6YEX6 from Mycobacterium 
tuberculosis were compared to Leishmania species. Homologous gene was 
identified as putative pyruvate/indole-pyruvate carboxylase, putative 
[Leishmania mexicana MHOM/GT/2001/U1103] with sequence id as 
XP_003878881.1 and corresponding E value of 6e-26. The gene activity has been 
well characterised in Mycobacterium tuberculosis which requires ascorbic acid as 
cofactor (Yin et al., 2011). 
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Step 2: Formation of (S)-2-hydroxy-2-ethyl-3-oxopentanoate: 2-oxobutanoate 
catalysed by ketol-acid reductoisomerase binds to Mg+2 in a metal-dependent 
reduction reaction by NADPH to yield (S)-2-hydroxy-2-ethyl-3-oxobutanoate with 
NADPH regeneration. 
 
Step 3: 3-methyl-2-oxopentanoate formation: Loss of water moiety of 2, 3-
dihydroxy-3-methylpentanoate catalysed by di-hydroxy-acid dehydratase leads to 
formation of 3-methyl-2-oxopentanoate. 
 
Step 4: Formation of isoleucine: This involves the enzyme branch chain amino 
transferase that catalyses the reversible reaction between the alpha keto acid, 
such as 3-methyl-2-oxopentanoate to yield L-isoleucine. Evidence of this enzyme 
was verified by blast analysis as shown in  
Figure 5.22. As shown in Figure 5.14, some of putatively identified metabolite 
leads to isoleucine biosynthesis pathway have been detected. The first committed 
step encoded by acetolactate synthase and last step encoded by branch chain 
transaminase showed significant homology in Leishmania genome by blast analysis 
as shown in  
Figure 5.22. 
 
Proline is oxidised by L-Proline oxidase and delta 1 pyrroline 5 carboxylate 
dehydrogenase which enter the TCA cycle as represented in Figure 5.24. Proline 
serves as major energy contributor of energy through oxidative phosphorylation. 
This is in agreement with previous studies by Mukkada et al (Bringaud et al., 2012, 
Glaser and Mukkada, 1992) where L-Proline serves as major energy contributor 
especially found in high concentrations within the insect midgut. Proline has 
shown to be the major molecule of osmoregulation and co-transported by L-
Proline-L-Alanine symporter (Zilberstein and Gepstein, 1993). It has shown that 
when promastigotes were subjected to osmotic stress, the Proline transporter 
gene LdAAP24 has been upregulated confirming their role in osomoregulation 
(Inbar et al., 2013).  
From growth analysis as elaborated in Chapter 4, promastigotes cultured in the 
single amino acid drop out media in the absence of L-serine, L-Histidine,  L-
isoleucine,  L-Threonine, L-Glutamate, L-Methionine, L-Glutamine, L-cysteine, L-
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L-Tyrosine,  L-Proline, L-Asparagine, L-Alanine,  L-glycine causes no significant 
increase in doubling time during the growth cycle of promastigotes. From the 
unbiased network of amino acids as shown in Figure 5.21, biosynthesis of L-
Glutamate, L-Methionine, L-Glutamine, L-cysteine, L-L-Tyrosine, L-Proline, L-
Asparagine, L-Alanine, L-glycine, L-serine, L-Histidine, L-isoleucine, L-Threonine 
could be active in Leishmania promastigotes via L-Aspartate metabolism. These 
biosynthetic pathways could be intermittently active since increased availability 
within the insect midgut leads to negative regulation. However, these enzymes 
involved in the biosynthesis of these amino acids, especially for L-Threonine 
biosynthesis could serve as potential drug target not found in mammals.  
 
This is first report using metabolomics data from defined medium with efforts 
being made to build unbiased networks of amino acid metabolism in Leishmania 
promastigotes. The dynamic information of change of intracellular metabolites 
has been captured from the log phase (Day 3) of the culture in defined medium 
with optimised protocol as described in the methods section.  Moreover, the 
knowledge from this study has allowed for new insights of amino acid metabolic 
pathways in Leishmania promastigotes unreported before. 
 
From the untargeted metabolomics of the intracellular metabolome, network 
mapping has highlighted that amino acids are metabolised by simplistic route in 
Leishmania promastigotes mostly for NADH regeneration as shown in Equation 1. 
Furthermore, metabolic route of the amino acid derived keto acids have been 
found unique to L. mexicana promastigotes.  
            𝐴𝑚𝑖𝑛𝑜 𝑎𝑐𝑖𝑑 → 𝐴𝑚𝑖𝑛𝑜 𝑎𝑐𝑖𝑑 𝑑𝑒𝑟𝑖𝑣𝑒𝑑 𝑘𝑒𝑡𝑜 𝑎𝑐𝑖𝑑𝑠 + 𝑁𝐴𝐷𝐻 
Equation 1 Unique metabolic route of amino acid catabolism in Leishmania promastigotes 
using enzyme amino acid carboxylases. 
Hence, this unique metabolic pathway involving the enzymes, amino acid 
carboxylases could serve as drug targets specific for the parasite alone without 
affecting the host system. Furthermore, inhibition of this particular enzymatic 
step of amino acid metabolism could inhibit increased production and secretion 
of amino acid derived keto acids  
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It is still intriguing that these parasites follow different metabolic pathway follow 
much simpler metabolic degradation pathway compared to other organisms. To 
further verify the role of small molecules in infection, time resolved metabolic 
foot-printing of exometabolome samples and biochemical assays of aromatic 
pyruvates on activated host cells were carried out as reported in Chapter 5. Time 
course metabolomics of the exometabolome highlights keto acids play in role in 
supporting infection with host cells, especially from aromatic amino acids were 
found be enriched in the Defined medium supernatant over time  indicating active 
secretion of these metabolites from procyclic to infective metacylic forms ( i.e 
Day 0 to Day 9 during growth phase in vitro culture in Defined medium) that have 
shown novel role in supporting early stages of infection in mammalian cells as 
further elaborated in chapter 5).
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Chapter 6 Determination of amino acids utilisation 
required for parasite development and infection. 
 
6.1 Introduction 
The human pathogenic Leishmania promastigotes colonise the sand-fly gut before 
infecting the macrophages in the mammalian host. As obligate parasites 
Leishmania promastigotes rely completely on host system for acquiring nutrients 
to complete their dynamic developmental life cycle (Burchmore and Barrett, 
2001). Routes of nutrients uptake have been shown as drug targets discussed in 
the past (Shaked-Mishan et al., 2006, Inbar et al., 2012). However, mapping of all 
nutrients in global unbiased manner had been challenge due to the complex nature 
of the in vitro medium used for axenic culture of parasites. In this chapter, the 
use of metabolic foot-printing for nutrients uptake have been explored. This is the 
first report of data from time resolved metabolic foot-printing from in house 
developed chemically defined medium (composition Chapter 4) that would allow 
to decipher accurate information about substrate utilisation during the growth of 
L. mexicana promastigotes. 
 
The true metabolome as described by Oliver (Oliver et al., 1998) as the complete 
set of all low molecular weight metabolites present in and around growing cells 
at a given time during their growth or production cycle cannot be captured using 
one single technique because of the diverse chemical nature and concentrations 
of metabolites. Studies on intracellular metabolomics optimised using different 
extraction procedures for comprehensive analysis of diverse nature of small 
molecules with a molecular weight of less than 1500Da known as metabolic finger-
printing (Mashego et al., 2007, T'Kindt et al., 2011). Unlike genomics, changes in 
metabolites composition reflect the phenotype of the organism as a result of the 
complex interplay between various signalling and regulatory factors (Fiehn, 2002). 
Studies on Leishmania metabolome in the past has been carried out using complex 
media containing undefined serum component (Scheltema et al., 2010, Silva et 
al., 2011, Westrop et al., 2015). Few other studies (Saunders et al., 2011) have 
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used chemically defined media containing many components (Merlen et al., 1999) 
which is not important for the viability and growth of Leishmania promastigotes 
(as shown from our results in chapter 3), thus the metabolomics studies in our 
defined medium allowed to derive further novel biological inferences unexplored 
in the past.  
 
6.1.1 Time resolved metabolic foot-printing in defined medium 
Metabolic foot-printing involves quantification of metabolite uptake and secretion 
from the culture media. Use of chemically defined media for metabolic foot-
printing brings new insights into compound utilisation different from that observed 
in complex undefined medium and allows for standardised platform for 
comparison between laboratories (Kell et al., 2005, Aurich et al., 2015).  Growth 
dependent changes of cellular metabolism can be captured using time-resolved 
metabolic foot-printing. In classic model organisms of the fungal and bacterial 
kingdoms, time resolved metabolic foot-printing have shown to be useful for 
various purposes including and not limited to taxonomic classifications of species, 
gene function identification by comparing profiles between mutated and wild-
type forms and varied metabolic adaptations of clinical isolates (Behrends et al., 
2009, Allen et al., 2003, Palmer et al., 2007).  
 
Leishmania promastigotes undergo a complex developmental cycle within the 
insect vector before transition into amastigotes stages within macrophages in the 
mammalian host. Metabolic foot-printing approach was applied to study time 
resolved utilisation of multiple metabolites simultaneously at different growth 
stages of promastigotes. The physiochemical environment encountered by 
promastigotes within the insect vector changes depending upon the host species 
and nutritional status of the sand-fly vector (Pimenta et al., 1992). Broadly, it has 
been described elsewhere that promastigotes undergo dynamic transformation 
from procyclics 24-48 hours, nectomonands 48-72 hours, leptomonads 4-7 days, 
about 5-7 days termed as metacyclics which infect the host cells and about 7-9 
days within the insect midgut referred to as haptomonads which forms the lining 
of the salivary duct (Walters, 1993). This transformation is associated with 
morphological changes from short procyclics to slender metacyclics with longer 
flagella and slender cell body (Gossage et al., 2003). Functional differences during 
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the different growth stages have been illustrated by Bates et al, 1993 that 
metacyclics have increased resistance to complement mediated lysis, increased 
infectivity and varied ultrastructure of the surface membrane (Bates, 1994).  
 
6.1.2 Research aims 
Time resolved metabolic foot-printing by untargeted metabolomics approach was 
conducted by: 
•  Samples from different time points of promastigotes growth were analysed 
to understand metabolic requirements during the developmental cycle.  
• Classification of metabolites those depleted and enriched were further 
investigated.  
• Secreted small molecules especially aromatic pyruvates in defined media 
have been tested with pure compounds as standards in biochemical assays 
to elucidate their role in establishment of parasitism with THP1 cells as 
macrophage infection model. 
6.2 Results  
6.2.1 Study objectives for time course metabolomics data  
L. mexicana promastigotes were cultured using serum and protein free, Defined 
medium (composition Chapter 4) and optimised experimental procedures for 
metabolomics as explained in chapter 2 and 4. In this study,  time resolved 
metabolic foot-printing was carried out starting from early log (Day 1 and Day2), 
mid log (Day 3) and stationary phase (Day 6 and Day 9) to determine uptake and 
secretion of metabolites during promastigote growth. With an untargeted 
metabolomics approach, it was possible to differentiate the salvage and 
biosynthesis pathways of Leishmania promastigotes and highlight parasite specific 
metabolic pathways as potential drug targets. Furthermore, secreted small 
molecules enriched in the culture media throughout the growth of the 
promastigotes were tested to derive physiological inferences during the 
establishment of parasitism, with macrophage cells as in vitro experimental 
model. 
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6.2.2 Experimental design 
Growth was monitored on day to day basis by manual cell counting using 
haemocytometer from Day 0 to Day 9 and six time points were chosen to represent 
the various stages of the promastigote life cycle as described in by Gossage et al 
(Gossage et al., 2003). Samples were collected from three different flasks set up 
independently from different inoculation flasks as elaborated in methods section 
(Chapter 2). From each flask, triplicates were collected at six different time 
points and analysed by Liquid chromatography Mass spectrometry (LC-MS) on 
pHILIC chromatographic column in both ionisation modes (positive and negative) 
as indicated in Figure 6.1.  The samples were run in 2 ionisation modes from 3 
independent cultures summing up to 36 data points of each compound.  
 
Figure 6.1 Growth of L. mexicana promastigotes  
(Arrow heads to indicate of the time points of the growth curve from which supernatant 
were collected from 4 x 107 cells at 0, 1, 2, 3, 6, and 9 day from the culture initiation in total 
of 6 time points, (n=9, Error bars = mean ± SD), as described in experimental procedures). 
6.2.3 Pre-processing and annotation  
The raw files were processed using IDEOM software for spectral feature detection. 
Briefly, peaks matched with compound identifications with a filtration criteria 
such that those below p < 0.05 retained in the data set analysed by unpaired t-
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test between time course samples (treatments) and naïve medium without cells 
(controls). Hence, about 206 metabolites were putatively identified across 
replicates in positive and negative mode with 64 metabolites matched with 
authentic standards for individual mass/charge ratio and retention time 
comparison. Raw spectral files with peak intensity, m/z and retention time 
included in appendix file. Furthermore, the 206 putatively identified metabolites 
were analysed by multi-variant data analysis techniques such as principal 
component analysis (PCA), Partial Least-Squares regression and Discriminant 
Analysis (PLS-DA model) and hierarchical clustering analysis (HCA) across samples 
to derive deeper insights that would help reduce the dimensions in the data set 
and uncover changes of metabolites pattern within the data(Fiehn, 2002) and 
individual metabolites analysed. 
 
6.2.4 Multi variant analysis 
Partial Least-Squares regression and Discriminant Analysis (PLS-DA), a supervised 
machine learning method was conducted for the metabolic foot-printing data, 
especially useful for visualisation of time course samples. PLS-DA allows for easier 
interpretation of data patterns as the number of samples (18) were lesser than 
the total number of variables (spectral peaks) measured. PLS-DA model analysis 
was accompanied by unsupervised classification method such as principal 
component analysis (PCA), for visual interpretation of underlying groups within 
the high dimensional data as shown in Figure 6.2. 
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Figure 6.2 PLS-DA model of exo-metabolome at six different time points during the growth 
of L. mexicana promastigotes cultured in Defined medium.  
PLS-DA model showed the variance plot with the first two components explaining 
the maximum variability within the data. Each sample of the mass spectrum has 
been mathematically represented as single point on the graph annotated by the 
respective sample number. The observation diagnostics shows the spread of the 
18 samples across the orthogonal distance on the score plot. The score plot 
(Principal component analysis) indicates clusters amongst the 18 samples with 
outliners within the dataset. The Loadings plot shows the placement of different 
metabolites subdivided into four sections (+/+, +/-, -/+, -/-) based on the levels 
of their peak intensities. Principal component analysis (PCA) of time course 
samples shows each group of clustered separately. Individual groups shown by 
different colours each for Day 0 (Ctrl-dark blue), Day 1 (D1-green), Day 2 (D2-
orange) and Day 3 (D3-pink) are clearly separated from Day 6 (D6-light-blue) and 
Day 9 (D9-red); indicating significant change in the media throughout the growth 
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of promastigotes from early log to stationary stage). The variance plot shows the 
first two principal components accounts for 26% and 37% of the variation 
respectively present in the LC-MS dataset. 
 
The colour coded ellipses as shown in Figure 6.2 shows that metabolic foot print 
of supernatant samples from day 1, day 2 and day 3 of the culture overlaps with 
each other (Fig 2) indicating that log phase (Day 1-3) promastigotes in culture are 
similar at the initial time points. Whilst, the samples from Day 6 and Day 9 form 
individual clusters which represent the metabolic profile during stationary phase 
of promastigotes, well separated from log phase promastigotes.  
 
Hierarchical clustering analysis (HCA) 
 
HCA used to depict the similarity between samples in the group from the total set 
of 18 samples as shown in Figure 6.3. 
197 
 
 
 
Figure 6.3 Hierarchical cluster analysis shows that the18 samples are sub divided into 3 
main clusters.  
(The naïve culture medium referred to as Cluster 1 with each sample abbreviated as M1, M2 
and M3 are completely separated from other two sub clusters with Cluster 2 consisting of 
Day 6 (6S1, 6S2, 6S3) and Day 9 (9S1, 9S2, 9S3) sample triplicates and Cluster 3 consisting 
of Day 1 (1S1, 1S2, 1S3), Day 2 (2S1, 2S2, 2S3), and Day 3 (3S1, 3S2, 3S3) sample triplicates). 
 
Hierarchical cluster analysis shows that the log phase promastigotes are clearly 
separated from stationary phase promastigotes with metabolic profiles 
significantly different from each other as shown in Figure 6.3. For this part of the 
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analysis, metabolites with confidence score of 8-10 were selected based on 
matching peaks from a set of 250 authentic standards below 5% error window for 
individual mass/charge ratio and retention time. HCA show that samples are sub 
divided into 3 main clusters indicating different metabolic signatures for log, 
stationary and medium only samples. 
 
6.2.5 Overview of distribution of metabolites in the exo-metabolome. 
Overall changes of the medium that followed the growth of L. mexicana 
promastigotes in a period of 6 days from the start of culture initiation is as shown 
in Figure 6.4. 
                
                
Figure 6.4 Overall distribution of metabolites in the spent medium of defined medium after 
the growth period of 6 days from the start of culture initiation.  
Defined medium with known composition of 45 compounds in naïve condition 
without cells were subjected to similar incubation time, temperature and pH and 
analysed along with supernatant samples at different points from the culture. Of 
the 206 metabolites putatively identified across replicates in both positive and 
negative ionisation mode, 64 metabolites matched with authentic standards for 
individual mass/charge ratio and retention time comparison. Overall pattern 
indicated that approximately 25% metabolites depleted from the medium, 14% not 
changed significantly, 5% unknown and unassigned metabolites and 40% of overall 
metabolites significantly enriched in the medium. In terms of numbers of 
metabolites; , only approximately ~14 metabolites could be identified with 
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authentic standard with confidence score of 10 that were depleted from the 
medium, and about ~56 metabolites were significantly enriched whose confidence 
score was between a range from 7-10. 
 
6.2.6 Changes in individual metabolites levels 
 
The amino acids present in defined medium were identified as putative 
metabolites with confidence score >10 that matched with authentic standards and 
expressed as change in fold intensity at Log2 scale. Here, they were compared 
between metabolite levels in supernatant medium and medium without cells 
incubated and treated for similar times as shown in Figure 6.5 to Figure 6.11. 
 
 
Figure 6.5  Changes of relative peak intensities of polar amino acids calculated from the 
exo-metabolome data.  
Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Histograms expressed as log2 
fold change from the baseline (medium only samples from fresh medium incubated 
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to similar times) over the course of growth from Day 0 to Day 9 of L. mexicana 
promastigotes in defined medium). 
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Amongst the amino acids with polar uncharged side groups, L-Threonine and L-
serine were depleted compared to L-Proline and L-Glutamine as shown in Figure 
6.5. 
 
 
 
 
Figure 6.6  Changes of relative peak intensities of non-polar amino acids calculated from the 
exo-metabolome data. 
Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Histograms expressed as log2 
fold change from the baseline (medium only samples from fresh medium incubated 
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to similar times) over the course of growth from Day 0 to Day 9 of L. mexicana 
promastigotes in Defined medium. Stereo isomers, L-Leucine and L-Isoleucine not 
differentiated in this study. 
 
Those amino acids with non-polar aliphatic side groups, L-Leucine, L-Valine and 
L-Methionine were depleted compared to L-glycine and L-Alanine as shown in 
Figure 6.6. 
               
                 
Figure 6.7 Changes of relative peak intensities of negatively charged amino acids calculated 
from the exo-metabolome data.  
Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD.  Histograms expressed as log2 
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fold change from the baseline (medium only samples from fresh medium incubated 
to similar times) over the course of growth from Day 0 to Day 9 of L. mexicana 
promastigotes in Defined medium. 
 
Aspartate and L-Glutamate were consumed rapidly with less than 50% remaining 
by day 1 of growth period in defined medium as shown in Figure 6.7. 
                    
                         
                                                                      
                       
Figure 6.8  Changes of relative peak intensities of positively charged amino acids calculated 
from the exo-metabolome data.  
Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD., Histograms expressed as log2 
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fold change from the baseline (medium only samples from fresh medium incubated 
to similar times) over the course of growth from Day 0 to Day 9 of L. mexicana 
promastigotes in Defined medium. 
Amongst the positively charged side groups, L-Lysine was taken up moderately 
from the medium, whilst L-Asparagine was found secreted as shown in Figure 6.8. 
 
Figure 6.9 Uptake of aromatic amino acids represented from the changes of relative peak 
intensities from the metabolomics data.  
Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Histograms expressed as log2 
fold change from the baseline (medium only samples from fresh medium incubated 
to similar times) over the course of growth from Day 0 to Day 9 of L. mexicana 
promastigotes in Defined medium. L-Histidine not detected. 
 
Phenylalanine is transiently released in the system as shown in Figure 6.9 but 
taken up during at later stages of growth cycle especially from day 3 to Day 9. 
Tyrosine is moderately utilised without much changes in the level of extra-cellular 
L-Tyrosine. L-Tryptophan was taken up more than 2 fold changes in the 
extracellular level from Day 0 to Day 3 and consumed completely with not 
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intensity detection on Day 6/9 compared to other amino acids from the medium. 
Histidine was not detected in this study, raw files were manually checked for 
retention time and mass which did not match the known values. 
 
 
Other medium components 
                                  
                              
Figure 6.10 Uptake of six carbon sugar such as L-Glucose represented from the changes of 
relative peak intensities from the metabolomics data.  
Six carbon sugar L-Glucose has been depicted in Figure 6.10; however, it is to be 
noted that these are putative identifications at that stage. The method of LC-MS 
adopted in this study would not allow to completely differentiate between six 
carbon sugars such as L-Glucose, L-Fructose or L-Galactose.  
 
Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation with n=3, Error bars = mean ± SD. Histograms expressed as 
log2 fold change from the baseline (which is the fresh medium only samples 
incubated to similar times) over the course of growth from Day 0 to Day 9 of     L. 
mexicana promastigotes in Defined medium. 
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Figure 6.11 Uptake of adenosine represented from the changes of relative peak intensities 
from the metabolomics data.  
Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Histograms expressed as log2 
fold change from the baseline (fresh medium only samples incubated to similar 
times) over the course of growth from Day 0 to Day 9 of L. mexicana promastigotes 
in Defined medium. 
From these results, Glucose and adenosine was recorded to be consumed throughout the 
growth cycle since the extra-cellular level was completely depleted by day 9 as shown in 
Figure 6.10 and Figure 6.11. 
 
6.2.7 Classification of amino acids based on depletion rate from the 
culture medium. 
Individual metabolites shown to be divided into 3 main categories, based on 
degree of change from base level in naïve medium (either metabolites >50% 
depleted, metabolites <50% depleted and metabolites enriched) from the defined 
medium at different phases of growth in culture. The amino acids were divided 
into three major groups depending upon their dynamic utilisation over time 
compared with naive medium.  
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Depending upon the relative rate of depletion from the medium, the amino acids 
are classified into three groups as follows: 
• Continuously utilised amino acids  
• Partially utilised amino acids 
• Continuously secreted amino acids 
 
6.2.7.1 Continuously utilised amino acids 
Amino acids categorised under continuous utilisation are L-Tryptophan, Aspartate, 
Glutamate, L-Arginine, Methionine and Serine as more than half the initial 
abundance were consumed from the medium in 9 days growth period as shown in 
Figure 6.12.  
 
                      
Figure 6.12 Relative abundance of continuously utilised amino acids with more than 50% 
depleted compared to naïve medium.  
(Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Samples were collected in 
triplicates from different culture flasks. 3D plot generated using Matlab (code 
specified in appendix) with changes of metabolites intensities expressed as 
relative abundance in the form of six column matrix (Y axis) versus time (X axis). 
Amino acids annotated using three letter abbreviations. Relative abundance of 
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metabolites in samples (Z axis) versus control with peak intensity ratio calculated 
from mean centred data.  
 
6.2.7.2 Partially utilised amino acids 
Amino acids such as L-Leucine, L-Threonine, L-Valine, L-Phenylalanine, L-Tyrosine 
and L-Lysine as shown in Figure 6.13 were salvaged partially during the entire 
growth of promastigotes. 
 
Figure 6.13 Relative abundance of partially utilised amino acids with less than 50% depleted 
compared to naïve medium.  
(Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Samples were collected in 
triplicates from different culture flasks. 3D plot generated using Matlab (code 
specified in appendix) with changes of metabolites intensities expressed as 
relative abundance in the form of six column matrix (Y axis) versus time (X axis). 
Amino acids annotated using three letter abbreviations. Relative abundance of 
metabolites in samples (Z axis) versus control with peak intensity ratio calculated 
from mean centred data.  
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6.2.7.3 Continuously secreted amino acids 
Glycine, L-Glutamine, L-Asparagine, L-Proline and L-Alanine are secreted in the 
medium over time with only minor transitory period of utilisation during Day 0 and 
Day 3 with less than 10% depleted from the medium as shown in Figure 6.14.   
 
 
        
 
Figure 6.14 Relative abundance of continuously secreted amino acids with more than 50% 
enriched compared to naïve medium.  
(Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Samples were collected in 
triplicates from different culture flasks. 3D plot generated using Matlab (code 
specified in appendix) with changes of metabolites intensities expressed as 
relative abundance in the form of six column matrix (Y axis) versus time (X axis). 
Amino acids annotated using three letter abbreviations. Relative abundance of 
metabolites in samples versus control with peak intensity ratio calculated from 
mean centred data.  
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6.2.7.4 Utilisation of other components in the Defined medium 
Glucose is consumed by more than 50%, as measured by the relative abundance of 
the medium alone without cells. Adenosine is completely depleted, suggesting it 
is growth limiting nutrient of the defined medium composition. Among the 
vitamins, there were no significant changes in the levels of metabolites from the 
baseline of naïve medium (cell free medium) as shown in Figure 6.15. 
 
 
Figure 6.15 Depletion of other components in the defined medium. 
(Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Samples were collected in 
triplicates from different culture flasks. 3D plot generated using Matlab (code 
specified in appendix) with changes of metabolites intensities expressed as 
relative abundance in the form of six column matrix (Y axis) versus time (X axis). 
Amino acids annotated using three letter abbreviations. Relative abundance of 
metabolites in samples (Z axis) versus control with peak intensity ratio calculated 
from mean centred data.  
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6.2.7.5 Continuously secreted amino acid intermediates 
Increasing amounts of indole lactate, 4 hydroxy-phenyl-pyruvate, phenyl-
pyruvate, pipecolate, citrulline/argininic acid, potentially derived from L-
Tryptophan, L-Tyrosine, L-Phenylalanine, L-Lysine and L-Arginine respectively 
were observed in the spent medium. The relative abundance of amino acid 
intermediates in the form of keto acids from L-Tryptophan and L-Arginine were 
higher compared to amino acid intermediates from L-Phenylalanine and L-
Tyrosine, hence these metabolites are represented separately in Figure 6.16 and 
Figure 6.17. 
                      
 
Figure 6.16 Continuously secreted keto acids enriched in the spent medium. 
Samples collected at various time as specified 0, 1st, 2nd, 3rd, 6th and 9th day of 
culture supernatant (Z axis) from the start of culture initiation. Samples were 
collected in triplicates from different culture flasks. 3D plot generated using 
Matlab (code specified in appendix) with changes of metabolites intensities 
expressed as relative abundance in the form of six column matrix (Y axis) versus 
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time (X axis). Peak intensity ratio between the sample and the control calculated 
from mean centred data.  
                 
 
Figure 6.17 Continuously secreted keto acids enriched in the spent medium. 
Samples were collected in triplicates from different culture flasks. 3D plot 
generated using Matlab (code specified in appendix) with changes of metabolites 
intensities expressed as relative abundance in the form of six column matrix (Y 
axis) versus time (X axis). Peak intensity ratio between the sample and the control 
calculated from mean centred log transformed data. Samples collected at various 
time as specified 0, 1st, 2nd, 3rd, 6th and 9th day of culture supernatant (Z axis) 
from the start of culture initiation. 
 
The alpha keto acids showed in Figure 6.16 and Figure 6.17 were noted to be 
derived from continuously utilised amino acids; and showed significant enrichment 
in the supernatant medium as growth response. Although the trend of enrichment 
in the supernatant was the same, peak intensities differed between the first set 
from L-Arginine and L-Tryptophan, whilst the second set from L-Phenylalanine, L-
Tyrosine and L-Lysine. 
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6.2.7.6 Partially secreted amino acid intermediates 
Trace amounts of keto acids from partially utilised amino acids such as L-
Methionine, L-Threonine, L-Leucine and L-Valine to citraconate, 2-oxo butanoate, 
5-guanidino 2 oxopentanoate and 4-guanadino-butanoate respectively were found 
enriched in the spent medium as shown in Figure 6.18. 
                   
 
Figure 6.18 Partially secreted keto acids enriched in the spent medium. 
Samples were collected in triplicates from three different culture flasks. 3D plot 
generated using Matlab (code specified in appendix) with changes of metabolites 
intensities expressed as relative abundance in the form of six column matrix (Y 
axis) versus time (X axis). Peak intensity ratio between the sample and the control 
calculated from mean centred data. Samples collected at various time as specified 
0, 1st, 2nd, 3rd, 6th and 9th day of culture supernatant (Z axis) from the start of 
culture initiation. 
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6.2.7.7 Secretion of intermediates from carbohydrate metabolism and 
nucleo-lactones 
 
 
Figure 6.19 Keto acids from carbohydrates metabolism enriched in spent medium  
(Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Samples were collected in 
triplicates from different culture flasks. 3D plot generated using Matlab (code 
specified in appendix) with changes of metabolites intensities expressed as 
relative abundance in the form of six column matrix (Y axis) versus time (X axis). 
Relative abundance of metabolites (Z axis) in samples versus control with peak 
intensity ratio calculated from mean centred data). 
                      
Significant enrichment of metabolites derived from carbohydrate metabolism such 
as (S)-Malate, cis-Aconitate, Fumarate, Succinate, Citrate, Maleic acid and L-
Lactaldehyde were observed as shown in Figure 6.19. Also, keto acids such as 
Ascorbate, D-Xylonolactone, Cystathionine, 1,4-Lactone, L-Rhamnono-1,4-lactone 
were also found enriched in the medium during the course of growth period from 
Day 0 to Day 9 as shown in Figure 6.20. Nucleolactones such as Orotate, Xanthine, 
Cytosine, Malonate and D-Ribose were found to be significantly enriched after day 
6 from the start of culture initiation as shown in Figure 6.21. 
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Figure 6.20 Keto acids from carbohydrates metabolism enriched in spent medium  
(Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Samples were collected in 
triplicates from different culture flasks. 3D plot generated using Matlab (code 
specified in appendix) with changes of metabolites intensities expressed as 
relative abundance in the form of six column matrix (Y axis) versus time (X axis). 
Relative abundance of metabolites (Z axis) in samples versus control with peak 
intensity ratio calculated from mean centred data). 
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Figure 6.21 Nucleo-lactones enriched in the spent medium 
Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=3, Error bars = mean ± SD. Samples were collected in 
triplicates from different culture flasks. 3D plot generated using Matlab (code 
specified in appendix) with changes of metabolites intensities expressed as 
relative abundance in the form of six column matrix (Y axis) versus time (X axis). 
Relative abundance of metabolites (Z axis) in samples versus control with peak 
intensity ratio calculated from mean centred data. 
 
From these results, it showed that amino acids were uniquely metabolised by 
Leishmania; not only for growth and protein production but metabolic 
intermediates such as keto acids were secreted into the spent medium (Figure 
6.16-Figure 6.20).  
 
Keto acids have a significant ROS scavenging activity and also has been shown to 
decrease ROS production (Beloborodova et al., 2012, Cotoia et al., 2014) 
described further in discussion section. Since exometabolome of L.mexicana  
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promastigotes show increased accumulation of keto acids towards the metacylic 
stages; it led to question whether small molecules secreted by the parasite could 
play a role as antioxidants to support establishment of parasitism with host cells?  
 
To further investigate the holistic nature of these metabolic intermediates 
secreted by the parasites; certain biochemical assays were carried out as 
described in 6.2.8 below. 
 
6.2.8 Biochemical assays 
 
These assays was carried out to determine the role of small molecules to test their 
impact on THP1 differentiated macrophage cells as infection model. Especially, 
intermediates from the aromatic acids such as L-Tryptophan and L-Phenylalanine 
were further evaluated since these two amino acids were found to be the most 
critical exogenous source amongst other amino acids for the viability of the 
promastigotes (Chapter 4). Samples with aromatic pyruvates found secreted in the 
extracellular environment throughout the growth period were isolated and tested 
with pure compounds in various biochemical assays below. Sample preparation 
and assay methodology has been elaborated in methods section. 
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6.2.8.1 Evaluation of THP1 viability in the presence of exo-metabolome 
samples      
In order to determine the impact of exometabolome on host cells, the viability of 
THP1 differentiated macrophages were tested as shown in Figure 6.22    
 
Figure 6.22 Evaluation of viability of THP1 cells  
(5 x 106 cells/mL cultured in RPMI, DM, DM (D6S) exo-metabolome from Day 6 
supernatant and DM with addition of extraneous pure compounds of with various 
compounds (+ Indole lactate, + phenyl-pyruvate, + 4-hydroxy phenyl pyruvate, 
+ascorbic acid at 1 mM each and phenyl arsine oxide as negative control at        10 
µM) for 24 hours at pH 7.4, 37 o C, n=6, Error bars = mean ± SD). 
 
It was observed from the results shown in Figure 6.22 that DM with addition of 
1mM each of Indole lactate, phenyl-pyruvate, 4-hydroxy phenyl pyruvate, ascorbic 
acid, or DM (D6S) did not negatively affect viability and growth compared to 
growth in control samples of THP1 differentiated macrophages in RPMI medium. 
 
6.2.8.2 Evaluation of THP1 viability under oxidative stress in the presence 
of exo-metabolome samples. 
To further investigate the role of exo-metabolome on THP1 viability under 
oxidative stress by day 6 culture supernatant and pure compounds in biochemical 
assays for nitrite scavenging activity of L. mexicana promastigotes as shown in 
Figure 6.23 and Figure 6.24. 
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Figure 6.23 LPS stimulated nitric oxide production suppressed by exo-metabolome-treated 
macrophages.  
(5 x106 cells/mL of THP1 cells treated with 5 ng/mL PMA for 24 hours undergoes 
differentiation to macrophages attached to the bottom of the wells in the 
chamber slides. Differentiated macrophages placed in wells each treated 
individually with naïve medium (DM), with promastigotes in 1:10 ratio (L. 
mexicana) or incubated with exo-metabolome (DM (D6S) in triplicates in two 
identical rows. For the wells in the first row, the samples were unstimulated 
(Control -white bars) and for the second row stimulated with 10ng/mL of LPS for 
24 hours (treated - grey solid bars. The nitrite scavenging activity of the exo-
metabolome and specific metabolites was analysed as described in methods 
section using Griess’s reagent, at pH 7.4, 37 o C, n=6, Error bars = mean ± SD. 
Asterisks indicate significant difference in nitrite suppression with ****, p<0.0001 
compared to DM, one way ANOVA with Dunnett’s multiple comparison test). 
 
The amount of nitrite was quantified using standard curve ranging from 0-100 µM 
and analysed using linear regression analysis of Graph-pad prism software. 
Stimulation of THP1 cells with LPS triggered nitrite secretion into the extracellular 
medium and no nitrite was recorded in wells without LPS. The amount of nitrite 
secreted by THP1 cells in naïve medium DM was recorded to be higher compared 
incubation with 1:10 L. mexicana or exometabolome. It was observed that 
L.mexicana infection inhibits NO production by 70% after            10 ng/mL of LPS 
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stimulation. Exo-metabolome incubation hampers NO production by 30% after 10 
ng/mL of LPS stimulation. 
Specific compounds of aromatic pyruvates enriched in the exo-metabolome were 
tested for nitrite scavenging activity as shown in Figure 6.24. 
 
 
Figure 6.24 LPS stimulated NO production inhibited by aromatic pyruvates and ascorbic 
acid.  
THP1 cells differentiated using 5 ng/mL PMA for 24 hours. Differentiated 
macrophages were untreated (naïve medium - DM), incubated with DM with 
various compounds (+pyruvate, + phenyl-pyruvate, + 4-hydroxy phenyl pyruvate, 
+ Indole lactate, +ascorbic acid) for 24 hours at 1 mM each in triplicates. All the 
wells were stimulated with 10ng/mL of LPS for 24 hours and amount of nitrite 
recorded using griess assay at pH 7.4, 37 o C, n=6, Error bars = mean ± SD. Asterisks 
indicate significant values with P value < 0.0001 by one way ANOVA using 
Dunnett’s multiple comparison test of graph-pad prism software.  
  
 
As shown in Figure 6.24, DM with addition of phenyl pyruvate and 4-hydroxy phenyl 
pyruvate significantly reduces free nitrite detected by ~20% each. Addition of 
indole lactate and ascorbic acid reduces amount of free nitrite detected by ~40% 
after 10 ng/mL of LPS stimulation compared to naïve medium without cells 
(sample-DM) as shown in Figure 6.24.  
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6.2.8.3 Determination of antioxidant power by reducing activity 
measurement. 
The antioxidant activity was measured in Figure 6.25 using reducing power of the 
specific metabolites (aromatic pyruvates) enriched in the spent medium by 
absorption at 700 nm using range of concentrations from 0-10 mM of ascorbic acid, 
acetate, phenylpyruvate, hydroxyl-phenylpyruvate and indole lactate. 
 
 
 
Figure 6.25 Determination of antioxidant power by measurement of reducing activity. 
(Ascorbic acid (blue), acetate (red), phenylpyruvate (green), hydroxyl-
phenylpyruvate (purple) and indole lactate (orange), n=6, mean centred data) 
 
Specific metabolites enriched in the exo-metabolome such as ascorbic acid, 
acetate, hydroxy phenyl pyruvate, phenyl pyruvate, indole lactate at a range of 
different concentrations from 0.001 mM-10 mM was tested were tested for 
reducing power as a measure of its antioxidant activity. Absorbance read at 700 
nm was used to determine the amount of ferric ferrocyanide (Prussian blue) 
formed. Increase in absorbance indicates linear relationship of the ability of the 
compounds to reduce ferric complex to ferrous form. Higher absorbance of the 
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reaction mixture indicates higher reducing power of the compounds tested with 
following order with indole lactate > phenyl pyruvate > ascorbic acid > hydroxy 
phenyl pyruvate > acetate. 
 
6.2.8.4 Estimation of phenolic content of exo-metabolome samples from 
different growth stages of promastigotes. 
The phenolic content of the exo-metabolome as shown in Figure 6.26 was 
determined by the number of hydroxyl groups available to react with 
phosphomolybdic acid in Folin-Ciocalteu reagent in an alkaline medium to produce 
a blue coloured complex using catechol equivalent standard curve (mg/µL).  
 
 
 
 
 
 
Figure 6.26 Phenolic content of the exometabolome represented as catechol equivalent 
(mg/µL)  
 (Supernatant collected from 4 x 107 cells on Day 0, 1, 2, 3, 6, and 9 from the start 
of culture initiation n=6, Error bars = mean ± SD. Samples were collected in 
triplicates from different culture flasks).  
 
From Figure 6.26, the phenolic content, i.e. the number of free hydroxyl groups 
have been recorded as increased during the entire growth phase in supernatant 
Time (day) of samples from 
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samples at various time points from Day 0 to Day 9 as specified from the start of 
culture initiation (n=6, ANOVA for multiple comparison using graph pad software). 
 
 
 
6.2.8.5 Estimation of phenolic content of specific metabolites enriched in the 
exo-metabolome. 
 
The phenolic content determined by the number of hydroxyl groups available for 
reaction was measured for specific metabolites enriched in the spent medium as 
shown Figure 6.27.  
 
Figure 6.27 Phenolic content of pure compounds represented as catechol equivalent 
(mg/µL). 
(Compounds tested included 1 mM of indole lactate, phenyl- pyruvate, 4-hydroxy-
phenyl-pyruvate and ascorbic acid at pH 7.4, 37 o C, n=6, Error bars = mean ± SD. 
Asterisks indicate significant values with ****p value < 0.0001, ***< 0.0005, *< 0.05   
compared to DM alone by one way ANOVA using Dunnett’s multiple comparison 
test of graph-pad prism software. 
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Phenolic content determines the number of free hydroxyl groups available for 
complex formation. Increase in absorbance indicates linear relationship of 
enrichment of free hydroxyl groups available for complex formation with 
phosphomolybdic acid tested with following order with phenyl pyruvate > hydroxyl 
phenyl pyruvate > indole lactate > ascorbic acid as shown in Figure 6.27 
 
6.3 Discussion  
 
In this study, an untargeted metabolomics approach was carried out throughout 
the growth period starting from early log (Day 1 and Day2), mid log (Day 3) and 
stationary phase (Day 6 and Day 9). Samples from the extracellular supernatant 
was used to determine uptake and secretion of metabolites during promastigotes 
growth referred to as time resolved metabolic foot-printing. Using the data, 
metabolic pathways were differentiated to ascertain specific salvage and 
biosynthesis pathways of Leishmania promastigotes which are parasite specific 
metabolic pathways as potential drug targets. 
 
Time points chosen for the experimental study was chosen such that the organism 
growth responses with time is linear during the initial phase and non-
linear/exponential during the log phase (Steel, 1967) leading to a mixed model of 
regression with linear and non-linear curves has been explained elsewhere. For 
comparative purposes between the six time points, consecutive points were 
chosen during early stages of growth than during the saturated stationary phase, 
ensuring proper regression rules were accounted capturing both linear and non-
linear responses of growth with time. This allowed for adequate spread among the 
data taking into consideration the independent variable (time in this experiment) 
has been measured with 6 time points including control. Day 1, 2 and 3 account 
for the start point of active uptake of metabolites to mid log phase and then on 
Day 6 and Day 9 to mark the stationary phase and saturation point respectively. 
The samples were analysed using LC-MS using both positive and negative ionisation 
modes with 36 data points of each compound. This approach allowed to identify 
reproducible metabolic trends with greater confidence statistically with 
additional spectral filtering algorithm (Scheltema et al., 2011). Data from 
untargeted metabolomics yields large amount of data which are not self-
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explanatory. Inference of meaningful biological information from the data 
requires careful experimental design, relevant quality control and extensive 
computational deconvolution of the spectral data to validate the change in 
metabolite levels (Dunn et al., 2012). 
 
For the pre-processing of data of Defined medium culture supernatant was 
analysed by LC-MS using orbitrap mass spectrometry in both positive and negative 
ionisation modes. The mass chromatograms, putative identifications and trends of 
certain individual metabolites were analysed using IDEOM software (Creek et al., 
2012b). Retention time alignment was carried out using XCMS as integrated in the 
mzMatch software (Scheltema et al., 2011). Manual verification was carried out 
for metabolites for peak shape verification using PeakML viewer supporting mass 
and retention time information for metabolite identification.  
 
6.3.1 Multi-variant analysis 
Those peaks that were typical contaminants of LC/MS analysis, for example, those 
with intensity trends that were not subjected to any change or intensities close 
to the detection limit were removed by manually setting the pre-filter intensity 
>1000 as rigorous filtering process of peak identification. A list of the detected 
peaks with intensity trends and stability score values were calculated from the 
IDEOM software (Creek, 2012). About ~206 putatively identified metabolites were 
analysed using multi-variant data analysis techniques such as PLS-DA model, 
principal component analysis (PCA), and hierarchical clustering analysis (HCA) to 
understand the underlying patterns within the data. PLS-DA model allows for 
application of supervised machine learning algorithm on the time resolved 
untargeted metabolomics dataset in an unbiased manner to highlight the 
underlying pattern within the data (Behrends et al., 2009, Allen et al., 2003). The 
variance plot as shown in Figure 6.2, the first two components explaining the 
maximum variability within the data which accounted for 26% and 37% of the 
variation respectively present in the LC-MS dataset. Visualisation of the data 
showed the spread of the 18 samples in an unbiased manner across the orthogonal 
distance on the score plot as shown in observation diagnostics. The score plot 
(PCA) indicates position of individual samples amongst the 18 samples analysed. 
The placement of individual metabolites were subdivided into four sections (+/+, 
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+/-, -/+, -/-) based on the levels of their peak intensities as shown in the Loadings 
plot as shown in Figure 6.2.  
 
Using PCA analysis, the maximum variance within the data is projected in two or 
more dimensions or orthogonal components without the loss of vital information 
to distinguish dominant features of the data set (Dien et al., 2003). Statistically, 
the mean and variance of the data are used to build the co-variance matrix of the 
orthogonal components. Computationally, PCA separates the classes based on the 
orthogonal components across the samples that reduces the dimensions in the 
data set and highlight underlying metabolites pattern within the data (Fiehn, 
2002).  
 
The PCA result as shown in Figure 6.2 showed different clusters with individual 
growth stages exhibit distinct metabolic signature that uniquely differentiates log 
phase promastigotes from infective metacyclics. About ~206 metabolites including 
the base-peaks from the dataset were used to visualise the PCA plot using R 
software package “ropls” (Thevenot et al., 2015) with appended files and code 
listed in the appendix. These results also highlight that distinct changes in 
metabolic profile of the extracellular environment might facilitate the growth and 
proliferation of promastigotes, thereby supporting the morphological and 
physiological transformation from procyclics to metacyclics within the 9 day 
growth period as tested. The HCA analysis as shown in Figure 6.3 confirmed that 
biological replicates at each time point form a cluster together and the metabolic 
profile of (naïve culture medium) Cluster 1 were completely separated from 
Cluster 2 (samples of Day 6 and Day 9) and Cluster 3 (Day 1, Day 2, and Day 3). 
 
Overall about ~205 metabolites that were putatively identified in the extracellular 
metabolome using IDEOM software. Amongst those ~25 % metabolites depleted 
from the medium, ~15% not changed significantly and ~40% significantly enriched 
in the medium over the growth period of 9 days as shown in Figure 6.4. The 
metabolite variations in the extracellular metabolome reflects the intracellular 
phenotype, especially about the pathway activities. The nature and pattern of 
individual metabolites that have been identified with authentic standards as 
expressed in base 2 logarithmic fold changes of their relative intensities as shown 
in Figure 6.5 to Figure 6.11.  
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Amongst the amino acids with polar uncharged side groups, L-Threonine and L-
serine were depleted compared to L-Proline and L-Glutamine as shown in Figure 
6.5.Those amino acids with non-polar aliphatic side groups, L-Leucine, L-Valine 
and L-Methionine were depleted compared to L-glycine and L-Alanine as shown in 
Figure 6.6. With negatively charged side groups, both L-Glutamate and L-
Aspartate were consumed as shown in Figure 6.7. Amongst the positively charged 
side groups, L-Lysine was taken up moderately from the medium, whilst L-
Asparagine was found secreted as shown in Figure 6.8. Those with aromatic side 
groups, L-Tryptophan was depleted compared to L-Phenylalanine and L-Tyrosine 
as shown in Figure 6.9. Amongst other identified metabolites, L-glucose and L-
adenosine were completely depleted as shown in Figure 6.10 and Figure 6.11. 
 
 
6.3.2 Classification of amino acids based on depletion rate from the media 
The overall pattern of utilisation has been further classified under different 
categories as shown in Figure 6.12 to Figure 6.15. Aspartate, Glutamate, L-
Tryptophan, L-Arginine, Methionine and Serine were recorded as continuously 
utilised amino acids since more than half the initial abundance were consumed 
from the medium in 9 days growth period as shown in Figure 6.12. During 
promastigotes growth in defined media, amino acids are consumed at various 
rates. Aspartate and L-Glutamate are completely consumed as shown in Figure 
6.7, indicating their consumption as carbon source, since the corresponding keto 
acids enter the TCA cycle [22]. It is particularly interesting to correlate that L-
Tryptophan and L-Arginine found critical for the growth of promastigotes (Chapter 
4) were amongst those amino acids that were continuously up taken from the 
medium and completely scavenged (Figure 6.9 and Figure 6.5).  
 
It is known that Leishmania encode for broad spectrum amino transferase acting 
on several amino acids such as L-Aspartate, L-Tyrosine, L-Tryptophan, L-
Glutamate thus leads to competitive binding amongst these substrates in 
transamination reactions. The amino group serves as nitrogen donor for other 
biological reactions (Leblancq and Lanham, 1984). Interestingly, the resulting keto 
acids were found secreted outside the cells, hence no contribution to the TCA 
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cycle, unlike the situation in mammalian cells (Figure 6.16). Aspartate has been 
shown to be catabolised by L-Aspartate transaminase, which results in 
oxaloacetate entering the TCA cycle for energy contribution, as shown in targeted 
metabolomics using labelled isotope studies (Saunders et al., 2011). Although L-
Aspartate in our defined minimal medium at 0.2 mM is less than other amino acids, 
L-Aspartate uptake is uninhibited by other amino acids at much higher 
concentration, suggesting the presence of an L-Aspartate-specific transporter. On 
the other hand, a L-Glutamate transporter with high substrate specificity has been 
well characterised in Leishmania amazonensis (Paes et al., 2008). Glutamate is 
responsible for 80% of energy generation with maximum flux as alpha keto 
glutarate enter the TCA cycle (Saunders et al., 2011).  
 
Apart from their importance for growth and viability, metabolic intermediates of 
these amino acids and their corresponding keto acids were enriched in the spent 
medium (Figure 6.16 to Figure 6.20). Enrichment of keto acids at the metacylic 
stages could modulate the host environment, since their chemical structure allows 
for conversion from keto to enol form. This characteristic of the enone moiety is 
responsible for scavenging free radicals and reactive oxygen species which may be 
encountered when the metacylic stages infect the host cells; thereby, favouring 
a reducing environment and potentially supporting viability of the promastigotes 
during early attachment and parasitism.  
 
 Unlike mammals which elaborate a catabolic pathway for L-Tryptophan 
contributing to the tricarboxylic acid cycle, radiolabelling experiments in         L. 
donovani have reported much simpler pathway (Leelayoova et al., 1992) with the 
first step in L-Tryptophan catabolism is mediated by L-Tryptophan 
aminotransferase, a broad spectrum transaminase catalysing the conversion of L-
Tryptophan to indole pyruvate and subsequently by hydroxyl-acid dehydrogenase 
to indole lactate as shown in Figure 6.16. Previous literature also suggest the 
potential reason for complete consumption of L-Tryptophan from the environment 
and simplistic pathway could be because of preferred nitrogen donor(Berger, 
1996), to deprive host cells from essential amino acids to evade host immune 
system (Wanasen, 2008).  
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Interestingly, our time course data indicates that indole lactate is progressively 
enriched in the spent medium over time (Figure 6.16). It is intriguing the parasite 
is continuously scavenging L-Tryptophan possibly for NADH regeneration as shown 
in chapter 4 required for the conversion of L-Tryptophan to indole pyruvate and 
subsequently indole lactate, which is effluxed out of the cell (Figure 6.16). A 
recent report suggests that L-Tyrosine transaminase is expressed in L. infantum 
promastigotes (Moreno et al., 2014b). Increased over-expression of the 
transaminase protein was also observed in nitric oxide resistant species. L-
Tryptophan, due to its hydrophobic nature, must rely on a transport process to 
enter the cell. Transport of L-Tryptophan is uninhibited by other amino acids 
present at much higher concentration in the Defined medium highlights the 
probability of transporter protein that have highest affinity and also substrate 
specificity towards L-Tryptophan alone. However, in the light recent literature 
and experimental results as described in chapter 5, the hypothesis that aromatic 
pyruvates could play major role in evading host immune system especially during 
initial host infection and establishment of parasitism has been tested in this 
chapter. 
 
L-Arginine has been extensively taken up from the medium, with less than 50% 
remaining in the medium on day 3 of growth of promastigotes in defined medium. 
L-Arginine transporter LdAAP3 is well studied in Leishmania (Shaked-Mishan et al., 
2006), indicating L-Arginine metabolic pathway is unique in kinetoplastids for the 
synthesis of unique antioxidants such as trypanothione (Colotti and Ilari, 2011). 
This polyamine pathway mediated by arginase play a pivotal role in Leishmania 
with enzymes localised both in glycosomes and acidocalcisomes, which might 
serve as intracellular sinks of L-Arginine (Darlyuk et al., 2009). Interestingly, 
equivalent amount of de-aminated product of L-Arginine enriched in the spent 
medium during the 9 day growth period is as shown in Figure 6.12. Recent studies 
confirm that the de-aminated product is arginic acid confirmed through MS-MS 
fragmentation spectral analysis (Westrop et al., 2015). Results from that 
particular study (Westrop et al., 2015) were carried out in dialysed serum 
containing medium which showed only significant L-Arginine and L-Tryptophan 
consumed from the medium, whilst most other amino acid levels were reported 
constant due to surplus in the extracellular medium. Here, we show that use of 
our defined medium allowed to classify six amino acids that are continuously 
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scavenged compared to other amino acids in the next category with moderate 
utilisation. 
 
As observed from Figure 6.12, more than 50% of serine (0.2mM) was consumed 
from the extra-cellular system but the amount of serine uptake saturated by day 
1 of growth period tested. This could possibly be because of de novo serine 
biosynthesis that limits the level of uptake of serine as elaborated in discussion 
section. Uptake of serine (0.2mM) in defined minimal medium not inhibited by 
other amino acids, suggesting that uptake of serine is mediated by a transporter 
protein with substrate specificity. Serine is converted into pyruvate entering the 
TCA cycle (Opperdoes and Coombs, 2007), but there is significant pyruvate 
enrichment in the spent medium Figure 6.19. 
 
Flux from the TCA cycle via glucose metabolism also results in pyruvate overflow 
as noted in NMR studies of Leishmania panamensis using PBS buffer (Rainey and 
Mackenzie, 1991). In our data, the pyruvate is enriched in the spent medium with 
increase in relative abundance over time, although the background signal from 
the control sample showed high peak intensity with the sterile media composition 
has 1mM sodium pyruvate. 
 
The exo-metabolome has been shown to decipher gene functions and also highlight 
disease related biomarkers as shown in yeast systems. Also, time resolved 
metabolic foot-printing in defined medium has been used to capture drug induced 
states to unravel the mode of action in yeast systems. This is the first report of 
its kind to report data about exo-metabolome of L. mexicana promastigotes in 
defined media and colorimetric assays for biochemical studies.  
Also, those metabolites enriched in the medium represents metabolic secretion 
depending upon the internal programming of growth adaptation with the 
progression of life cycle. Metabolites enriched over time have been shown in 
Figure 6.16 to Figure 6.20. The major advantage in this study with the use of 
defined medium, enabled collection and purification of extracellular metabolome 
samples from different time points. The extracellular metabolites at individual 
growth stages by time resolved metabolic foot-printing allowed to identify the 
trend of utilisation of individual metabolites, especially those absent in the 
medium but enriched over time. 
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In most organisms, amino acids that are surplus to requirement for protein 
synthesis enter the TCA cycle as energy intermediates (Sherman, 1977). However, 
our results from metabolic foot-printing of L. mexicana promastigotes in defined 
medium highlights an intriguing observation that Leishmania promastigotes rapidly 
scavenge amino acids, metabolise into corresponding keto acids and equivalent 
amounts secreted out of the cell (Figure 6.16, Figure 6.17, Figure 6.18). Berger et 
al in (Berger et al., 1996) incorporated radiolabelled L-Tryptophan in L. donovani 
promastigotes and reported indole lactate secreted by the cells. In this study, 
using untargeted metabolomics, we show the presence of various keto acids 
enriched in the spent medium over time. The question why these parasites 
increase their transaminase activity in infective forms and secrete equivalent keto 
acids in their extracellular medium has not been investigated before.  
 
Increasing amounts of arginic-acid, indole lactate, 4 hydroxy-phenyl-pyruvate, 
phenyl-pyruvate, pipecolate derived from L-Arginine, L-Tryptophan, L-Tyrosine, 
L-Phenylalanine and L-Lysine are observed in the spent medium (Figure 6.16, 
Figure 6.17). Also, trace amounts of keto acids from L-Methionine, L-Threonine, 
L-Leucine, L-Valine to citraconate, 2-oxo butanoate, 5-guanidino 2 
oxopentanoate, 4 guanadino butanoate respectively (Figure 6.18) were also 
enriched in the spent medium. This phenomenon of increased secretion of keto 
acids has been reported in Trypanosoma brucei extracellular medium (Creek et 
al., 2013, Berger et al., 1996). Alpha keto aciduria has been reported in patients 
affected with chronic African trypanosomiasis (Hall et al., 1985). 
 
Amino acids such as L-Phenylalanine, L-Tyrosine, L-Leucine, L-Threonine, L-
Valine, and L-Lysine as shown in Figure 6.13 were taken up moderately during the 
entire growth of promastigotes. Berger et al have shown that L-Phenylalanine used 
as preferential nitrogen donor in L. mexicana promastigotes.  Studies by Blum et 
al indicated that (Blum, 1996) the kinetic release of L-Phenylalanine as an 
adaptive behaviour employed by Leishmania promastigotes for osomo-regulation. 
Initially on Day 1 of the culture, the promastigotes in defined medium released L-
Phenylalanine transiently, probably indicating adaptive osomo-regulation.  
Moderate consumption of amino acids could also be because of competitive 
inhibition with other amino acids, for example, L-Methionine and L-Phenylalanine 
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for Locus D (Hasne and Barrett, 2000). Methionine has been classified under 
category 1 under continuous utilisation which might competitively inhibit L-
Phenylalanine uptake, hence the data indicates saturated uptake of this amino 
acid.  
 
Metabolism of L-Phenylalanine occurs in a series of reactions mainly involving 
enzymes such as aromatic acid aminotransferase, indolepyruvate oxidoreductase, 
3 oxoadipyl CoA thiolase, phenylacetyl CoA isomerase, enoyl CoA hydratase and 3 
hydroxybutanoyl CoA dehydrogenase. Although few studies indicates the role of 
L-Phenylalanine has preferential nitrogen donor, the major metabolic pathway of 
L-Phenylalanine degradation had not been completely elucidated before. Genome 
annotation indicates the absence of enzymes for complete L-Phenylalanine 
degradation to TCA cycle intermediate in Leishmania (Opperdoes and Coombs, 
2007), however, metabolic intermediates of L-Phenylalanine decarboxylase have 
been detected in the spent medium (Figure 6.16) with significant amount of 
phenyl pyruvate, end product of amino transferase activity. Enrichment of these 
phenyl-pyruvate has been speculated to have potential role in decreasing reactive 
oxygen species during haemorrhagic shock (Cotoia et al., 2014). Role of this 
particular metabolite as antioxidant potentially supporting parasitism has been 
investigated in last section of this chapter. 
 
Leucine, Threonine and Valine show similar depletion profile with active uptake 
from Day 1 of growth in defined medium and then saturates after until Day 9. 
Leucine is important amino acid for protein synthesis and also serves as metabolic 
fuel (Ginger et al., 2001). Leucine is ketogenic in nature and converted to 
acetoacetyl CoA and acetyl CoA via corresponding keto acid, alpha 
ketoisocaproate. Subsequent set of oxidative decarboxylation reactions converts 
alpha ketoisocaproate to isovaleryl CoA, dehydrogenated to betamethylcrotonyl 
CoA with FAD as hydrogen acceptor. ATP is utilised for the carboxylation of beta-
methyl-crotonyl CoA in the presence of biotin as a cofactor for 
betamethylglutaconyl CoA formation. Hydration reaction of betamethylglutaconyl 
CoA leads to betahydroxy beta methylglutarylCoA on cleavage results in 
acetoacetate and acetyl CoA. However, it has been shown in Leishmania species 
that radiolabelled L-Leucine can be directly incorporated into sterol synthase, in 
contrast to other trypanosomatids or mammalian systems (Ginger et al., 2001). 
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This is in agreement with our data as there was no detection of this keto acid in 
the spent medium. Leucine is also shown as important regulator of gene expression 
by mTOR signalling controlling the rate of protein synthesis (Ginger et al., 1999). 
Protein production in the absence of L-Leucine has been further explored in 
Chapter 4 to determine its impact on protein synthesis.  
 
Threonine is moderately utilised (Figure 6.13) during the entire 9 day growth 
period of Leishmania promastigotes. Threonine is very important for protein 
synthesis; however, it was much less consumed; possibly indicating residual 
biosynthetic capacity of the parasites. It has been shown that L-Threonine, L-
Alanine and L-Proline constitute the major components of free amino acid pool in 
Leishmania donovani promastigotes (Simon et al., 1983) which may be the reason 
for moderate uptake of L-Threonine from the medium. The enzyme serine/L-
Threonine dehydratase, responsible for removing the alpha amino group and the 
hydroxyl group of serine/L-Threonine to yield alpha keto glutarate and NH4+, is 
the major route followed by many eukaryotic organisms including mammals. The 
resulting alpha keto butyrate into succinyl CoA feeds into TCA cycle for energy 
contribution. In trypanosomatids, an alternative pathway involving serine hydroxyl 
methyl transferase (SHMT) has been discussed for the formation of glycine and 
serine, with tetrahydrofolate as an important coenzyme (Williams et al., 2009).  
 
 Slow degradation of L-Threonine within the intracellular pool might be another 
reason for moderate uptake of L-Threonine from the medium. The L-Threonine 
degradation pathway in Leishmania has been of considerable debate (Opperdoes 
and Coombs, 2007). Enzyme mining for putative L-Threonine pathway components 
was conducted as described in experimental procedures with a total of 74 
different proteins annotated in the KEGG database for L-Threonine degradation 
pathways across different organisms. Bioinformatics analysis of individual enzymes 
between pairs of metabolites detected in the L-Threonine degradation leading to 
isoleucine biosynthesis has been detailed in the next chapter.  
Valine is moderately consumed by L. mexicana promastigotes as shown in Figure 
6.13. Valine is an important regulator for protein synthesis and gene transcription 
(Sriphochanart et al., 2011). Metabolic end products of L-Valine to its 
corresponding keto acid from conversion into 3 methyl 3 oxobutanoate to 
isobutanoyl CoA. The branched chain alpha keto acid dehydrogenase complex is 
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the main linking enzyme for L-Valine utilisation as carbon source. The 
intermediate, beta hydroxyl acid, is oxidised to methylmalonate semialdehyde 
and propanoyl CoA (Opperdoes, 2008).  
 
Glycine is enriched in the extracellular medium as the procyclic reach the 
metacylic infective forms compared to Day 0 to Day 6 spent medium as shown in 
Figure 6.14. It has been shown that glycine plays important cyto-protective and 
antioxidant properties (Zhong et al., 2003, Wang et al., 2013) in many organisms. 
It has been shown that glycine release in the extracellular system hampers 
reactive oxygen species in human neutrophils (Giambelluca and Gende, 2009). 
From our dataset, the nature of most small molecules secreted by promastigotes 
such as keto acids, ascorbate and even glycine have antioxidant properties that 
modify the extracellular environment. The chemical structure of the small 
molecules enriched in the extracellular medium has been further discussed as 
indicated from results of the biochemical assays. 
 
Alanine is commonly produced as a result of proton exchange reactions with alpha 
keto glutarate, which is a substrate for transamination reactions as shown in 
Figure 6.14. It has been shown that L-Alanine transaminase in Leishmania exhibits 
narrow specificity compared to L-Alanine transaminases in Tcruzi, mammals, 
yeast and plant counterparts clustered within the same cladogram in the 
phylogenetic tree (Marciano et al., 2009). Alanine is enriched during stationary 
phases of growth compared to other amino acids. L-Alanine/L-Proline anti-
transporter (Inbar et al., 2013) has been shown to play important role in cell 
swelling required for osomo-regulation in Leishmania. Glutamine and L-Asparagine 
were transiently utilised on Day 1, however, there is increased secretion into the 
extracellular medium at later stages of growth as shown in Figure 6.14. The amino 
acids utilisation from the medium are summarised as shown in Table 6-1. 
 
Table 6-1 Classification of amino acids based on pattern of utilisation during growth of L. 
mexicana promastigotes 
 
Continuously  
utilised 
  
      Partially 
      utilised                      
 
  Continuously 
  secreted 
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L-Tryptophan  L-Leucine L-Glycine 
L-Aspartate L-Threonine L-Glutamine 
L-Glutamate L-Valine L-Asparginine 
L-Arginine L-Phenylalanine  L-Proline  
L-Methionine L-Tyrosine  L-Alanine 
L-Serine L-Lysine  
 
Footnotes- L-Histidine, L-Cysteine and L-Isoleucine were not detected under 
conditions of exactive orbitrap mass spectrometer used in this study. 
 
Glucose is consumed by more than 50%, as measured by the relative abundance of 
the medium alone without cells. Adenosine is completely depleted, suggesting it 
is growth limiting nutrient of the defined medium composition. Among the 
vitamins, not all of them were matched by authentic standards for mass and 
retention time. For example, biotin although present in standard list, was not seen 
in the mass spectrum data on cross verification. This could be because of multiple 
reasons such as small concentration below detection limit of the instrument, mass 
drift due to fragmentation, unstable complex and adducts not matching with 
retention time as explained elsewhere (Dunn et al., 2012). Remaining components 
such as salts, vitamins, co-factors and metals those below limits of detection, and 
without comparable standards. 
 
6.3.3 Chemical structural analysis of secreted metabolites 
 
Critical examination of the amino acid derived keto acids enriched in the spent 
medium showed that there is common “enone” moiety within their chemical 
structures (Figure 6.28). Chemically the double bond structure of the keto acids 
has the potential to undergo rapid conversion to enol structure in a reaction with 
high energy molecules such as reactive oxygen species or free radicals by 
accepting a proton (Cotoia et al., 2014). This led to the hypothesis that apart from 
amino acids contribution to protein synthesis and energy metabolism, parasites 
might have a particular use for amino acid-derived keto acids during infection. 
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This was further examined by various biochemical assays using THP1 host cells as 
infection model.   
 
Figure 6.28 Structural representation of amino acid to keto acids production.  
(All of the above mentioned show a common side chain with the keto moiety 
interchangeable with Enol form upon accepting a proton.) 
 
It has been recently shown that keto acids have ROS scavenging action 
(Beloborodova et al., 2012). Especially, phenolic acids such as phenyl-lactate and 
p-hydroxy-phenyl-lactate decrease ROS production within mitochondria and 
neutrophils ofpatients affected with sepsis (Beloborodova et al., 2012). Keto acids 
such as p-hydroxy-phenyl-pyruvate have been shown  as potential therapeutic 
agents; improving stress condition in haemorrhagic rats as a result of antioxidant 
activity towards mitochondria generated reactive oxygen species (Cotoia et al., 
2014).  
 
Interestingly, the data from this study highlights that the amount of keto acids 
secreted by Leishmania increases with time; especially leading to an accumulation 
at the infective metacylic stages. This led to further investigate about the role of 
the exo-metabolome in facilitation of parasitism with host cells. The chemical 
nature of small molecules were explored using biochemical assays as shown in 
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section 6.2.8. Results indicate that exometabolome fraction of L. mexicana have 
nitrite scavenging activity. Previously, it was shown that secreted proteins alone 
accounted for 50% of nitrite scavenged versus 70% in infected macrophages 
(Hassani et al., 2011). The nature of small molecules secreted by Leishmania has 
not been thoroughly investigated before in this context. Hence, it was of interest 
to test pure compounds detected in the mass spectral data for nitrite scavenging 
activity to uncover pathophysiological role of these keto acids.  
 
Presence of ascorbate enriched in the spent medium, strengthens the hypothesis 
that L. mexicana promastigotes secrete small molecules possibly for combating 
oxidative stress. Ascorbic acid was also putatively identified as enriched in the 
spent medium over time as shown in Figure 6.20. Ascorbic acid has been classified 
as enol lactone and known for its antioxidant property (Izumi et al., 1989). 
Ascorbate peroxidase is involved in the reaction of ascorbate quenching hydrogen 
peroxide (Pal et al., 2010). Literature points to the fact that ascorbate peroxidase 
characterised in Leishmania major is essential for maintenance of infectivity 
through regulation of oxidative stress (Dolai et al., 2008). It has been explained 
that ascorbic acid forms a complex with free nitrite to form complex nitroso-
ascorbic acid and therefore reduces the free nitrite concentration in aqueous 
solution (Izumi et al., 1989).  
 
 Metabolites significantly enriched in spent medium; such as indole lactate and 
phenyl pyruvate have been tested for scavenging nitrite levels produced by the 
host system. The antioxidant activity of the aromatic pyruvates were determined 
by an assay of reducing power measurement. Briefly, this assay measures the 
property of the compounds to act as electron donor by potassium ferricyanide 
reduction. Here the Fe3+/ferricyanide complex is reduced to ferrous form.  Colour 
change from yellow to the blue and green range as shown in Figure 6.26 and Figure 
6.27. Ascorbic acid is known for its antioxidant properties; thus used as positive 
control for the assay. Also, ascorbate has been putatively identified in the mass 
spectrometry data as a metabolite enriched in the spent medium, as shown in 
Figure 6.20. Ascorbic acid, acetate and aromatic pyruvates such as Indole lactate, 
phenyl pyruvate, 4 hydroxy phenyl pyruvate significantly enriched in the spent 
medium were tested in multiple orders of magnitude ranging from 1 µM-100 mM. 
It was observed that with increasing concentration of ascorbic acid and 4 hydroxy 
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phenyl pyruvate; there was a corresponding increase in absorbance indicating 
greater reducing power of these metabolites compared to others tested at the 
same time 
 
Among the compounds tested, indole lactate at more than 1mM concentration, 
there was sharp rise in the absorbance observed due to increased ferrous complex 
formation. Phenyl pyruvate showed sharp increase in absorbance between 0.1-
1mM and then saturated at increasing concentration. These results indicate small 
molecules secreted by L. mexicana promastigotes could act as natural antioxidants 
similar to ascorbate action, possibly conferring protection during initial host 
infection stages. This is in agreement with studies showing that incubation of 
sandfly Lutzomiya sp. saliva alone has a significant effect on supporting infection 
of Leishmania to host cells (Menezes et al., 2008).  
 
Parasites secreted several low molecular weight metabolites bearing an enone 
moiety, as observed from metabolomics spent medium analysis. In order to 
analyse their chemical nature over time, the phenolic content of spent medium 
was assessed. Aromatic compounds with hydroxyl groups react with 
phosphomolybdic acid in Folin-Ciocalteu reagent in an alkaline medium to produce 
a blue coloured complex (Lee et al., 2014).  It has been reported elsewhere that 
increase in phenolic content is positively correlated with increase in the number 
of hydroxyl groups. Results from mass spectrometry data (Figure 6.16-Figure 6.20) 
highlight that the supernatant medium is enriched by low molecular weight 
compounds such as indole lactate, phenyl pyruvate, 4-hydroxy-phenyl-pyruvate. 
Enrichment of these compounds allow for increased hydroxyl groups available for 
scavenging free radicals by stimulated macrophages within the host system. 
Phenolic content increase in supernatant samples at various time points as 
specified from culture initiation, especially during the metacyclics stages with 
molecules that act as natural antioxidants.  
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Figure 6.29 Pictorial summary to demonstrate unique role of exo-metabolome in scavenging 
reactions to defend against macrophage immune responses to support establishment of 
infection. 
(Diagrammatic representation of exo-metabolome from Leishmania promastigotes 
able to scavenge reactive oxygen species, free radicals and supress nitric oxide 
production from activated macrophages potentially supporting establishment of 
infection with the host cells).   
 
In summary, adaptable consumption of broad range of amino acids and 
simultaneous substrate (glucose and purines) utilisation in L. mexicana 
promastigotes is as shown in  
 
Figure 6.29. Although amino acids contribute to the TCA cycle, our results show 
novel pathway of secretion of multiple keto acids enriched in the extracellular 
Components of promastigotes 
exometabolome 
 
 
Exometabolome acts as 
scavengers by enol lactone 
formation  
Components of naïve medium 
Components released by activated 
macrophages such as reactive oxygen 
species, nitric oxide 
Activated 
macrophage 
Infected 
macrophage 
Immune suppressed 
macrophage 
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medium. Keto acids with interchangeable to enone forms upon accepting protons 
have been tested for ability to scavenge nitrite, reactive oxygen species and free 
radicals as shown in Figure 6.22 to Figure 6.27. This might suggest pre-adaptive 
metabolic changes to modify immediate extracellular environment to support 
parasitism with host cells during macrophage infection. 
 
Thus, during promastigote growth in defined media, amino acids are consumed at 
various rates. Aspartate and L-Glutamate are completely consumed as shown in 
Figure 6.12, indicating their consumption as carbon source with their 
corresponding keto acids enter the TCA cycle. Threonine is very important for 
protein synthesis; however, it was much less consumed; possibly indicating 
residual biosynthetic capacity of the parasites as shown in Figure 6.13. It is 
particularly interesting to note that L-Tryptophan and L-Arginine are amongst 
those amino acids that are completely scavenged (Figure 6.12) compared to other 
amino acids such as L-Phenylalanine, L-Leucine, L-Valine and L-Lysine (Figure 
6.13) are much less consumed, albeit essential for the viability of the parasites as 
explained in earlier report. Despite their importance for growth and viability, 
concentrations of the corresponding keto acids are enriched in the spent medium 
(Figure 6.16, Figure 6.17, Figure 6.18, Figure 6.19, Figure 6.20). Enrichment of 
keto acids at the metacylic stages could modulate the host environment, since 
their chemical structure allows for conversion from keto to enol form. This 
characteristic of the enone moiety is responsible for scavenging free radicals and 
reactive oxygen species which may be encountered when the metacylic stages 
infect the host cells; thereby, favouring a reducing environment and potentially 
supporting viability of the promastigotes during early attachment and parasitism. 
These results are in agreement with recent studies by Moreno et al demonstrated 
that protein expression of L-Tyrosine transaminases were found to be increased in 
infective and nitric oxide resistant species compared to wild type forms. It has 
also been proved that L-Tyrosine transaminases have structural differences with 
no homology to human L-Tyrosine transaminases (Moreno et al; 2014b).   
 
Thus, Leishmania aromatic acid transaminases have been proposed as potential as 
drug targets. Especially, inhibition of parasite specific L-Tryptophan and L-
Phenylalanine metabolism using aromatic analogues as insecticides as novel 
strategy leading to disruption of Leishmania promastigotes development within 
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sand-fly insects and combat the spread on this lethal disease. Targeting L-
Tryptophan and L-Phenylalanine metabolism as preferential drug targets amongst 
the other amino acids utilised by Leishmania would also inhibit the enrichment of 
keto acids in the exometabolome, thereby preventing establishment of infection 
and strengthening the pro-inflammatory activities of the mammalian host system 
against parasite proliferation.
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Chapter 7 Discussion 
Leishmania promastigotes develop in the midgut of the sand-fly vector. Sand flies 
are known to feed on plant phloem, and derivatives of this such as aphid 
honeydew, rich in sugars and amino acids (Killickkendrick et al; 1990, Pimenta et 
al., 1992). During blood meal consumption by the sandfly, the transmission of 
parasites into the mammalian host causes a wide spectrum of clinical diseases 
associated with leishmaniasis. Increased incidence of leishmaniasis due to global 
warming, lack of vector control and emergence of resistance to current drugs have 
necessitated the discovery of novel drug targets (Tiuman et al., 2011, Murray et 
al., 2005). Perturbations in the nutrient transporters have been discussed as 
effective drug targets (Dean et al., 2014, Landfear, 2011).  
 
Identification of transport repertoires and characterisation of individual proteins 
has been greatly facilitated by the availability of whole genome sequences (Ivens 
et al., 2005). Transporters involved in purines (LdNT1/LdNT2/ LdNT3/ LdNT4, 
LmaNT1/LmaNT2/LmaNT3/LmaNT4)(Carter et al., 2001, Ortiz et al., 2010), 
hexoses (LmxGT1, LmxGT2, LmxGT3), iron (LIT1), polyamines (LmaPOT1) and 
amino acids transportation (LdAAP3/LdAAP7/LdAAP24) (Shaked-Mishan et al., 
2006, Inbar et al., 2012, Inbar et al., 2013) have been validated as drug targets 
based on essentiality for the viability of the parasite, functional expression under 
different environmental conditions and subcellular localisation studies (Landfear, 
2011).  
 
However, the nutritional environment encountered by the parasites would vary 
depending on the feeding frequencies and the diet of the host system. It has been 
reported that only small percentage of transporter proteins are well characterised 
compared to the broad range of substrates encountered by the parasites during 
its developmental cycle within the diverse systems (Dean et al., 2014). This 
indicates that the parasites must have an adaptive metabolism with activation of 
the compensatory metabolic pathways under adverse nutrient conditions, often 
less emphasised. 
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In this study, efforts have been made to decipher the utilisation of multiple 
nutrients by Leishmania promastigotes using growth and high throughput 
metabolomics in defined medium. The known medium composition, developed 
with a minimalistic approach, enabled mapping of multiple nutrient requirements 
in an unbiased manner.  
 
Furthermore, special emphasis has been drawn to elucidate the importance of 
amino acids for viability, utilisation and metabolism unique to L. mexicana 
promastigotes. Better understanding about the nutrient requirements and 
metabolic differences of amino acid pathways within L. mexicana promastigotes 
from their mammalian hosts could accelerate the discovery of novel drug targets.  
 
7.1 Conclusions  
The first aim addressed in my PhD research was to develop serum and protein free 
defined medium for in vitro culture of L. mexicana promastigotes, the insect stage 
of the parasites. This aim was achieved firstly by systematic literature search of 
previous in vitro medium compositions with individual concentrations collated and 
compared as shown in Chapter 3. From a minimalistic approach, the Steiger 
medium (Steiger and Black, 1980) developed for L. donovani was chosen as 
starting point for optimising the growth conditions for L. mexicana promastigotes 
with and without individual components of the medium as shown in Chapter 3. 
Extensive experiments were carried out to optimise concentrations, especially for 
zinc and iron which at increasing concentrations were found to have toxic effects 
on the viability of the parasites.  Cofactors and metals tested at optimised 
concentrations ideal to support growth of L. mexicana promastigotes were 
included in the culture composition. Addition of cofactors such as folic acid, 
riboflavin, biopterin, lipoic Acid, biotin together metal salts of magnesium, 
calcium, zinc, iron, manganese and cobalt decreased the lag phase with improved 
doubling time and growth of L. mexicana promastigotes in Nayak medium as shown 
in Chapter 3 supporting growth in this defined media for continuous passages.  
 
The second aim of my PhD research project was to elucidate the requirements of 
amino acids in their order of importance for viability, growth and development of 
parasites using various biochemical assays. It is known that amino acids are 
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classified as essential and non-essential amino acids primarily based on the 
requirements of mammalian species (Reeds, 2000). Earliest study of amino acids 
essentiality in parasitic protozoa was reported on studies in lizard parasite L. 
tertentole (Krassner and Flory, 1971) adapted in other protozoa. In this study 
human infecting L. mexicana promastigotes were cultured in single amino acid 
knock out media and found that exogenous source of L-Tryptophan, L-
Phenylalanine, L-Lysine, L-Arginine, L-Leucine and L-Valine as most critical for 
the viability of parasites as shown in Chapter 4 under identical conditions of 
starting inoculum, temperature and pH. 
The amino acids were also evaluated as relative contribution to growth doubling 
time, protein synthesis and energy quantification determined by acetate 
overflow. Owing to Leishmania unique acetate succinate CoA transferase (ACST) 
enzyme, amino acids contributution to acetate production was also evaluated. 
Acetate overflow is an indirect measure of energy generation in the form of ATP, 
as a bypass of the extensive oxidative phosphorylation for majority of energy 
generation not found in mammalian systems. Based on these results for L. 
mexicana promastigotes as shown in Chapter 4, exogenous supply of L-Aspartate, 
L-Glutamate, L-Glutamine and L-serine significantly promoted growth and 
exogenous supply of L-Threonine, L-Histidine, L-Methionine and L-Isoleucine were 
found to increase total intracellular protein content; compared to its absence. 
 
The third aim of my PhD study was to identify Leishmania specific amino acid 
pathways which could serve as potential drug targets.  In this study, efforts have 
been made to highlight amino acids utilisation by unbiased metabolic mapping of 
amino acid metabolites by network mapping at structural, empirical and 
functional levels. Unlike mammals which follow an elaborate amino acid 
degradation pathway, results as shown in Chapter 5 indicate that amino acid 
utilisation in promastigotes follows a simpler degradation pathway involving a 
transamination and decarboxylation step. Examination of these individual 
reactions show that these pathways involved in high energy intermediates such as 
NADH production. It has been shown in fungal systems that a simpler amino acid 
degradation as an efficient pathway for NADH regeneration  compared to glucose 
metabolism (Hazelwood et al., 2008). This indicates that amino acids salvaged 
from the environment has a different metabolic route in parasite to mammals with 
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non-homologous enzymes that could potentially serve as better drug targets. 
Untargeted metabolomics data was also employed to build novel biosynthetic 
amino acid pathways which requires further validation. However, one of the main 
highlights of this study is to show compensatory metabolic processes that might 
be adapted by the parasite to support its own viability during changing nutritional 
dynamics of the host system. Understanding these complex biochemical 
compensatory processes becomes imperative for validation of drug targets. 
 Furthermore, untargeted metabolomics of the culture supernatant across 
multiple time points as shown in Chapter 6 allowed for classification of amino 
acids with L-Tryptophan, L-Aspartate, L-Glutamate, L-Arginine, L-Methionine and 
L-Serine as continuously utilised amino acids; L-Leucine, L-Threonine, L-Valine, L-
Phenylalanine, L-Tyrosine and L-Lysine as partially utilised amino acids and L-
Glycine, L-Glutamine, L-Aspargine, L-Proline and L-Alanine as continuously 
secreted amino acids as observed based on their depletion profile of the exo-
metabolome data throughout the growth cycle of L. mexicana promastigotes in 
defined medium. Also, the exometabolome of L. mexicana promastigotes showed 
enrichment of amino acid derived alpha keto acids secreted into the extracellular 
system.  These results highlight the ability of keto acids, especially the aromatic 
pyruvates to chemically interchange to enol lactones; which are known to 
scavenge reactive oxygen species, nitric oxide suppression released by activated 
macrophages as shown in Chapter 6. Hence, unravelling a novel role of amino acids 
utilisation in supporting early steps of infection and thereby, establishment of 
parasitism with host cells. 
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Figure 7.1 Pictorial summary to demonstrate amino acid utilisation in the order of 
importance for viability, growth and development of Leishmania promastigotes supporting 
establishment of infection with macrophage host cells. 
(All amino acids specified using their three letter abbreviation with exogenous 
supply of amino acids critical for viability are shown in blue circles, (Trp, Phe, 
Lys, Arg, Leu and Val) Orange circles denotes those required for increased growth 
rate (Asp, Glu, Gln, Ser) Green circles denotes those required for increased 
protein production (Thr, Met, His, Ile) Pink circles denotes those secreted (Ala, 
Pro, Gly, Asn) and Red stars denotes those continuously utilised throughout the 
growth period from procyclics to metacyclics). 
                            
The main findings from this study summarised as follows: 
 
• In chapter 3, progressive steps followed for the development and 
establishment of defined medium of L. mexicana promastigotes has been 
elaborated. Chemically defined medium for in vitro culture allows 
extensive scientific investigations in controlled environment, especially for 
antigen isolation for vaccine development, metabolomics, drug therapies 
and design of novel experimental protocols.  
• Elucidation of the nutritional requirements of the parasite by growth 
analysis in media with and without each individual component in chapter 3 
highlights the essentiality of specific co factors and metal ions with data on 
concentration dependent effect on proliferation. Inhibitors of specific co 
factors (Biopterin) and metal transport (magnesium and calcium) have been 
shown as detrimental for the viability of the parasite. Hence, these data 
could serve useful for vector control strategies especially for sandfly 
breeding infected areas.  
• In Chapter 4, comparative utilisation amongst the 20 proteogenic amino 
acids on the viability and growth of L. mexicana promastigotes has been 
Critical for viability 
Increased growth rate 
Increased protein production 
Secreted  
Continuously utilised  
Enol lactones  
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reported. For the first time, individual amino acids have been analysed to 
determine their order of importance by growth analysis. These results of 
the growth analysis from the single amino acid knockout media were 
validated by protein and energy quantification; in turn paved way for new 
type of classification of amino acids based on utilisation. 
• Metabolic network mapping using intracellular metabolomics data showed 
a unique amino acid metabolism pattern in L. mexicana promastigotes with 
a two-step process undergoing transamination and unusual decarboxylation 
step leading to generation of high energy intermediates such as NADH 
shown schematically in Chapter 5. Using bioinformatics analysis, the 
enzyme commission number (EC number) compared between mammalian 
and parasite species indicated that the enzymes responsible for 
decarboxylation step are unique parasite specific enzymes that could 
potentially serve as drug targets. 
• In Chapter 6, time resolved metabolic foot-printing of defined medium 
throughout the growth cycle of L. mexicana promastigotes provided novel 
information about nutrients utilised from the extracellular medium without 
interference from serum molecules. From this data, it was possible to 
categorically name amino acids as continuously utilised, partially utilised 
or continuously secreted based on their nature of depletion during growth 
of the parasites in the medium. 
• Further investigation of the exo-metabolome in Chapter 6 showed that most 
small molecules secreted by the promastigotes derived from amino acids 
were metabolic end products with common chemical structure that 
belonged to the class of enol lactones. Using pure compounds as control 
samples, experiments were carried out to investigate whether the exo-
metabolome played a role during infection with host cells. Results confirm 
that small molecules of the exo metabolome, especially the aromatic 
pyruvates have ROS scavenging and reducing activity, leading to anti-
inflammatory environment. Thus, indicating a novel role of amino acid 
utilisation by Leishmania in establishment of infection with host cells and 
to support parasitism. 
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 7.2 Future directions 
 
This study highlights that aromatic amino acids L-Tryptophan and   L-Phenylalanine 
have been found as most important amongst other amino acids for the viability, 
growth and establishment of parasitism in L. mexicana promastigotes by evading 
host immune responses and supporting infection within host cells. Future work is 
required with targeted molecular biology approaches to characterise the transport 
of these aromatic amino acids. Inhibitors for enzymes involved in unique 
decarboxylation step during indole pyruvate and phenylpyruvate formation in 
Leishmania is proposed as suitable for drugs as it is different from mammals. For 
example, selected amino acids analogues, especially of L-Tryptophan and L-
Phenylalanine tagged with nanoparticles could be useful for targeted studies 
within insect vectors to investigate their effectiveness against parasite growth 
(Mitchison and Wilcox 1973, Tiuman et al., 2011). 
 
 Also, quantitative data on infection biomarkers and validation of the exploratory 
biomarker profile gained from the implementation of complementary 
metabolomics platforms could have tremendous implications for disease diagnosis 
(Saiki et al, 2013). In particular, amino acids profiling in defined medium could 
serve as gold standard platform for species comparison, strain identifications, 
mutant isolation studies, diagnostic tests and others. The knowledge gained from 
the metabolomics data in this study could also cater for improved predictions from 
stoichiometric models and genome scale reconstruction (Putri et al., 2013). It 
would be interesting to understand whether dose dependent inhibition of 
Leishmania exometabolome impacts host gene expression and regulation of niche 
environment required for the acceleration of infection within the host system as 
shown in bacterial systems by Beloborodova et al, 2012. 
 
In summary, the results from this study demonstrate the advantages of defined 
media to gain new insights on nutrients utilisation in L. mexicana promastigotes. 
Growth analysis of individual nutrients under different conditions; with and 
without individual components was used for the development and establishment 
of defined minimal medium for in vitro culture of L. mexicana promastigotes. 
Cofactors and metal ions were found to exhibit positive growth effect only under 
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optimal concentrations. From single omission of amino acid media, it was 
demonstrated that six critical amino acids as the most important exogenous 
sources amongst other amino acids required for the viability of the parasites. It 
was fascinating that the intracellular data showed putative metabolites that have 
been shown to build novel biosynthetic pathways which requires further validation 
as proof for compensatory activation during parasitic adaptation to diverse host 
nutrient systems.  
Thus, these results not only demonstrated the potential of intracellular 
metabolomics in the study of L. mexicana promastigotes but also the changes in 
time resolved metabolic foot-printing of defined medium, elucidating the 
constituents of the exometabolome useful for various purposes discussed above. 
New insights have been gained about the unique amino acid utilisation for the 
production of exometabolome; enriched in enol lactones that could cater for the 
establishment of parasitism within host cells. Finally, although the promastigotes 
life stage of the parasites precedes the clinically significant stage of infection in 
mammalian cells, the knowledge from this study facilitates designing better 
chemotherapy and novel drug targets within parasite specific amino acid 
metabolic pathways which is often less emphasised. 
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Appendices 
 
Appendix Table 1- Amino acid concentraions used for alamar blue assay as shown 
in Figure 4.5.  
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Appendix table 2- Amino acid analogues tested in 12 different concentrations with 
serial dilutions starting from 100 µM to 49 nM depicted as log of molar 
concentration described in Figure 4.13 
 
Appendix Figure 1- Raw spectral investigation of L-Histidine not detected in LC-
MS in the conditions used in the study.  
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Appendix Figure 2- Schematic representation of the software used for LC-MS data 
analysis.   
 
P_Id Mass RT FORMULA Putative metabolite 
p_cells 
1 
175.095
7 
13.4180
8 
C6H13N3O3 L-Citrulline 4.27 
2 
159.068
5 
5.61802
5 
C10H9NO Indole-3-acetaldehyde 3.67 
3 129.079 
11.5496
5 
C6H11NO2 L-Pipecolate 3.61 
4 
156.053
5 
10.3906
6 
C6H8N2O3 Imidazole lactate 3.38 
5 
138.042
9 
10.2204
9 
C6H6N2O2 Urocanate 4.16 
6 
131.069
4 
12.9381
6 
C4H9N3O2 Creatine 6.16 
7 
132.089
9 
18.0489
4 
C5H12N2O2 L-Ornithine 3.89 
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8 
173.080
1 
12.7505
1 
C6H11N3O3 
5-Guanidino-2-
oxopentanoate 
2.96 
9 
188.152
5 
17.7864
3 
C9H20N2O2 
N6,N6,N6-Trimethyl-L-
Lysine 
6.32 
10 
205.073
9 
7.33708
2 
C11H11NO3 Indolelactate 2.06 
11 
246.132
7 
18.2690
3 
C9H18N4O4 
N2-(D-1-Carboxyethyl)-
L-Arginine 
0.44 
12 
360.644
2 
15.6352
1 
C27H47N9O10S
2 
Trypanothione disulfide 4.85 
13 
188.116
1 
11.7009
4 
C8H16N2O3 N6-Acetyl-L-Lysine 2.27 
14 
103.099
7 
18.5094
5 
C5H13NO Choline 2.16 
15 
145.085
1 
13.2362
8 
C5H11N3O2 4-Guanidinobutanoate 0.60 
16 
89.0476
6 
12.9627
5 
C3H7NO2 L-Alanine 1.93 
17 145.074 
13.2228
8 
C6H11NO3 
[FA oxo,amino(6:0)] 3-
oxo-5S-amino-hexanoic 
acid 
0.58 
18 
130.110
6 
16.4605
6 
C6H14N2O N-Acetylputrescine 0.52 
19 
146.105
5 
19.2855 C6H14N2O2 D-Lysine 0.48 
20 
131.094
6 
10.7806
7 
C6H13NO2 L-Leucine 0.53 
21 
142.037
9 
11.4241
9 
C5H6N2O3 4-Imidazolone-5-acetate 0.53 
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22 
144.101
1 
20.7205
9 
C5H12N4O 4-Guanidinobutanamide 0.55 
23 
115.063
3 
11.7863
6 
C5H9NO2 L-Proline 0.67 
24 
177.078
9 
11.8964
2 
C10H11NO2 indole-3-glycol 0.59 
25 149.051 
10.9053
9 
C5H11NO2S L-Methionine 0.52 
26 237.086 
10.7859
1 
C9H19NO2S2 
8-
[(aminomethyl)sulfanyl]
-6-sulfanyloctanoic acid 
1.25 
27 
208.084
8 
10.5018
9 
C10H12N2O3 L-Kynurenine 0.60 
28 
119.058
3 
12.6587
1 
C4H9NO3 L-Threonine 0.55 
29 
219.110
7 
8.41133 C9H17NO5 Pantothenate 0.58 
30 
221.089
9 
11.2121
6 
C8H15NO6 N-Acetyl-D-glucosamine 0.61 
31 
155.069
5 
12.7654
8 
C6H9N3O2 L-Histidine 0.67 
32 
131.058
2 
13.0044 C5H9NO3 
L-Glutamate 5-
semialdehyde 
0.51 
33 
174.111
6 
20.6102
2 
C6H14N4O2 L-Arginine 0.53 
34 
236.079
5 
11.0494
5 
C11H12N2O4 L-Formylkynurenine 0.46 
35 
128.095
1 
16.4912
1 
C6H12N2O L-Lysine 1,6-lactam 0.69 
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36 
103.063
3 
11.9841
5 
C4H9NO2 N,N-Dimethylglycine 1.02 
37 
161.068
8 
13.1571
9 
C6H11NO4 O-Acetyl-L-homoserine 0.44 
38 
117.078
9 
11.5409 C5H11NO2 L-Valine 0.65 
39 
190.095
3 
19.2786
3 
C7H14N2O4 
LL-2,6-
Diaminoheptanedioate 
0.47 
40 
181.073
9 
11.8829
5 
C9H11NO3 L-Tyrosine 0.55 
41 165.079 
9.97961
7 
C9H11NO2 L-Phenylalanine 0.57 
42 126.043 
10.6689
4 
C5H6N2O2 Imidazole-4-acetate 0.97 
43 165.046 
11.8400
4 
C5H11NO3S L-Methionine S-oxide 0.52 
44 
132.053
5 
13.1217
3 
C4H8N2O3 L-Asparagine 0.59 
45 
160.084
8 
7.62405
2 
C6H12N2O3 
N-gamma-
Acetyldiaminobutyrate 
2.24 
46 
240.023
7 
13.3716
6 
C6H12N2O4S2 L-L-Cysteine 0.38 
47 
146.069
1 
13.0035
1 
C5H10N2O3 L-Glutamine 0.76 
48 
75.0320
1 
13.4997
5 
C2H5NO2 Glycine 0.68 
49 
204.089
9 
11.0723
2 
C11H12N2O2 L-Tryptophan 0.48 
50 
105.042
6 
13.4873
6 
C3H7NO3 L-Serine 0.39 
51 
174.079
3 
12.2729
8 
C10H10N2O Indole-3-acetamide 0.97 
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52 
147.053
1 
12.5122
9 
C5H9NO4 L-Glutamate 0.85 
53 
133.037
5 
12.7177 C4H7NO4 L-Aspartate 0.55 
54 
173.047
8 
4.91275
8 
C10H7NO2 indole-3-glyoxal 0.73 
55 
175.063
3 
7.36051 C10H9NO2 Indole-3-acetate 0.52 
56 
113.047
7 
7.41206
1 
C5H7NO2 
(S)-1-Pyrroline-5-
carboxylate 
0.82 
57 129.079 
7.30733 C6H11NO2 N4-Acetylaminobutanal 3.12 
58 
188.127
3 
19.0615
8 
C7H16N4O2 Homoarginine 3.84 
59 
145.157
9 
13.6049
2 
C7H19N3 Spermidine 1.01 
60 
307.083
5 
12.2260
1 
C10H17N3O6S Glutathione 3.98 
61 
216.110
9 
10.5716
2 
C9H16N2O4 
gamma-Glutamyl-
gamma-
aminobutyraldehyde 
3.98 
62 
250.062
3 
12.1383
7 
C8H14N2O5S 
gamma-L-Glutamyl-L-
cysteine 
3.46 
63 
169.085
1 
11.5219 C7H11N3O2 
N(pi)-Methyl-L-
Histidine 
3.15 
 
Appendix table 3 Table with metabolites in the intracellular samples enriched over 
time compared to naïve medium without cells. Metabolites in yellow are matched 
to authentic standards. Chemical formula in red are those with more than one 
isomeric peak. 
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Appendix table 3 Enzymes in aromatic amino acids metabolism compared between 
mammals and kinetoplastid species. Specified in blue are those enzymes with no 
homologues enzymes in mammals. 
Table 1 Enzymes involved in phenylalanine degradation pathway
EC Number Name Reaction NumberL.major   T.brucei   T.cruzi H.sapiens
1.11.1.7 Peroxidase R07443 PRDX6
1.13.11.27 4-hydroxyphenylpyruvate dioxygenaseR02521 HPD
1.14.16.1 Phenylalanine 4-monooxygenaseR07211 LmjF.28.1280 PAH
1.2.1.5 Aldehyde dehydrogenase (NAD(P)(+))R08307 ALDH3A1
1.4.3.2 L-amino-acid oxidaseR06124 IL41
1.4.3.21 Primary-amine oxidaseR06740 AOC2
1.4.3.4 Monoamine oxidaseR08348 MAOA
2.3.1.13 Glycine N-acyltransferaseR05841 GLYAT
2.6.1.1 Aspartate transaminaseR05052 LmjF.35.0820 Tb927.10.3660 GOT1
2.6.1.5 Tyrosine transaminaseR07396 LmjF.36.2360 Tc00.1047053510565.11TAT
4.1.1.28 Aromatic-L-amino-acid decarboxylaseR04909 DDC
5.3.2.1 Phenylpyruvate tautomeraseR03342 MIF
1.1.1.157 3-hydroxybutyryl-CoA dehydrogenaseR01976 NA
1.1.1.222 (R)-4-hydroxyphenyllactate dehydrogenaseR03339 NA
1.1.1.237 Hydroxyphenylpyruvate reductaseR03373 NA
1.1.1.90 Aryl-alcohol dehydrogenaseR05348 NA
1.13.11.16 3-carboxyethylcatechol 2,3-dioxygenaseR06788 NA
1.13.11.16 3-carboxyethylcatechol 2,3-dioxygenaseR06788 NA
1.13.12.9 Phenylalanine 2-monooxygenaseR00690 NA
1.14.12.19 3-phenylpropanoate dioxygenaseR06783 NA
1.14.12.19 3-phenylpropanoate dioxygenaseR06783 NA
1.14.13.- With NADH or NADPH as one donor, and incorporation of one atom of oxygen.R09353 NA
1.14.13.- With NADH or NADPH as one donor, and incorporation of one atom of oxygen.R09353 NA
1.14.13.- With NADH or NADPH as one donor, and incorporation of one atom of oxygen.R09353 NA
1.14.13.11 Trans-cinnamate 4-monooxygenaseR08815 NA
1.14.13.14 Trans-cinnamate 2-monooxygenaseR02254 NA
1.14.13.4 Melilotate 3-monooxygenaseR03369 NA
1.17.5.1 Phenylacetyl-CoA dehydrogenaseR07222 NA
1.2.1.10 Acetaldehyde dehydrogenase (acetylating)R01172 NA
1.2.1.39 Phenylacetaldehyde dehydrogenaseR02536 NA
1.2.1.58 Phenylglyoxylate dehydrogenase (acylating)R02450 NA
1.3.1.11 2-coumarate reductaseR03709 NA
1.3.1.31 2-enoate reductaseR02252 NA
1.4.1.20 Phenylalanine dehydrogenaseR00688 NA
1.4.99.1 D-amino-acid dehydrogenaseR07166 NA
1.5.1.18 Ephedrine dehydrogenaseR03614 NA
2.1.1.- Methyltransferases.R09371 LmjF.36.5360 Tb927.8.3130Tc00.1047053510515.130NA
2.1.1.- Methyltransferases.R09371 LmjF.36.5360 Tb927.8.3130Tc00.1047053510515.130NA
2.1.1.104 Caffeoyl-CoA O-methyltransferaseR06578 NA
2.3.1.- Transferring groups other than amino-acyl groups.R09258 LmjF.29.1310 Tb927.5.4330Tc00.1047053510351.90NA
2.3.1.14 Glutamine N-phenylacetyltransferaseR04776 NA
2.3.1.36 D-amino-acid N-acetyltransferaseR03903 NA
2.3.1.53 Phenylalanine N-acetyltransferaseR00693 NA
2.3.1.71 Glycine N-benzoyltransferaseR02452 NA
2.6.1.- Transaminases (aminotransferases).R09373 NA
2.6.1.21 D-amino-acid transaminaseR05053 NA
2.6.1.57 Aromatic-amino-acid transaminaseR07396 NA
2.6.1.58 Phenylalanine(histidine) transaminaseR09254 NA
2.6.1.9 Histidinol-phosphate transaminaseR03243 NA
3.1.2.- Thiolester hydrolases.R08273 NA
3.1.2.25 Phenylacetyl-CoA hydrolaseR07294 NA
3.5.1.32 Hippurate hydrolaseR01424 NA
3.5.1.4 Amidase R06134 NA
3.7.1.- In ketonic substances.R09238 NA
3.7.1.- In ketonic substances.R09238 NA
4.1.1.- Carboxy-lyases. R09208 LmjF.28.1580 NA
4.1.1.43 Phenylpyruvate decarboxylaseR01974 NA
4.1.1.53 Phenylalanine decarboxylaseR00699 NA
4.1.2.41 Vanillin synthase R05773 NA
4.1.3.39 4-hydroxy-2-oxovalerate aldolaseR05298 NA
4.2.1.101 Trans-feruloyl-CoA hydrataseR05772 NA
4.2.1.17 Enoyl-CoA hydrataseR08093 LmjF.32.3680 Tb927.3.4850Tc00.1047053511529.160NA
4.2.1.80 2-oxopent-4-enoate hydrataseR05864 NA
4.3.1.24 Phenylalanine ammonia-lyaseR06132 NA
4.3.1.25 Phenylalanine/tyrosine ammonia-lyaseR06132 NA
5.1.1.11 Phenylalanine racemase (ATP-hydrolyzing)R00686 NA
6.2.1.12 4-coumarate--CoA ligaseR06583 LmjF.19.1005 NA
6.2.1.30 Phenylacetate--CoA ligaseR02539 NA
GenBank accession number(s)
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plot<-read.csv('amino_acid_intermediates(recent analysis).xlsx') 
symbols(plot$Mass, plot$RT, circles=plot$p_cells) 
radius <- sqrt( plot$p_cells/ pi ) 
symbols(plot$Mass, plot$RT, circles=radius)symbols(plot$Mass, plot$RT, 
circles=radius, inches=0.35, fg="black", bg="yellow", xlab="Mass", ylab="RT") 
text(plot$Mass, plot$RT, plot$P_id, cex=1.0) 
 
Appendix code 1 R script written for data analysis and visualisation as shown in 
Figure 5.4 Bubble plot of all metabolites detected in the intracellular dataset 
 
data<-read.csv('inensity_time_course.csv') 
library(ropls) 
sample<-read.csv('sample.csv') 
group<-sample[,'Group'] 
data.plsda <- opls(data[-1], group) 
data.pca <- opls(data[-1]) 
plot(data.pca), typeVc = "x-score", 
parAsColFcVn = group, parEllipsesL = TRUE 
 
Appendix code 2 R script written for data analysis and visualisation as shown in 
Figure 6.2 PLS-DA model of exo-metabolome at six different time points during 
the growth of L. mexicana promastigotes cultured in Defined medium.  
 
inputdata <- read.csv("StatsTable3.csv", header=TRUE, 
row.names=1,stringsAsFactors=FALSE) 
inputdata <- read.csv("int", header=TRUE, row.names=1,stringsAsFactors=FALSE) 
inputdata <- read.csv("inensity_time_course.csv", header=TRUE, 
row.names=1,stringsAsFactors=FALSE) 
inputdata [is.na(inputdata)] <- 0 
colnames (inputdata) <- abbreviate(colnames(inputdata), minlength = 64) 
PeakTable <- inputdata[-c(1)] 
prelog_data <- inputdata 
prelog_data[prelog_data==0] <- 0.5*(min(PeakTable[PeakTable>0],na.rm=TRUE)) 
library (metabolomics) 
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log_data <- LogTransform(prelog_data, base = 2,saveoutput = FALSE, 
outputname = "log.results2") 
sampleclasses <- log_data$Group 
HeatMap(log_data$output, colramp = redgreen(75), scale = c("row"),dendrogram 
= c("none"),distmethod = "euclidean", aggmethod = "complete", margins = c(5, 8), 
key = TRUE, keysize = 1.5, cexRow = 2.0, ColSideColors = NULL) 
 
Appendix code 3 R script written for data exploration and visualisation Figure 5.4 
Bubble plot of all metabolites detected in the intracellular dataset 
 
A=importdata('bargraph.txt') 
Y = A(1:6,:); 
width = 0.25; 
figure 
bar3(Y,width) 
set(gca,'XTickLabel',{'metabolites names;},'FontSize',12)  
set(gca,'YTickLabel',{'Ctrl';'D1';'D2';'D3';'D6';'D9'}) 
title('Other DM components') 
 
Appendix code 4 Matlab script for data analysis and visualisation as shown in 
Figure 6.12 to Figure 6.21 
 
 
 
 
282 
 
 
Appendix figure 3 Isoleucine biosynthesis enzymes with positive results as verified 
using blast analysis from NCBI server.  
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0
8 
C6H1
4O8P
2 
1 
3,4-
epoxy-3-
methyl-1-
butyl 
diphosph
ate 
7 0 0 
704
20 
0
.
0
0 
22
.8
4 
53
.1
5 
54.
56 
13
2.6
3 
13
5.7
8 
13
2.
09 
1
8.
6
2 
C5H1
2N2
O2 
6 
L-
Ornithine 
8 
Amino 
Acid 
Metab
olism 
L-Arginine 
and L-
Proline 
metabolism
__D-L-
Arginine 
and D-
ornithine 
metabolism
__Glutathio
ne 
metabolism 
836
35 
1
.
0
0 
20
.6
7 
21
.9
2 
11.
04 
22.
57 
68.
56 
13
4.
02 
1
3.
2
8 
C4H6
O5 
4 
(S)-
Malate 
1
0 
Carboh
ydrate 
Metab
olism 
Citrate 
cycle (TCA 
cycle)__Glu
tamate 
metabolism
__Alanine 
and L-
Aspartate 
metabolism
__Pyruvate 
metabolism
__Glyoxylat
e and 
dicarboxyla
te 
308
313
4 
1
.
0
0 
19
.6
9 
36
.3
8 
62.
42 
27
6.8
1 
34
2.3
0 
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metabolism
__Carbon 
fixation__R
eductive 
carboxylate 
cycle (CO2 
fixation) 
13
3.
07 
1
2.
5
7 
C5H1
1NO
3 
4 
1-
deoxyxyl
onojirimy
cin 
7 0 0 
155
426 
1
.
0
0 
16
.5
9 
35
.3
5 
50.
00 
10
2.7
7 
11
7.9
2 
17
4.
02 
1
4.
1
7 
C6H6
O6 
3 
cis-
Aconitat
e 
1
0 
Carboh
ydrate 
Metab
olism 
Citrate 
cycle (TCA 
cycle)__Gly
oxylate and 
dicarboxyla
te 
metabolism
__C5-
Branched 
dibasic acid 
metabolism
__Reductiv
e 
carboxylate 
cycle (CO2 
fixation) 
148
120 
1
.
0
0 
10
.3
8 
34
.6
4 
91.
81 
21
9.8
1 
34
7.3
3 
13
0.
06 
4.
7
9 
C6H1
0O3 
1
8 
Ethyl 3-
oxobutan
oate 
7 0 0 
802
88 
1
.
0
0 
7.
56 
17
.6
0 
11.
31 
2.4
1 
6.1
1 
43
0.
16 
4.
1
8
9 
C23H
26O8 
4 
Sesartem
in 
5 0 0 
909
926 
1
.
0
0 
5.
77 
3.
46 
0.8
3 
0.6
9 
1.9
9 
25
6.
24 
3.
7
4 
C16H
32O2 
2
7 
Hexadeca
noic acid 
8 
Lipid 
Metab
olism 
Fatty acid 
biosynthesi
s__Fatty 
acid 
elongation 
in 
mitochondr
ia__Fatty 
acid 
metabolism
__Biosynth
esis of 
unsaturate
d fatty acids 
320
838
5 
1
.
0
0 
5.
22 
3.
14 
1.4
3 
0.7
6 
0.5
6 
39
4.
15 
1
0.
7 
C14H
26N4
O7S 
4 
Ala-Met-
Ser-Ser 
5 
Peptid
e(tetra
-) 
Hydrophobi
c peptide 
338
91 
0
.
0
0 
5.
11 
11
.2
5 
29.
82 
14
7.6
1 
21
5.2
8 
286 
 
17
3.
08 
1
3.
0
7 
C6H1
1N3
O3 
1 
5-
Guanidin
o-2-
oxopenta
noate 
8 
Amino 
Acid 
Metab
olism 
D-L-
Arginine 
and D-
ornithine 
metabolism 
538
852 
1
.
0
0 
3.
67 
2.
84 
2.0
1 
2.4
6 
3.8
1 
19
6.
06 
1
2.
4
9 
C6H1
2O7 
1
1 
L-
Gulonate 
6 
Carboh
ydrate 
Metab
olism 
Pentose 
and 
glucuronate 
interconver
sions__Asc
orbate and 
aldarate 
metabolism 
542
77 
1
.
0
0 
3.
43 
12
.3
8 
7.1
7 
17.
21 
24.
92 
22
8.
21 
3.
8
0
3 
C14H
28O2 
2
3 
Tetradec
anoic 
acid 
6 
Lipid 
Metab
olism 
Fatty acid 
biosynthesi
s 
108
547
9 
1
.
0
0 
3.
37 
4.
09 
1.1
1 
0.6
4 
0.3
1 
11
6.
01 
1
3.
2
8 
C4H4
O4 
3 
Fumarat
e 
8 
Carboh
ydrate 
Metab
olism 
Citrate 
cycle (TCA 
cycle)__Oxi
dative 
phosphoryl
ation__L-
Arginine 
and L-
Proline 
metabolism
__Glutamat
e 
metabolism
__Alanine 
and L-
Aspartate 
metabolism
__L-
Arginine 
and L-
Proline 
metabolism
__Tyrosine 
metabolism
__Phenylal
anine 
metabolism 
126
139 
1
.
0
0 
3.
34 
7.
38 
13.
44 
67.
63 
10
1.4
9 
32
5.
37 
7.
6
0
2 
C22H
47N  
1 
di-n-
Undecyla
mine 
7 0 0 
120
956
9 
1
.
0
0 
3.
07 
2.
13 
1.7
3 
0.9
2 
0.8
2 
20
6.
17 
4.
1
5
5 
C14H
22O 
6 
[PR] (+)-
15-nor-4-
thujopse
n-3-one 
7 
Lipids: 
Prenol
s 
Isoprenoids 
126
749 
1
.
0
0 
3.
03 
1.
25 
2.8
8 
1.9
1 
0.9
0 
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28
6.
1 
4.
9
4
2 
C12H
18N2
O4S 
1 
4-
Hydroxyt
olbutami
de 
7 0 0 
153
270 
1
.
0
0 
2.
87 
2.
99 
2.3
0 
0.5
8 
0.3
1 
11
8.
03 
1
2.
8
1 
C4H6
O4 
7 Succinate 
1
0 
Carboh
ydrate 
Metab
olism 
Citrate 
cycle (TCA 
cycle)__Oxi
dative 
phosphoryl
ation__Glut
amate 
metabolism
__Alanine 
and L-
Aspartate 
metabolism
__Tyrosine 
metabolism
__Phenylal
anine 
metabolism
__gamma-
Hexachloro
cyclohexan
e 
degradatio
n__Glyoxyl
ate and 
dicarboxyla
te 
metabolism 
652
279
9 
1
.
0
0 
2.
34 
6.
41 
28.
97 
23
0.3
9 
27
0.3
5 
74
.0
37 
8.
7
6
3 
C3H6
O2 
7 
(S)-
Lactaldeh
yde 
8 
Carboh
ydrate 
Metab
olism 
Fructose 
and 
mannose 
metabolism
__Pyruvate 
metabolism 
176
117 
1
.
0
0 
2.
31 
5.
65 
12.
34 
34.
28 
36.
82 
45
9.
26 
4.
0
6
1 
C26H
37N
O6 
1 
Militarino
ne A 
5 0 0 
276
821 
1
.
0
0 
2.
14 
0.
14 
3.9
2 
3.6
1 
0.2
4 
19
2.
03 
1
4.
3
4 
C6H8
O7 
1
2 
Citrate 8 
Carboh
ydrate 
Metab
olism 
Citrate 
cycle (TCA 
cycle)__Glu
tamate 
metabolism
__Alanine 
and L-
Aspartate 
metabolism
__Glyoxylat
e and 
dicarboxyla
te 
191
389
4 
1
.
0
0 
1.
90 
2.
67 
3.8
1 
4.2
2 
4.0
1 
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metabolism
__Reductiv
e 
carboxylate 
cycle (CO2 
fixation) 
11
1.
04 
1
1.
2
5 
C4H5
N3O 
1 Cytosine 
1
0 
Nucleo
tide 
Metab
olism 
Pyrimidine 
metabolism 
684
5 
0
.
0
0 
1.
89 
8.
08 
6.3
5 
27.
91 
14
1.1
4 
17
6.
05 
8.
5
8
5 
C4H8
N4O
4 
1 
Allantoat
e 
6 
Nucleo
tide 
Metab
olism 
Purine 
metabolism 
670
058 
1
.
0
0 
1.
86 
2.
04 
2.6
5 
3.4
0 
2.4
1 
18
9.
04 
7.
5
2
6 
C10H
7NO
3 
6 
Kynurena
te 
6 
Amino 
Acid 
Metab
olism 
L-
Tryptophan 
metabolism 
141
76 
1
.
0
0 
1.
76 
3.
50 
5.5
5 
38.
33 
77.
26 
13
6.
07 
1
0.
4
5 
C5H1
2O4 
2 D-Apiitol 7 0 0 
778
58 
1
.
0
0 
1.
60 
1.
90 
1.1
5 
0.5
4 
2.6
5 
11
3.
08 
5.
9
6
8 
C6H1
1NO 
1 
epsilon-
Caprolact
am 
5
.
5 
Xenobi
otics 
Biodeg
radatio
n and 
Metab
olism 
Caprolacta
m 
degradatio
n 
325
476 
1
.
0
0 
1.
47 
0.
89 
1.1
6 
1.0
6 
0.5
2 
16
5.
08 
1
0.
3
8 
C9H1
1NO
2 
7 
L-
Phenylal
anine 
1
0 
Amino 
Acid 
Metab
olism 
Phenylalani
ne 
metabolism
__Phenylal
anine, L-
Tyrosine 
and L-
Tryptophan 
biosynthesi
s__Phenylp
ropanoid 
biosynthesi
s__Alkaloid 
biosynthesi
s II 
148
902
7 
1
.
0
0 
1.
44 
1.
30 
0.7
6 
0.7
7 
0.8
0 
19
3.
07 
7.
5
4
9 
C10H
11N
O3 
1
0 
5,6-
Dihydrox
y-3-
methyl-2-
oxo-
1,2,5,6-
tetrahydr
oquinolin
e 
5 0 
3-
methylquin
oline 
degradatio
n 
180
826
7 
1
.
0
0 
1.
41 
1.
38 
1.8
4 
2.1
0 
2.6
7 
289 
 
32
9.
18 
5.
7
3
3 
C16H
27N
O6 
1 Europine 5 0 0 
100
583 
1
.
0
0 
1.
34 
1.
51 
0.3
0 
0.4
8 
3.9
4 
10
0.
05 
7.
5
2
2 
C5H8
O2 
1
8 
Tiglic acid 5 
Lipids: 
Fatty 
Acyls 
Fatty Acids 
and 
Conjugates 
156
424 
1
.
0
0 
1.
26 
5.
09 
22.
57 
86.
64 
74.
68 
13
6.
05 
4.
9
3
4 
C8H8
O2 
1
6 
4-
Hydroxyp
henylacet
aldehyde 
8 
Amino 
Acid 
Metab
olism 
Tyrosine 
metabolism
__Alkaloid 
biosynthesi
s I 
479
641 
1
.
0
0 
1.
25 
1.
01 
1.1
3 
1.5
0 
1.6
4 
25
0.
06 
8.
4
5
7 
C8H1
4N2
O5S 
2 Glu-Cys 7 
Peptid
e(di-) 
Acidic 
peptide 
392
820 
1
.
0
0 
1.
25 
1.
39 
1.5
4 
1.6
1 
1.0
5 
29
4.
18 
3.
8
6 
C17H
26O4 
3 
[6]-
Gingerol 
5 0 0 
163
936 
1
.
0
0 
1.
20 
1.
41 
1.1
4 
0.8
4 
0.3
5 
18
2.
08 
1
2.
8
3 
C6H1
4O6 
6 
D-
Sorbitol 
6 
Carboh
ydrate 
Metab
olism 
Fructose 
and 
mannose 
metabolism
__Galactos
e 
metabolism 
675
03 
1
.
0
0 
1.
17 
2.
32 
1.1
0 
5.9
9 
20.
72 
28
9.
12 
9.
7
2
6 
C29H
34N6
O5S 
1 
Met-Trp-
Trp-Gly 
7 
Peptid
e(tetra
-) 
Hydrophobi
c peptide 
219
750 
1
.
0
0 
1.
16 
1.
92 
2.7
6 
2.6
6 
2.6
8 
19
3.
07 
4.
9
8
7 
C10H
11N
O3 
1
0 
Cichorine 7 0 0 
413
715 
1
.
0
0 
1.
14 
1.
00 
1.0
9 
0.9
4 
1.0
9 
89
.0
48 
1
3.
2
9 
C3H7
NO2 
9 L-Alanine 
1
0 
Amino 
Acid 
Metab
olism 
Alanine and 
L-Aspartate 
metabolism
__Cysteine 
metabolism
__Taurine 
and 
hypotaurin
e 
metabolism
__Selenoa
mino acid 
metabolism
__D-
Alanine 
metabolism
__Carbon 
fixation__R
280
621
8 
1
.
0
0 
1.
12 
1.
61 
2.5
4 
5.5
5 
6.0
4 
290 
 
eductive 
carboxylate 
cycle (CO2 
fixation) 
38
5.
19 
1
1.
2
6 
C22H
27N
O5 
1 
O-
methylan
drocymbi
ne 
7 
Biosynt
hesis 
of 
Second
ary 
Metab
olites 
colchicine 
biosynthesi
s 
902
59 
1
.
0
0 
1.
11 
0.
92 
1.4
8 
2.3
0 
2.7
7 
79
.9
66 
1
2.
8 
[PO3
]3- 
1 
Phosphit
e 
5 0 0 
821
16 
1
.
0
0 
1.
11 
1.
71 
1.2
7 
0.4
3 
2.9
8 
81
.9
82 
1
2.
8
1 
H3O
3P 
1 
Phospho
nate 
7 0 0 
524
381 
1
.
0
0 
1.
10 
1.
54 
1.1
1 
0.5
6 
2.7
5 
16
4.
07 
7.
5
5
9 
C6H1
2O5 
2
5 
L-
Rhamnul
ose 
6 
Carboh
ydrate 
Metab
olism 
Fructose 
and 
mannose 
metabolism 
302
140 
1
.
0
0 
1.
08 
1.
06 
0.2
0 
0.4
7 
4.4
2 
11
6.
01 
1
1.
1
6 
C4H4
O4 
3 
Maleic 
acid 
8 
Carboh
ydrate 
Metab
olism 
Butanoate 
metabolism
__Nicotinat
e and 
nicotinamid
e 
metabolism 
170
705 
1
.
0
0 
1.
04 
1.
61 
1.6
0 
1.5
9 
0.4
6 
10
4.
01 
1
3.
1
9 
C3H4
O4 
3 
Malonat
e 
8 
Nucleo
tide 
Metab
olism 
Pyrimidine 
metabolism
__beta-
Alanine 
metabolism 
748
28 
1
.
0
0 
1.
00 
1.
53 
1.4
8 
3.3
6 
5.0
9 
24
4.
09 
9.
0
1
6 
C10H
16N2
O3S 
1 Biotin 8 
Metab
olism 
of 
Cofact
ors and 
Vitami
ns 
Biotin 
metabolism 
477
019 
1
.
0
0 
1.
00 
0.
76 
1.3
1 
1.6
8 
0.9
2 
18
0.
06 
1
6.
3
8 
C6H1
2O6 
5
7 
myo-
Inositol 
8 
Carboh
ydrate 
Metab
olism 
Inositol 
metabolism
__Galactos
e 
metabolism
__Ascorbat
e and 
aldarate 
metabolism
__Streptom
ycin 
biosynthesi
457
081 
1
.
0
0 
0.
98 
1.
12 
1.0
4 
1.3
1 
1.1
0 
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s__Inositol 
phosphate 
metabolism 
97
.9
67 
1
4.
3
7 
H2O
4S 
1 Sulfate 8 
Nucleo
tide 
Metab
olism 
Purine 
metabolism
__Cysteine 
metabolism
__Sulfur 
metabolism 
837
950 
1
.
0
0 
0.
96 
1.
23 
1.5
4 
1.7
8 
1.6
0 
88
.0
52 
7.
5
7
8 
C4H8
O2 
8 
Butanoic 
acid 
6 
Carboh
ydrate 
Metab
olism 
Butanoate 
metabolism 
354
951 
1
.
0
0 
0.
90 
1.
78 
2.9
3 
6.5
6 
7.5
4 
21
9.
11 
8.
9
0
4 
C9H1
7NO
5 
1 
Pantothe
nate 
1
0 
Amino 
Acid 
Metab
olism 
beta-
Alanine 
metabolism
__Pantothe
nate and 
CoA 
biosynthesi
s 
127
111
2 
1
.
0
0 
0.
89 
0.
65 
1.3
2 
1.3
5 
0.7
8 
14
5.
09 
1
3.
6
4 
C5H1
1N3
O2 
3 
4-
Guanidin
obutanoa
te 
8 
Amino 
Acid 
Metab
olism 
L-Arginine 
and L-
Proline 
metabolism 
444
22 
1
.
0
0 
0.
89 
1.
23 
1.3
3 
2.5
7 
3.0
6 
13
0.
03 
1
1.
0
4 
C5H6
O4 
7 
2,5-
Dioxopen
tanoate 
6 
Carboh
ydrate 
Metab
olism 
Ascorbate 
and 
aldarate 
metabolism
__L-
Arginine 
and L-
Proline 
metabolism 
192
938 
1
.
0
0 
0.
88 
1.
50 
1.6
9 
1.6
6 
0.5
9 
10
2.
07 
7.
5
3
2 
C5H1
0O2 
9 
Pentanoa
te 
7 
Lipids: 
Fatty 
Acyls 
Fatty Acids 
and 
Conjugates 
150
728 
1
.
0
0 
0.
88 
1.
91 
4.4
4 
12.
78 
13.
28 
17
7.
05 
7.
5
7
3 
C6H1
1NO
3S 
3 
N-
Formyl-L-
Methioni
ne 
8 
Amino 
Acid 
Metab
olism 
Methionine 
metabolism 
382
845 
1
.
0
0 
0.
88 
0.
38 
0.4
3 
0.9
5 
2.1
8 
38
1.
15 
1
2.
2
7 
C17H
23N3
O7 
3 
Phe-Thr-
Asp 
5 
Peptid
e(tri-) 
Hydrophobi
c peptide 
100
050 
1
.
0
0 
0.
87 
0.
70 
0.8
3 
1.4
0 
0.8
7 
21
8.
06 
1
2.
6
9 
C13H
21N6
O9P 
1 
(L-
Seryl)ade
nylate 
7 0 0 
120
92 
1
.
0
0 
0.
86 
5.
02 
1.2
5 
15.
24 
27.
76 
15
5.
07 
1
3.
5
3 
C6H9
N3O
2 
5 
3-
(Pyrazol-
1-yl)-L-
Alanine 
7 0 
beta-
pyrazole-1-
ylalanine 
734
849 
1
.
0
0 
0.
86 
0.
99 
1.1
5 
1.6
2 
1.6
6 
292 
 
biosynthesi
s 
18
1.
07 
1
2.
3
4 
C9H1
1NO
3 
1
1 
L-
Tyrosine 
1
0 
Amino 
Acid 
Metab
olism 
Tyrosine 
metabolism
__Phenylal
anine, L-
Tyrosine 
and L-
Tryptophan 
biosynthesi
s__Novobio
cin 
biosynthesi
s__Thiamin
e 
metabolism
__Phenylpr
opanoid 
biosynthesi
s__Alkaloid 
biosynthesi
s I 
166
260
1 
1
.
0
0 
0.
86 
0.
84 
0.9
0 
0.9
4 
0.9
3 
28
7.
1 
7.
7
4
4 
C12H
17N
O7 
1 Volkenin 5 0 0 
176
987 
1
.
0
0 
0.
85 
0.
94 
1.0
7 
1.7
8 
1.5
4 
20
0.
18 
3.
8
9
6 
C12H
24O2 
1
5 
Dodecan
oic acid 
8 
Lipid 
Metab
olism 
Fatty acid 
biosynthesi
s 
380
864 
1
.
0
0 
0.
85 
1.
45 
1.2
6 
0.8
9 
0.0
8 
11
5.
06 
1
2.
0
9 
C5H9
NO2 
4 L-Proline 
1
0 
Amino 
Acid 
Metab
olism 
L-Arginine 
and L-
Proline 
metabolism
__Novobioc
in 
biosynthesi
s 
413
160
36 
1
.
0
0 
0.
85 
0.
92 
1.0
9 
1.3
7 
1.3
9 
30
0.
1 
1
0.
4
5 
C17H
16O5 
4
8 
Farrerol 5 
Lipids: 
Polyket
ides 
Flavonoids 
111
310
4 
1
.
0
0 
0.
85 
0.
83 
0.9
3 
1.0
8 
0.9
6 
14
0.
98 
1
5.
8 
CH4
NO5
P 
1 
Carbamo
yl 
phosphat
e 
6 
Amino 
Acid 
Metab
olism 
L-Arginine 
and L-
Proline 
metabolism
__Purine 
metabolism
__Pyrimidin
e 
metabolism
__Glutamat
e 
metabolism
103
727 
1
.
0
0 
0.
84 
0.
71 
0.5
5 
0.6
1 
0.6
9 
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__Nitrogen 
metabolism 
11
6.
08 
4.
8
8
1 
C6H1
2O2 
2
4 
4-
Hydroxyh
exan-3-
one 
5 0 0 
332
290 
1
.
0
0 
0.
83 
1.
73 
1.6
2 
1.1
6 
0.2
2 
17
3.
14 
5.
6
1
1 
C9H1
9NO
2 
4 
[FA 
amino(9:
0)] 3R-
aminono
nanoic 
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Appendix table 6 metabolites in the exometabolome samples enriched over time 
compared to naïve medium without cells. Metabolites in yellow are matched to 
authentic standards. Chemical formula in red are those with more than one 
isomeric peak. 
 
 
 
 
